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Abstract 
Effects of plant sterols and olive oil phenols on serum lipoproteins in humans 
PhD thesis by Maud N. Vissers, Division of Human Nutrition and Epidemiology, 
Wageningen University, The Netherlands. October 23,2001. 
The studies described in this thesis investigated whether minor components from vegetable oils 
can improve health by decreasing cholesterol concentrations or oxidative modification of low-
density-lipoprotein (LDL) particles. 
The plant sterols (3-sitosterol and sitostanol are known to decrease cholesterol 
concentrations, but it is not clear whether other chemically related structures have similar 
effects. We examined the cholesterol-lowering effects of concentrates of p-sitosterol and 4,4'-
dimethylsterols from rice bran oil and triterpene alcohols from sheanut oil. Plant sterols from rice 
bran oil lowered serum LDL cholesterol by 9%. This was probably due to f5-sitosterol rather than 
the 4,4'-dimethylsterols. Triterpene alcohols did not affect serum cholesterol concentration. 
Oxidative modification of LDL is hypothesised to play a role in the development of 
atherosclerosis. Extra virgin olive oil contains phenols with antioxidant activity that could prevent 
oxidative modification of LDL. Three weeks of consumption of phenol-rich olive oil or a single 
dose of olive oil phenols did not decrease LDL oxidisability, neither in fasting plasma nor 
postprandial plasma samples. We showed that olive oil phenols reduce LDL oxidisability in 
vitro, but only in amounts that are much higher than can be reached by olive oil consumption in 
vivo. 
The first requirement for an in vivo action of a dietary antioxidant in humans is that it enters 
the blood circulation. We therefore studied the absorption and urinary excretion of olive oil 
phenols in humans. We found that apparent absorption of the ingested olive oil phenols was 
more than 55-66 mol%. Absorption was confirmed by the urinary excretion of at least 5 mol% 
tyrosol and hydroxytyrosol. A further requirement for a dietary antioxidant to prevent oxidative 
modification of LDL is that it becomes present in the circulation or in LDL in a form with 
antioxidant activity. In the body olive oil phenols are extensively metabolised. The antioxidant 
activity of these phenol metabolites is unknown. To determine the antioxidant activity of olive oil 
phenols in vivo future studies should focus on the antioxidant activity of the metabolites actually 
present in plasma rather than on the in vitro antioxidant activity of the phenols as present in the 
olive oil. 
In conclusion, although the olive oil phenols are well absorbed, the amount of phenols in 
olive oil and their consequent attainable plasma concentration in humans is probably too low to 
reduce LDL oxidisability. Furthermore, our studies provide no evidence that 4,4'-dimethylsterols 
from rice bran oil or triterpene alcohols from sheanut oil are able to decrease cholesterol 
concentrations. Thus, there are no indications that the minor components from vegetable oils 
described in this thesis have important effects on serum lipoproteins. 
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Introduction 
BACKGROUND 
Worldwide, cardiovascular diseases are the most common cause of death and a substantial 
source of chronic disability and health costs (Assmann etal, 1999). In the Netherlands coronary 
heart disease accounted for 38% of all cardiovascular diseases in 1997 (Konings-Dalstra & 
Reitsma, 1999). Coronary heart disease is characterised by insufficient blood supply to the 
heart muscle as a result of narrowed coronary arteries. The underlying cause is 
atherosclerosis; lipids accumulate in the artery and the artery vessel wall becomes enlarged 
and inflexible (atherogenic plaque). Risk factors for coronary heart disease include elevated 
LDL cholesterol concentrations, high blood pressure, obesity, diabetes, and lifestyle factors 
such as smoking and physical inactivity (Assmann ef al, 1999). The oxidisability of LDL may 
also play a role in the development of atherosclerosis (Diaz ef al, 1997; Steinberg et al, 1989). 
The studies described in this thesis focus on the cholesterol lowering effect of plant sterols and 
on the protective effects of olive oil phenols against LDL oxidation. 
This introduction provides background information on the chemistry of plant sterols and 
olive oil phenols and the current knowledge of their health effects. Finally, this introduction will 
describe the rationale and outline of this thesis. 
HEALTH EFFECTS AND CHEMISTRY OF PLANT STEROLS 
High LDL or total cholesterol concentrations are established risk factors for coronary heart 
disease. In the Netherlands 20-35% of adult population has a plasma total cholesterol 
concentration above 6.5 mmol/L (de Graaf & Stalenhoef, 2000). In people with a total 
cholesterol concentration above 6 mmol/L a decrease of 10% in total cholesterol has been 
predicted to reduce the risk of coronary heart disease by 10-50% (Kannel et al, 1986). 
Plant sterols or phytosterols are used as cholesterol-lowering agents in foods (Jones & 
Raeini-Sarjaz, 2001). The interest for plant sterols as cholesterol lowering agents already exists 
since the early 1950's. For a short period they were used in capsules to treat high blood 
cholesterol concentrations before the introduction of pharmacological agents with higher 
efficacy and patients acceptance. There has been renewed interest in plant sterols since the 
late 1980's with the development of food processing technologies whereby they can be 
incorporated into margarine and other food products (Lichtenstein & Deckelbaum, 2001). These 
products rich in plant sterols can be consumed as part of a cholesterol lowering diet. 
Sterols are essential constituents of cell membranes in animals and plants. Plant sterols 
are synthesised from squalene in plants and are structurally similar to cholesterol. Two types of 
plant sterols are the 4,4'-dimethylsterols like cycloartenol, intermediate products of plant sterol 
synthesis (Goodwin 1980), and the 4-desmethylsterols like p-sitosterol which are end products 
of plant sterol synthesis. Plant sterols can be converted into stands, such as sitostanol, by 
hydrogenation, but they hardly occur in nature (Figure 1.1). 
2. cycloartenol 3. p-sitosterol 4. sitostanol 
Figure 1.1 Structures of various types of sterols. Cholesterol (1) is the sterol of mammalian cells. Plant 
sterols are synthesised in plants. The intermediate products are the 4,4'-dimethy1sterols like cycloartenol (2), 
while 4-desmethylsterols, such as p-sitosterol (3), are the end products of plant sterol synthesis. Plant sterols 
can be converted into stanols, such as sitostanol (4). 
Plant sterols are naturally present in the diet, and (3-sitosteroi, campesterol, and stigmasterol 
are the most common ones. The main dietary sources are vegetable oils and margarine. Intake 
level of plant sterols is with 200-300 mg/day comparable to the usual intake of about 300 
mg/day of cholesterol. Intake of the stanols is much lower, about 30 mg/day (De Vries et al, 
1997; Normen etal, 2001). 
Plant sterols themselves are like cholesterol potentially atherogenic, but they are poorly 
absorbed which reduces their atherogenic potential. Cholesterol is absorbed in the body for 
40-50%, whereas p-sitosterol is absorbed for about 5%, campesterol for 15%, and sitostanol for 
less than 1% (Heinemann etal, 1993; Jones etal, 1997). 
A daily intake of 2 g of plant sterols has been shown to decrease total cholesterol 
concentrations by 9-14% (Law 2000). Plant sterols may decrease blood cholesterol 
concentrations by inhibiting cholesterol absorption via micelles in the intestine. Plant sterols 
competitively replace dietary and biliary cholesterol from the micelles. Instead of being 
absorbed, cholesterol is precipitated and excreted via the faeces. When cholesterol absorption 
is decreased, the hepatic cholesterol pool reduces, resulting in enhanced cholesterol synthesis 
by the liver. At the same time LDL receptors are up-regulated, which leads to lower LDL 
cholesterol concentrations in blood (Miettinen & Gylling, 1997). 
The cholesterol lowering effect of p-sitosterol and sitostanol has been well established 
(Miettinen etal, 1995; Weststrate & Meijer, 1998; Law 2000). However, it is not known if and to 
what extent other types of plants sterols reduce plasma cholesterol concentrations. 
HEALTH EFFECTS AND CHEMISTRY OF OLIVE OIL PHENOLS 
The Mediterranean diet, which is high in olive oil, fruits, vegetables, grains, and legumes and 
relatively low in meat, has been associated with a reduced incidence of coronary heart disease 
in epidemiological studies (Keys et al, 1986). Olive oil is the main source of fat in the 
Mediterranean area where it is consumed in relatively high amounts; the average daily intake is 
about 50 g/day in Italy, Greece, and Spain (Boskou 2000; Helsing 1995). Replacing dietary 
saturated fatty acids with monounsaturated oleic acid from olive oil decreases plasma LDL 
concentrations, which presumably contributes to the low incidence of coronary heart diseases 
(Katanefa/, 1995). 
However, not only a high concentration of LDL cholesterol, but also the oxidisability of LDL 
might increase the risk of coronary heart disease. The LDL-oxidation-hypothesis states that 
when LDL particles accumulate in the artery wall, they can undergo progressive oxidation. 
Oxidised LDL may recruit circulating monocytes which undergo modification into macrophages 
once in the intima of the arterial wall. Oxidised LDL can be internalised by macrophages by 
means of the scavenger receptors on the surfaces of these cells. The intemalisation of oxidised 
LDL leads to the accumulation of cholesterol esters in macrophages and these become so-
called foam cells. These foam cells are the start of atherogenic plaques (Figure 1.2) (Diaz et al, 
1997; Steinberg etal, 1989). Dietary antioxidants, such as vitamin E, may inhibit atherogenesis 
by reducing the oxidation of LDL and subsequently the accumulation of LDL in macrophages. 
(Steinberg 1991; Esterbauer etal, 1991; Princen etal, 1995). Phenols that are present in extra 
virgin olive oil are such antioxidants in vitro (Visioli & Galli, 1994; Visioli et al, 1995). As a 
consequence, olive oil may reduce the risk of atherosclerosis through the antioxidant activities 
of its phenols, besides the cholesterol lowering effect of monounsaturated oleic acids. However, 
the ability of olive oil phenols to decrease LDL oxidation in vivo still requires confirmation. 
Extra virgin olive oil has a high concentration of phenols due to the way olive oil is 
extracted: Olives are crushed to burst the fruit cells and to crush the kernel, resulting in an olive 
paste. The paste is then mixed with water, a process which is called malaxation, to promote the 
coalescing of small oil droplets into larger ones. This facilitates the separation of the oil and 
water phases. The final stage in the process, centrifugation of the oil, separates the water and 
the olive residue (Kiritsakis & Markakis, 1987). Because olive oil is obtained without using 
heating or solvents, the process is referred as 'cold pressing'. This cold press method enables 
extra virgin olive oil to retain the phenols. These phenols are responsible for the specific taste of 
olive oil (Visioli & Galli, 1998). On the other hand, refined olive oil does not contain phenols. 
During refining the oil is extracted by alkaline agents to reduce the excessive acidity of the oil 
and to get rid of the free fatty acids and metals. At the same time many phenols are lost. The 
following deodorisation step, when the oil is heated at 190-210°C for 1-3 hours, results in 
additional losses (Belitz & Grosch, 1987). 
monocytes 
wm
" °8oL £<9Q 
ENDOTHELIAL, 
CELLS i DC 
0, O 
o o o 
radicals ^jk ^ 
SUBENDOTHELIAL OX-LDL 
4 
SPACE macrophage foam eel 
Figure 1.2 LDL particles become trapped in an artery, where they can be oxidised. Oxidised LDL recruits 
circulating monocytes which become macrophages. Oxidised LDL is internalised by these macrophages. This 
leads to the accumulation of cholesterol esters in macrophages, which become so-called foam cells. These 
foam cells are the start of atherogenic plaques (Steinberg etal, 1989; Diaz etal, 1997). 
The most abundant phenols in extra virgin olive oil are the largely non-polar oleuropein- and 
ligstroside-aglycones and their derivatives. The aglycones are formed in olives by the 
enzymatic removal of glucose from the polar parent compound oleuropein-glycoside. The 
various derivatives of those aglycones differ mainly in their ring structure, which can either be 
open or closed in two different forms (Personal communication from Dr. S. van Boom). The end 
products of the hydrolysis of oleuropein- and ligstroside-aglycones are the polar compounds 
hydroxytyrosol and tyrosol, respectively (Figure 1.3). 
The antioxidant effect of the olive oil phenols has been observed in a number of in vitro and 
animal studies. However, it is not clear whether these phenols can also protect LDL from 
oxidation in humans. To date, studies in humans have been inconclusive (Nicolaiew etal, 1998; 
Ramirez-Tortosa etal, 1999; Bonanome etal, 2000; Visioli etal, 2000). 
To act as potential antioxidants in humans, the olive oil phenols have to be absorbed from 
the intestines, to pass the intestinal wall, and to enter the blood circulation. In other words, the 
phenols have to be bioavailable. Bioavailability can be defined as 'the fraction of the ingested 
nutrient that is utilised for normal physiological functions or storage' (Jackson 1997). Once 
entered to the blood circulation phenols are metabolised or transformed into other compounds 
(Williamson etal, 2000; Hollman & Katan, 1998; Manna etal, 2000). For antioxidant activity in 
the body and the potential to prevent oxidative modification of LDL, it is essential that these 
metabolites of ingested phenols retain their antioxidant activity in plasma. Thus, insight into the 
kinetics of phenol metabolism in humans is required to understand the potential health effects 
that olive oil phenols may have in humans. 
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Figure 1.3 Structures of oleuropein-glycoside and -aglycones, and their degradation into hydroxytyrosol 
(Personal communication from Dr. S. van Boom). Hydrolysis of ligstroside-glycoside into tyrosol is similar; only 
the hydroxyl group at carbon 3 of the benzene ring is absent. Oleuropein- and ligstroside-glycosides are 
mainly present in unripe olives, while their aglycones and tyrosol and hyxroxytyrosol are present in olive oil. 
RATIONALE AND OUTLINE OF THIS THESIS 
The studies described in this thesis were designed to investigate whether minor components 
from vegetable oils can improve health by decreasing cholesterol concentrations or by 
preventing oxidative modification of low-density-lipoprotein (LDL) particles. This objective was 
subdivided into three main questions: 
1. What is the effect of various plant sterols from rice bran oil and triterpene alcohols from 
sheanut oil on serum cholesterol concentrations in humans? 
Plant sterols are minor constituents in vegetable oils and are present in the unsaponifiable 
fraction. The most common plant sterols in the human diet are 4-desmethylsterols 
p-sitosterol, campesterol, and stigmasterol, and these are found in edible vegetable oils, 
such as corn, soybean and rapeseed oil. Beta-sitosterol can be converted by 
hydrogenation into a saturated counterpart sitostanol, which rarely occurs in nature. The 
cholesterol lowering effect of p-sitosterol and sitostanol has been well established 
(Miettinen era/, 1995; Weststrate & Meijer, 1998). Sterols with other structures, such as the 
4,4'-dimethylsterols, may vary in their potential to reduce plasma cholesterol 
concentrations. Chapter 2 describes a study on the effect of plant sterols from rice bran oil 
and triterpene alcohols from sheanut oil on serum cholesterol concentrations in humans. 
2. Do phenols from extra virgin olive oil decrease LDL oxidisability in humans? 
A high intake of olive oil has been proposed as an explanation for the low incidence of 
coronary heart disease in Mediterranean countries, but it is unclear whether olive oil offers 
specific benefits beyond a low saturated fat content. Olive oil phenols may dissolve into 
plasma LDL particles and protect them from becoming atherogenic by oxidative 
modification. In chapter 3 we investigated the effect on the susceptibility of LDL to oxidation 
and other markers of oxidation when healthy humans consumed phenol-rich extra virgin 
olive oil for three weeks. In chapter 4 we studied whether a single dose of olive phenols 
could decrease the postprandial susceptibility of LDL to oxidation. Chapter 5 describes an 
in vitro study designed to mimic the exposure of olive oil phenols in plasma to LDL in order 
to estimate the minimum plasma concentration of olive oil phenols needed to reduce 
oxidative modification of LDL. 
3. To what extent are olive oil phenols absorbed and how are they metabolised? 
The first requirement for a potential antioxidant in vivo is that it enters the blood circulation 
and that it retains its antioxidant capacity. Phenols are extensively metabolised in the 
human body (Williamson et al, 2000; Hollman & Katan, 1998; Manna et al, 2000). 
Therefore, the kinetics and metabolism of olive oil phenols is critical for our understanding 
of their potential as antioxidants in the human body. In chapter 6 we estimate the apparent 
absorption of the various phenols from extra virgin olive oil in healthy ileostomy subjects 
with a complete small intestine. We also determined urinary excretion of the phenols. As 
the ileostomy model does not take into account the influence of colonic bacteria in the 
metabolism of those phenols, we also determined the urinary excretion of tyrosol and 
hydroxytyrosol in subjects with a colon. 
Chapter 7 reviews the potential health effects of phenols from extra virgin olive oil, based on 
human and animal intervention trials. Chapter 8 presents the concluding remarks. 
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Effect of plant sterols from rice bran oil 
and triterpene alcohols from sheanut oil 
on serum lipoprotein concentrations 
in humans 
Maud N Vissers, Peter L Zock, Gert W Meijer, Martijn B Katan 
American Journal of Clinical Nutrition 2000;72:1510-1515 
ABSTRACT 
Background: Intake of unsaponifiable compounds from edible oils, such as plant sterols, can 
lower serum cholesterol concentrations in humans. However, little is known about effects of 
other chemically related unsaponifiables in edible oils, such as triterpene alcohols. 
Objective: We studied the effects of plant sterols from rice bran oil and triterpene alcohols from 
sheanut oil on cholesterol concentrations in healthy, normolipemic volunteers. 
Design: Twenty-eight men and 32 women consumed 29 g/d of 3 margarines for 3 wk each on 
a crossover double-blind basis. A margarine based on sunflower oil was used as the control. 
Concentrates of plant sterols from rice bran oil or triterpene alcohols from sheanut oil were 
added to make 2 experimental margarines with the same fatty acid composition as the control 
margarine. 
Results: Intake of 2.1 g plant sterols/d from rice bran oil decreased total cholesterol by 
0.19 mmol/L (95% CI, -0.31, -0.07 mmol/L) and LDL cholesterol by 0.20 mmol/L (95% CI, -0.30, 
-0.10 mmol/L). HDL cholesterol and triacylglycerol concentrations did not change significantly. 
Intake of 2.6 g triterpene alcohols/d from sheanut oil did not significantly affect lipoprotein 
concentrations in all subjects combined. 
Conclusion: We found that 2.1 g of plant sterols/d from rice bran oil lower serum total 
cholesterol by 5% and LDL cholesterol by 9% in normolipemic humans, whereas triterpene 
alcohols from sheanut oil did not significantly affect lipoprotein concentrations in all subjects 
combined. The effect of rice bran oil sterols is probably due to (3-sitosterol and other 
4-desmethylsterols and not to 4,4'-dimethylsterols. 
INTRODUCTION 
Plant sterols or phytosterols are minor constituents of vegetable oils present in the 
unsaponifiable fraction. Large doses of plant sterols inhibit cholesterol absorption in humans 
and cause a modest decrease in serum cholesterol concentration (Lees ef al, 1977; Pollak 
1985; Jones et al, 1997). The most common plant sterols in the human diet are the 
4-desmethylsterols p-sitosterol, campesterol, and stigmasterol, which are found in edible 
vegetable oils, such as corn, soybean and rapeseed (canola) oil. Like cholesterol, these plant 
sterols are unsaturated with a double bond at carbon 5 (Figure 2.1). Plant sterols can be 
converted into stands by hydrogenation: p-sitosterol is transformed into its saturated 
counterpart sitostanol. Stands rarely occur in nature. The cholesterol lowering effect of 
p-sitosterol and sitostanol has been well established (Miettinen ef al, 1995; Weststrate & Meijer, 
1998). Sterols with other structures may vary in their potential to reduce plasma cholesterol 
concentrations. 
Plant sterols are synthesised from squalene; one of the first intermediate products is 
cycloartenol, a 4,4'-dimethylsterol (Figure 2.1; Goodwin 1980). Rice bran oil contains these 
4,4'-dimethylsterols such as cycloartenol and 24-methylene cycloartanol as ferulic acid esters 
(oryzanol) (Rukmini & Raghuram, 1991). In addition rice bran oil contains a mixture of ferulic 
acid esters of 4-desmethylsterols, such as p-sitosterol and campesterol, which are the end 
products of plant sterol synthesis from squalene. The results of animal and some human 
studies suggest that rice bran oil may reduce plasma cholesterol concentrations (Raghuram & 
Rukmini, 1995; Sugano & Tsuji, 1997; de Deckere & Korver, 1996). 
Another class of unsaponifiables is the triterpene alcohols. Strictly speaking, triterpene 
alcohols are not plant sterols, but there are similarities in their structures (Figure 2.1). Sheanut 
oil contains approximately 8% unsaponifiable material, which is a mixture of fatty acid and 
cinnamic acid esters of such triterpene alcohols as oc-amyrine, butyrospermol, lupeol, and 
p-amyrine (Peers 1977). Little is known about the effect of sheanut oil on cholesterol 
concentrations (Weststrate & Meijer, 1998). 
We examined the effects of plant sterols from rice bran oil and triterpene alcohols from 
sheanut oil on serum lipoprotein concentrations in healthy humans in order to define the 
structural elements responsible for such effects. 
SUBJECTS AND METHODS 
Subjects 
Subjects were recruited via publicity in local newspapers and posters in university buildings and 
dormitories. We carefully explained the study protocol to the subjects before they gave their 
written informed consent. The study protocol was approved by the Medical Ethical Committee 
of Wageningen University. 
1. cholesterol 
25.CH3 
2. cycloartenol, 
a typical 4,4'-dimethylsterol 
3. p-sitosterol, 
a typical 4-desmethylsterol 
4. a-amyrin, 
a typical triterpene alcohol 
Figure 2.1 Structures of plant sterols and triterpene alcohols in rice bran oil and sheanut oil compared to the 
structure of cholesterol (1). Rice bran oil contains the 4,4'-dimethylsterols cycloartenol (2) and 24-methylene 
cycloartanol, and the 4-desmethylsterols p-sitosterol (3) and campesterol. Sheanut oil contains the triterpene 
alcohols a-amyrine (4), butyrospermol, lupeol and p-amyrine. In triterpene alcohols the cyclopentane ring 
specific for sterols is replaced by 2 cyclohexane rings. 
Subjects were eligible if they were >18 y of age, did not use drugs known to affect 
concentrations of serum lipoproteins, and were not pregnant, lactating, or following a prescribed 
diet. Volunteers filled out a medical questionnaire that was reviewed by an independent 
physician. Persons with a history of gastrointestinal, liver or kidney disease were excluded, as 
were those with glucosuria, proteinuria, anemia, or a serum concentration of total cholesterol 
>7.5 mmol/L or of fasting triacylglycerol >2.3 mmol/L. Thirty-two women and 28 men aged 
18-59 y were enrolled in the study. 
Design and treatment 
The 9-wk study was conducted on a multiple cross-over double-blind basis. Subjects consumed 
29 g/d of 3 margarines for 3 wk each. The subjects were stratified according to age and sex 
and then randomly allotted to 1 of the 6 possible treatment sequences. A commercially 
available diet margarine (Flora; Van den Bergh Foods, Purfleet, United Kingdom) was used as 
the control margarine and served as the base for preparing the 2 experimental margarines 
(Unilever Research Vlaardingen, the Netherlands). Concentrates of plant sterols from rice bran 
oil or triterpene alcohols from sheanut oil were added so that each margarine had the same 
fatty acid composition (Table 2.1). The margarines were provided in tubs that contained on 
average 28.9 g. The subjects consumed the contents of 1 tub over 1 d. They were not allowed 
to use the margarine for baking or frying; they usually consumed it as a spread on bread for 
breakfast, lunch and in-between meals or added it to prepared hot meals. The mean intake of 
total plant sterols (in free sterol equivalents) was 0.06 g/d from the control margarine, 2.1 g/d 
from the rice bran oil margarine, and 2.6 g/d from the sheanut oil margarine (as triterpene 
alcohols). 
Table 2.1 Compositions of the experimental margarines. 
Component 
Fat phase (fat + sterols + other esters) 
Total fatty acids 
Saturated 
Monounsaturated 
Polyunsaturated 
Total known plant sterols6 
4,4'-dimethylsterols 
Monomethylsterols 
4-desmethylsterols 
Triterpene alcohols6 
Other unknown sterol-related compounds 
Phenolic acids 
Ferulic acid 
Cinnamic acid 
Water phase 
Lithium chloridec 
Control 
70 
70 
16 
15 
40 
0.2 
<0.1 
<0.1 
0.2 
-
-
-
-
30 
997 
Rice brana 
%by wt 
82 
71 
14 
19 
38 
7.3 
3.4 
0.4 
3.5 
-
1.2 
2.9 
-
18 
859 
Sheanut3 
86 
75 
19 
20 
35 
0.4 
<0.1 
<0.1 
0.4 
8.9 
-
-
2.1 
14 
999 
3
 Mean of 3 batches. 
6
 Amounts as free sterol or triterpene alcohol equivalents. 
cumol/100g. 
The subjects were asked to maintain their usual diet and lifestyle. All subjects kept daily records 
of illness and deviations from the protocol and they returned empty margarine tubs. Ninety-six 
percent of the tubs were returned empty; diaries kept by the subjects and anonymous 
questionnaires administered after the trial showed that 99.5% of the scheduled amount of the 
control margarine, 97.3% of the rice bran oil margarine, and 99.1% of the sheanut oil margarine 
was consumed. To check adherence independently we added 285 umol lithium chloride to 
each 30 g margarine and determined plasma lithium concentrations (by inductively coupled 
plasma mass spectrometry, model Elan 6000 spectrometer; Perkin-Elmer Corp, Norwalk, CT). 
Mean plasma lithium concentration increased to 4.6 ± 1.3 umol/L which was about 5 times the 
baseline concentration of 0.9 ± 0.3 umol/L in similar subjects who did not consume added 
lithium chloride (de Roos etal, 2001). This confirmed adherence to the protocol. 
In each 3-wk period, intakes of energy, fatty acids and cholesterol were estimated by a 24-h 
recall. Intake was similar for each treatment, although cholesterol intake was slightly higher in 
the period in which the control margarine was consumed (Table 2.2). Body weights were 
measured on day 18 of each 3-wk period. Mean body weight did not differ significantly between 
treatments: 70.4 ± 9.4 kg with the control margarine, 70.2 ± 9.2 kg with the rice bran oil 
margarine, and 70.1 ±9.1 kg with the sheanut oil margarine. 
Table 2.2 Dietary intake of energy, fatty acids, and cholesterol of the subjects while on the 3 study 
margarines.3 
Energy 
MJ/d 
kcal/d 
Fat (% of energy) 
Saturated fatty acids 
Monounsaturated fatty acids 
Polyunsaturated fatty acids 
Cholesterol (mg/d) 
Control 
11.8 ±3.9" 
2820 ±941.6 
34.9 
12.1 
11.2 
9.2 
225.9 ±190.2 
Margarine 
Rice bran oil 
11.8±3.6 
2819 ±854.4 
35.2 
12.2 
11.4 
9.4 
188.6 ±125.5 
Sheanut oil 
11.4±3.7 
2719.8 ±870.5 
34.4 
12.1 
10.6 
9.5 
175.0 ±109.1 
3
 Each subject consumed each margarine for 3 wk in random order. Values are based on one 24-h recall per person in 
each 3-wk period, n = 60. 
"Mean±SD. 
Blood sampling 
Two venous blood samples were taken from subjects after an overnight fast at the end of each 
3-wk period, one on day 18 and another on day 21. Serum was obtained by centrifugation at 
1187 x g for 10 min at 4°C and stored at -80°C. Samples were analysed enzymatically for total 
and HDL cholesterol and triacylglycerol concentrations (Siedel et al, 1983; Wamick et al, 1982; 
Fossati & Prencipe, 1982). The mean bias for control samples provided by the Centers for 
Disease Control and Prevention in Atlanta was -1 % for total and HDL cholesterol and 10% for 
triacylglycerol. The within-run CV ranged from 0.5% to 1.1%. LDL cholesterol concentrations 
were calculated (Friedewald et al, 1972). For each subject the serum lipoprotein values of day 
18 and 21 of each period were averaged before statistical analysis. 
Margarine analyses 
The fatty acid compositions of the 3 margarines were analysed by methanolysis of the fatty 
acids in a sample of margarine extracted with a methanolic NaOH solution using boron 
trifluoride as catalyst. The methyl esters were extracted with hexane and analysed on a gas 
chromatograph (Hewlett Packard, Wilmington, DE) with a CP Wax 58 column (Chrompack, 
Middelburg, The Netherlands). Analysis of plant sterols and triterpene alcohols was done by 
saponifying the margarine with KOH and extracting the unsaponifiable part into 
diisopropylether. After extraction and derivation with 1% TMCS (trimethylsilyl chloride) in 
BSTFA [A/,0-£>/s(trimethylsilyl)trifluoroacetamide] and A/,A/-dimethylformamide, the fractions 
were analysed on a gas chromatograph (Hewlett Packard) by means of splitless injection with 
hydrogen as carrier gas. In the case of the 4,4'-dimethylsterols, the response factor compared 
with cholesterol was 0.87 on the basis of 5 concentrations of cycloartenol. For this reason, we 
also analysed the plant sterols by using on-column injection with hydrogen as carrier gas and 
with helium as carrier gas. The response factors were 0.91 for hydrogen and 0.98 for helium as 
carrier gas. We therefore used the data from the on-column injection with helium as carrier gas. 
Statistical analyses 
The data were analysed by two-factor, repeated-measures analysis of variance with interaction 
by using the general linear models (GLM) subprogram of SAS (SAS Institute Inc. 1989). 
Because the interaction between sex and margarine was significant for total and LDL 
cholesterol the analysis was also performed for men and women separately. Tukey's procedure 
was used for pair-wise comparisons of the margarines and for calculation of 95% CI's of the 
differences in plasma lipoprotein concentrations between 2 margarines. 
RESULTS 
All 60 subjects completed the study. None of the subjects used medications that could have 
affected the results. Three subjects became ill during the period in which they consumed the 
rice bran oil margarine. Excluding the data of these subjects from the analyses did not alter the 
results. We therefore present results of analyses that included all subjects. Because there was 
a significant interaction between sex and margarine for total cholesterol and LDL cholesterol, 
we also present the results of men and women separately. 
Serum lipids and lipoproteins 
In all subjects combined rice bran oil margarine decreased total cholesterol by 0.19 mmol/L 
(95% CI: -0.31, -0.07 mmol/L) and LDL cholesterol by 0.20 mmol/L (95% CI: -0.30, 
-0.10 mmol/L) compared with the control margarine (Table 2.3). Of the 60 subjects, 44 showed 
lower concentrations and 15 showed higher concentrations of LDL cholesterol with rice bran oil 
margarine than with control margarine (Figure 2.2) Rice bran oil margarine did not affect HDL 
cholesterol or triacylglycerol concentrations (Table 2.3). 
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Sheanut oil margarine did not affect total, LDL, or HDL cholesterol or triacylglycerol 
concentrations compared with the control margarine in all subjects combined (Table 2.3). 
Thirty-three subjects showed lower concentrations and 25 showed higher concentrations of 
LDL cholesterol with sheanut oil margarine than with the control margarine (Figure 2.2). In 
men, sheanut oil margarine decreased LDL cholesterol by 0.13 mmol/L (95% CI: -0.26, 
-0.01 mmol/L) and non-significantly decreased total cholesterol by 0.14 mmol/L (95% CI: -0.31, 
0.03 mmol/L) (Table 2.3). 
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Figure 2.2 Individual differences in serum LDL cholesterol concentration between the end of 3 wk 
consumption of experimental margarine (rice bran oil margarine or sheanut oil margarine) and the end of 3 wk 
consumption of control margarine. 
DISCUSSION 
The results of this study show that 2.1 g of plant sterols/d from rice bran oil lowers serum total 
cholesterol by 5% and LDL cholesterol by 9% in normolipemic subjects whereas triterpene 
alcohols from sheanut oil have no or much smaller effects. 
Earlier studies on rice bran oil could not disentangle the effects of the fatty acids from those 
of plant sterols (Suzuki & Oshima, 1970a; Suzuki & Oshima, 1970b; Raghuram et al, 1989; 
Lichtenstein et al, 1994). In these studies intake of rice bran oil sterols was 4-9 times lower than 
in our study, and these studies addressed the consumption of complete oils, not their plant 
sterols per se. One other study investigated the effects of concentrated rice bran oil sterols in 
humans and found - in contrast with our study - no significant effect on cholesterol 
concentrations in normo- and mildly hypercholesterolemic subjects (Weststrate & Meijer, 1998). 
Our study cannot directly answer the question whether 4,4'-dimethylsterols alone affect 
cholesterol concentrations; half of the plant sterols supplied by the rice bran oil margarine were 
4,4'-dimethylsterols (1.0 g/d) and half were 4-desmethylsterols (1.0 g/d, mainly (3-sitosterol and 
campesterol). The rice bran oil margarine in the study of Weststrate and Meijer, who found no 
effect on cholesterol concentrations, supplied mainly 4,4'-dimethylsterols such as cycloartenol 
and 24-methylene cycloartanol (1.1 g/d) and much less 4-desmethylsterols including 
p-sitosterol (0.5 g/d) (Weststrate & Meijer, 1998). This suggests that 4,4'-dimethylsterols may 
have no effect on cholesterol concentrations. Any effect of rice bran oil sterols is therefore 
probably due to 4-desmethylsterols. This notion is also supported by the studies of Hendriks ef 
al (1998) and Sierksma ef al (1999) in which 0.8 g of 4-desmethylsterols/d from soybean oil 
lowered cholesterol concentrations by 4.9% and 3.8% respectively. In our study 1.0 g of 4-
desmethylsterols/d decreased cholesterol concentrations by 5%, the same extent as observed 
in these 2 studies. Also in rats a combination of the 4,4'-dimethylsterol cycloartenol and the 4-
desmethylsterol p-sitosterol did not lower cholesterol concentrations more than did p-sitosterol 
alone (Ikeda ef al, 1985). Thus, any effect of rice bran oil sterols on cholesterol is probably due 
to the 4-desmethylsterols, with 4,4'-dimethylsterols having no or a much smaller effect. 
However, this issue can be settled only in a study that directly tests the effects of 4,4'-
dimethylsterols. 
Plant sterols probably decrease plasma cholesterol concentrations by inhibiting cholesterol 
absorption in the small intestine (Lees etal, 1977; Mattson et al, 1982; Miettinen & Vanhanen, 
1994; Gylling & Miettinen, 1994). The 4-desmethylsterol p-sitosterol and cholesterol are more 
similar in structure than are the 4,4'-dimethylsterols and cholesterol. The 4,4'-dimethylsterols 
have 2 extra methyl groups at carbon 4, a methyl group at carbon 14, and an extra cyclopropyl 
ring at carbons 9 and 10 compared with 4-desmethylsterols (Figure 2.1). Therefore, p-sitosterol 
may be more effective than are 4,4'-dimethylsterols in competing with cholesterol for 
incorporation in mixed micelles, which is the supposed mechanism for the cholesterol 
absorption-inhibiting action of plant sterols (Jones ef al, 1997). In addition, Heinemann ef al 
(1993) suggested that increasing the side chain substitution of cholesterol decreases its 
absorbability in humans. For example, p-sitosterol has a side chain substitution of an ethyl 
group compared to cholesterol (Figure 2.1) and is absorbed less than is cholesterol. 
Heinemann ef al (1993) also indicated an inverse relation between the absorbability of plant 
sterols and their efficiency in inhibiting cholesterol absorption. Compared with cholesterol the 
4,4'-dimethylsterol cycloartenol does not have a side chain substitution but has an additional 
double bond at carbon 24, and 24-methylene cycloartanol has a methylene group at carbon 24. 
Hence, these 4,4'-dimethylsterols might be more absorbable and therefore less effective in 
inhibiting cholesterol absorption than the 4-desmethylsterol p-sitosterol. No data are available in 
the literature with respect to the absorption of the 4,4'-dimethylsterols in humans. However, in 
rats the absorption rate of cycloartenol was 4-fold higher than that of p-sitosterol (Ikeda ef al, 
1985). Thus, the differential effects of 4-desmethylsterols and 4,4'-dimethylsterols on serum 
cholesterol concentrations may be explained by several structural differences. 
In our study, intakes of 4-desmethysterols and 4,4'-dimethylsterols were 5-10-fold higher 
than in a normal diet, and potential adverse effects of such relatively high intakes need to be 
considered carefully. In patients with homozygous sitosterolemia a high percentage of the 
4-desmethylsterol p-sitosterol is absorbed from the intestine; this is believed to account for the 
plant sterol accumulation in plasma and early atherosclerosis in such patients (Salen ef al, 
1992). Homozygous sitosterolemia is an extremely rare condition, but heterozygotes occur 
more frequently and such heterozygotes might theoretically hyperabsorb plant sterols. One 
study found that plasma plant sterol concentrations in heterozygous subjects were 2-3 times 
higher than in control subjects and 10-20 times lower than in homozygous subjects (Hidaka et 
al, 1990). Two other studies (Beaty et al, 1986; Salen et al, 1992) found normal plasma 
concentrations in heterozygous subjects. These data suggest that there is no reason to expect 
important adverse effects of foods rich in plant sterols in heterozygous subjects. Weststrate and 
Meijer (1998) showed that an intake of 1.5 g (J-sitosterol/d and 0.8 g campesterol/d compared 
to a control (<0.1 g/d) increased plasma p-sitosterol concentration from 3.3 to 4.6 mg/L and 
plasma campesterol concentration from 7.0 to 12.1 mg/L. These concentrations are within the 
range of normal values (Ling & Jones, 1995). Thus, adverse effects of high intakes of 
4-desmethylsterols such as p-sitosterol and campesterol seem unlikely, but long-term 
observational data are still desirable to confirm the safety of high intakes, especially for subjects 
who carry the sitosterolemia gene or genes. 
We did not analyse plasma plant sterol concentrations in our study, and we are not aware 
of other data with respect to the absorption of the 4,4'-dimethylsterols such as cycloartenol in 
humans. If cycloartenol is as highly absorbed in humans as in rats (Ikeda etal, 1985) it could be 
a reason to avoid fortification of food with rice bran sterols because these are rich in 
4,4'-dimethylsterols. 
Sheanut oil margarine did not significantly affect lipoprotein and triacylglycerol 
concentrations in all subjects combined. This is in line with the results of Weststrate and Meijer 
(1998). The unsaponifiables of sheanut oil consist of triterpene alcohols and minor amounts of 
4-desmethylsterols and 4,4'-dimethylsterols (Peers 1977). Like 4,4'-dimethylsterols, triterpene 
alcohols have 2 extra methyl groups at carbon 4 compared to 4-desmethylsterols. Also, in 
triterpene alcohols the cyclopentane ring specific for sterols is absent; instead triterpene 
alcohols have 2 cyclohexane rings (ring D; Figure 2.1). A sterol structure with a cyclopentane 
ring might be a minimum requirement for inhibiting cholesterol absorption in the intestine. This 
may explain why triterpene alcohols do not lower serum cholesterol concentrations. 
In our study, there was a significant interaction between sex and margarine for total and 
LDL cholesterol. Sheanut oil margarine slightly lowered total and LDL cholesterol 
concentrations in men but not in women. However, the sex-specific analyses were not planned 
a priori and the difference between men and women was not very large. Therefore, this finding 
may have been due to chance. Only one postmenopausal woman, aged 59 y, participated in 
our study and omitting her data did not change the conclusions (data not shown). Therefore our 
data refer to pre-menopausal women. 
Only normocholesterolemic subjects participated in our study, and we cannot answer the 
question of what the effect would have been in hypercholesterolemic subjects. If we calculated 
treatment effect for tertiles on the basis of the study entry value for total cholesterol 
concentration, the response in the lowest tertile (range 3.15-4.16 mmol/L) was -0.16 ± 0.3 
mmol/L, in the mid tertile (range 4.17-4.71 mmol/L) -0.32 ± 0.3 mmol/L, and in the highest tertile 
(range 4.74-7.32 mmol/L) -0.10 ± 0.5 mmol/L. There were no significant differences between 
tertiles. We therefore estimate that the effect of plant sterols from rice bran oil is similar in 
normo- and hypercholesterolemic subjects. However, this issue can be settled only in a study 
that directly tests the effect of plant sterols from rice bran oil in hypercholesterolemic subjects. 
In summary, plant sterols from rice bran oil lowered serum total and LDL cholesterol 
concentrations in normolipemic humans, whereas triterpene alcohols from sheanut oil did not 
affect the average cholesterol concentration in all subjects combined. The effect of rice bran oil 
sterols on serum cholesterol concentrations is probably due to the 4-desmethylsterol 
p-sitosterol and not to 4,4'-dimethylsterols such as cycloartenol and 24-methylene cycloartanol. 
Because rice bran oil contains mainly 4,4'-dimethylsterols and less 4-desmethylsterols, it might 
not be an efficient dietary source of cholesterol lowering plant sterols. 
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ABSTRACT 
Objective: We studied whether consumption of phenol-rich extra virgin olive oil affects the 
susceptibility of low density lipoprotein (LDL) to oxidation and other markers of oxidation in 
humans. 
Design: Randomised cross-over intervention trial, stratified according to sex, age, and energy 
intake. 
Setting: Division of Human Nutrition and Epidemiology, Wageningen University, The 
Netherlands. 
Subjects: Forty-six healthy men and women completed the study. 
Intervention: Subjects consumed two diets supplying 69 g/d of extra virgin olive oil either rich 
or poor in phenols for 3 wk each. The mean difference in phenol intake between the treatments 
was 18 mg/d. Vitamin E intake was low during the whole study. Fasting blood samples were 
taken twice at the end of each period. 
Results: Resistance of LDL and high density lipoprotein (HDL) to oxidation was not affected by 
treatment. The mean lag time of copper-induced formation of conjugated dienes was 1.6 min 
shorter in LDL and 0.4 min longer in HDL after the high phenol diet. Other markers of 
antioxidant capacity in plasma were also not affected: mean lipid hydroperoxides were 0.07 
umol/L higher, mean malondialdehydes were 0.001 umol/L higher, mean protein carbonyls 
were 0.001 nmol/mg protein lower, and the mean ferric reducing ability of plasma (FRAP) was 
0.006 mmol/L higher after the high phenol diet. All 95% confidence intervals enclosed zero. 
Serum cholesterol concentrations were not affected by the treatment. 
Conclusion: Consumption of 18 mg/d of phenols from extra virgin olive oil for 3 wk did not 
affect LDL or HDL oxidation or other markers of antioxidant capacity in fasting plasma samples. 
INTRODUCTION 
The Mediterranean diet, with olive oil as the major fat source, has been shown in 
epidemiological studies to be associated with a reduced incidence of coronary heart disease 
(Keys et al, 1986). The replacement of dietary saturated fatty acids with monounsaturated oleic 
acid from olive oil decreases plasma LDL concentrations, which presumably contributes to the 
low incidence of coronary heart diseases (Katan et al, 1995). It has also been suggested that a 
high-monounsaturated fat diet lowers the risk of coronary heart disease by producing oleic acid-
enriched LDL particles, which are more resistant to oxidative modification (Bonanome et al, 
1992; Reaven et al, 1991; Aviram & Eias, 1993). Oleic acid, however, may not be the only 
component of olive oil protecting LDL from oxidation; some types of extra virgin olive oil contain 
phenols with antioxidative properties. These phenols are formed during ripening of olives by 
hydrolysis of the parent compound oleuropein (Figure 3.1), and they are, in contrast to phenols 
from, for example, tea and wine, partly lipid-soluble. 
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Figure 3.1 Structures of various phenols and their degradation into tyrosol and hydroxytyrosol in olives and 
extra virgin olive oil. 
The oxidative modification hypothesis of atherosclerosis suggests that LDL particles are 
oxidatively modified and then taken up by macrophages inside the arterial wall. Such 
cholesterol-laden macrophages form the start of atherosclerotic plaques. Dietary antioxidants 
may therefore inhibit atherogenesis by inhibiting oxidation of LDL and accumulation of LDL in 
macrophages (Witztum & Steinberg, 1991). When olive oil is ingested, the lipid-soluble phenols 
are possibly taken up by LDL particles in plasma. Thus, these phenols may protect LDL 
particles from becoming atherogenic by oxidative modification. The aim of this study was to 
determine whether consumption of phenols from olive oil affects the susceptibility of LDL to 
oxidation and other markers of oxidation in normolipemic humans. 
SUBJECTS AND METHODS 
S u b j e c t s 
Subjects were recruited via publicity in local newspapers and posters in university buildings and 
student apartments. We carefully explained the study protocol before subjects gave their written 
informed consent. The study protocol was approved by the Medical Ethical Committee of the 
Division of Human Nutrition and Epidemiology of Wageningen University. 
Subjects were eligible if they were older than 17 years, did not use any drugs known to 
affect concentrations of serum lipids, were not pregnant, not lactating, and not on a prescribed 
diet. Volunteers filled out a medical questionnaire that was reviewed by an independent 
physician. Persons with a history of gastrointestinal, liver or kidney disease were excluded, as 
were those with glucosuria, proteinuria, anaemia, a serum concentration of total cholesterol 
>7.0 mmol/L, or fasting triglycerides >2.3 mmol/L, and serum values of liver enzymes >30 U/L 
for alanine aminotransferase (ALT), or >30 U/L for aspartate aminotransferase (AST). Thirty-
two women and 17 men, 18-58 y, were enrolled in the study. Three subjects withdrew during 
the study; one because of illness unrelated to the treatment, and two because of personal 
reasons. Forty-six subjects completed the study. None of the subjects used medications that 
could have affected the results. 
Design and treatment 
The study consisted of two 3-wk treatment periods, during which each subject consumed 2 
diets, one with phenol-rich extra virgin olive oil and one with phenol-poor extra virgin olive oil, in 
random order (cross-over). Before the study subjects were stratified according to sex, age, and 
energy intake and then randomly allocated to 1 of 2 sequence groups. During the 2 wk before 
the study (run-in) and 2 wk in-between the treatment periods (wash-out) subjects consumed 
diets without olives, olive oil and olive oil products. 
The high phenol olive oil was prepared from Tsunati olives with a high content of phenols. 
The low phenol olive oil was prepared from Koroneiki olives; most of the phenols were removed 
by washing with hot water. Vitamin E was added to the high phenol olive oil to obtain the same 
vitamin E content in both oils. The 2 olive oils had a similar fatty acid composition (data not 
shown). The phenol concentration in the experimental oils was determined as described by 
Montedoro era/(1993). The high phenol olive oil contained 308 mg/kg of phenols (mean intake 
21 mg/d), of which 2% was tyrosol, 1% was hydroxytyrosol, 72% were oleuropein-aglycones, 
and 25% were ligstroside-aglycones. The low phenol olive oil contained 43 mg/kg of phenols 
(mean intake 3 mg/d), of which 16% was tyrosol, 2% was hydroxytyrosol, 13% were 
oleuropein-aglycones, and 69% were ligstroside-aglycones. The mean difference in phenol 
intake between the high and low phenol diet was 18 mg/d. 
Before the trial, energy intake of individual subjects was estimated by a food frequency 
questionnaire (Feunekes et al, 1993). Each subject received the amount of olive oil that fulfilled 
energy needs. Energy intakes were subdivided into 4 levels, ranging from 7.5 to 17.5 MJ/d. The 
amount of olive oil per day varied from 55 g to 102 g, with a mean intake of 69 g. Forty percent 
of the daily oil was incorporated into a mayonnaise (78 w/w% olive oil), 30% was incorporated 
into sauces for hot meals, and 30% in cookies and raisin rolls baked by a local bakery. We 
recorded body weights twice weekly and adjusted the intake of olive oil when necessary so as 
to maintain a stable weight. Over the duration of the trial average body weight increased by 0.3 
± 0.9 kg (range -1.2 to 2.8 kg). Body weight did not differ between treatments; it was 68.0 ± 9.6 
kg on the high phenol diet, and 67.8 ± 9.5 kg on the low phenol diet. 
Each study diet was assigned a colour code that was used for labelling all foods supplied 
during the trial. In this way, subjects were blinded to the type and the sequence of the olive oils. 
On weekdays at noon, hot meals were served and eaten at the department in the presence of 
the researchers. These meals supplied at least 50% of the experimental olive oil. Foods that 
contained the remaining part of the olive oil were consumed at home. Foods containing the 
experimental olive oil were weighed or counted for each subject. During the whole study 
subjects followed instructions for a background diet low in vitamin E. A margarine with a low 
vitamin E content was supplied (Van den Bergh Foods, United Kingdom). Apart from this, 
subjects were asked to maintain their usual diet. During the study subjects were not allowed to 
take vitamin supplements or aspirin, which is a radical scavenger (Kuhn et al, 1995; Hermann 
et al, 1999). Therefore they were provided with acetaminophen (paracetamol). Subjects were 
asked to maintain their usual pattern of physical activity and not to change their smoking habits, 
consumption of coffee, or use of oral contraceptives. All subjects kept daily records of illness 
and deviations from the protocol. Diaries and anonymous questionnaires administered after the 
trial showed that consumption of experimental olive oil was 90% of the scheduled amount for 
the low phenol diet and 87% for the high phenol diet. To check adherence, we added 
6.8 umol/g of lithium chloride to the mayonnaise. The daily intake of lithium was 
190-360 umol/d, depending on the level of energy intake and consequently the amount of olive 
oil consumed per day. Mean plasma lithium concentrations after olive oil consumption was 
4.7 ± 1.3 umol/L, which was about 5 times the concentration of 0.9 ± 0.3 umol/L in similar 
subjects that did not consume added lithium chloride (De Roos et al, 2001). This confirmed 
adherence of the subjects to the protocol. 
Blood sampling 
Venous blood samples were taken twice after a 12-h fast at the end of each 3-wk period (days 
17 and 21). Plasma or serum was immediately obtained by low speed centrifugation and stored 
at -80°C. For the determination of the concentration of serum lipids, the liver enzymes, uric 
acid, and the ability of plasma to reduce iron (III) (FRAP), the 2 samples of each subject at the 
end of each period were analysed separately and the results were averaged before statistical 
analysis. For the determination of the susceptibility of LDL and HDL to oxidation, the 2 samples 
obtained at the end of each period were pooled before analytical analyses. For all other 
analyses, only the last samples obtained at the end of each period were used. 
Lipoprotein isolation 
Plasma lipoproteins were isolated by density gradients ultracentrifugation in a SW 41 Ti rotor 
(Beckman Instruments, Palo Alto, USA) for 24 h at 10°C (Redgrave et al, 1975). LDL was 
isolated in a density range of 1.019-1.063 g/mL, and HDL in a density range of 1.063-
1.210 g/mL. Density gradients solutions contained 0.1 mM Na2EDTA to inhibit metal ion 
catalysed LDL and HDL oxidation during the isolation procedure. 
Markers of oxidisability 
The susceptibility of LDL and HDL to copper-mediated oxidation was determined by monitoring 
the formation of conjugated dienes, essentially as described by Princen et al (1992). 
Malondialdehyde in plasma was determined as described by Wong et al (1987), except that the 
HPLC eluent was monitored using fluorescence detection. The excitation wavelength was 537 
nm and the emission wavelength was 554 nm. Lipid hydroperoxides in plasma were 
determined by the K-Assay LPO-CC kit (Kamiya Biomedical Company, Seattle, WA USA). 
Protein carbonyls in plasma were determined by an ELISA method as described by Buss et al 
(1997). The ability of plasma to reduce iron (III) (FRAP) was determined by the method of 
Benzie and Strain that measures the reduction of ferric to ferrous iron in the presence of 
antioxidants (Benzie & Strain, 1996). 
Vitamin and uric acid concentrations in serum 
The concentrations of lycopene, p-carotene, retinol, and oc-tocopherol in serum samples were 
determined by high performance liquid chromatography (HPLC, Waters Instruments, Milfoil, 
USA). Serum was deproteinised with ethanol-intemal standard solution (1:1 v/v) and extracted 
with hexane. A part of the hexane layer was evaporated after centrif ugation and reconstituted in 
the mobile phase. Samples to determine retinol and cc-tocopherol were injected into a Resolve 
C18-5 urn column (30 cm x 3.9 mm; Waters Instruments, Milfort, USA) with methanol/ 
dichloromethane/acetonitrile (10:20:70, v/v) as the mobile phase, with detection at 325 nm and 
292 nm, respectively. Samples to determine lycopene and p-carotene were injected into a 
Sperisorb 5 urn ODS-2 column (25 cm x 4.6 mm; Waters Instruments, Milfort, USA) with 
methanol/dichloromethane/acetonitrile (30:20:50, v/v) as the mobile phase, with detection at 
472 nm and 450 nm, respectively. Calibration was performed by a single standard solution on 
the same way as a salmple. Serum uric acid was determined by UA plus kit (Boehringer, 
Mannheim, Germany). 
Plasma lipids and liver enzymes 
Plasma lipids were analysed enzymatically (Siedel et al, 1983; Warnick et al, 1982; Fossati & 
Prencipe, 1982). Mean bias for control samples provided by the Centers of Disease Control in 
Atlanta was - 1 % for total and HDL cholesterol and 10% for triglycerides. The coefficient of 
variation within runs ranged from 0.5 to 1.1%. LDL cholesterol concentrations were calculated 
(Friedewald etal, 1972). Alanine and aspartate aminotransferase were measured at 37°C using 
Abbott Spectrum reagents (Bergmeyer et al, 1978). The mean bias for 'Monitrol' control sera 
(Baxter Dade, Switzerland) ranged from 0 to 2%. The coefficient of variation within runs ranged 
from 2 to 8%. 
Statistical analyses 
The data were analysed by ANOVA using the General Linear Models (GLM) of the Statistical 
Analyses System (SAS Institute Inc. 1989). The Tukey method was used for calculation of 95% 
confidence limits of the differences between the 2 diets. 
RESULTS 
Markers of oxidisability 
Resistance of LDL and HDL to copper-mediated oxidation and other markers of antioxidant 
capacity or oxidative processes were not affected by treatment (Table 3.1). The lag time of 
copper-induced formation of conjugated dienes was 1.6 min shorter in LDL and 0.4 min longer 
in HDL after the high phenol diet. Maximum rate of diene formation in LDL and HDL was similar 
after both treatments (Table 3.1). 
Other oxidation markers were also not affected. Plasma lipid hydroperoxides and 
malondialdehydes, both markers of lipid peroxidation, were respectively 0.07 and 0.001 umol/L 
higher after the high phenol diet. Protein carbonyls, a marker of protein oxidation in plasma, 
were 0.001 nmol/mg protein lower after the high phenol diet. The ferric reducing ability of 
plasma (FRAP), a marker for the antioxidant capacity of plasma, was 0.006 mmol/L higher after 
the high phenol diet. All 95% confidence intervals enclosed zero (Table 3.1). 
Vitamin and uric acid concentrations in serum 
Serum uric acid, lycopene, retinol, p-carotene, or a-tocopherol concentrations were not affected 
by the treatment (Table 3.2). The concentration of a-tocopherol in our subjects was 19.4 ± 
5.0 umol/L, which is relatively low compared to normal plasma vitamin E concentrations from 
11 to 37 umol/L (Cohn 1997). This can be explained by the low vitamin E content in the diet. 
This suggested adherence of the subjects to the protocol. 
Serum lipids and liver enzymes 
Mean total cholesterol concentration was 0.06 mmol/L lower (not significant) on the high phenol 
diet than on the low phenol diet. Concentrations of LDL, HDL, triglycerides, and the liver 
enzymes alanine and aspartate aminotransferase also did not differ between the high and low 
phenol diet (Table 3.3). 
Table 3.1 Oxidisability of LDL and HDL, and other markers of oxidation at the end of the high and the low 
phenol diet (n = 46). 
Low phenol High phenol 
diet diet 
Differences between high and 
low phenol diet 
(95% CI) 
LDL oxidisability3 
Lag time (min) 
Maximum rate 
(nmol dienes/min/mg LDL protein) 
HDL oxidisability 
Lag time (min) 
Maximum rate 
(nmol dienes/min/mg HDL protein) 
Malondialdehyde (umol/L) 
Lipid hydroperoxides (umol/L) 
Protein carbonyls (nmol/mg protein) 
Ferric Reducing Ability of Plasma 
(mmol/L) 
110.2 ±25.0 108.6 ±20.4 
12.0 ±2.6 11.8 ±2.3 
69.3 ±47.5 
4.6 ± 2.2 
0.68 ±0.15 
0.36 ± 0.52 
0.23 ±0.12 
1.05 ±0.18 
69.7 ± 50.5 
4.4 ± 2.2 
0.69 ±0.13 
0.44 ± 0.54 
0.23 ±0.12 
1.06 ±0.18 
-1.6 (-8.2, 5.0) 
-0.1 (-0.6, 0.4) 
0.4 (-12.8,13.5) 
-0.1 (-0.3, 0.03) 
0.001 (-0.03, 0.03) 
0.07 (-0.07, 0.21) 
-0.001 (-0.02, 0.02) 
0.006 (-0.01, 0.02) 
Values are means ± SD. Participants (15 men and 31 women) consumed both diets in random order for 3 wk each. 
an = 44 
Table 3.2 Serum concentration of uric acid, lycopene, p-carotene, retinol, and a-tocopherol at the end of 
the high and the low phenol diet (n = 46). 
Low phenol diet High phenol diet Differences between high and 
low phenol diet 
(95% CI) 
Uric acid (umol/L) 
Lycopene (umol/L)a 
P-carotene (umol/L)a 
Retinol (umol/L) 
a-tocopherol (umol/L) 
260.6 ±56.1 
0.59 ± 0.20 
0.54 ± 0.23 
2.51 ± 0.55 
19.77 ±4.58 
264.4 ± 58.0 
0.61 ±0.19 
0.52 ± 0.24 
2.47 ± 0.70 
18.97 ±5.37 
3.8 (-2.2, 9.8) 
0.01 (-0.05, 0.08) 
-0.02 (-0.08, 0.04) 
-0.04 (-0.2, 0.1) 
-0.8 (-2.1, 0.5) 
Values are means ± SD. Participants (15 men and 31 women) consumed both diets in random order for 3 wk each. 
an = 40 
Table 3.3 Serum lipid and lipoprotein cholesterol concentrations at the end of the high and the low phenol 
diet (n = 46). 
Lipoproteins (mmol/L) 
Total cholesterol3 
HDL cholesterol3 
LDL cholesterol3 
Triglycerides6 
Liver enzymes (U/L) 
Alanine aminotransferase 
Aspartate aminotransferase 
Low phenol diet 
4.25 ± 0.83 
1.54 ±0.36 
2.29 ± 0.65 
0.92 ± 0.35 
20.3 ± 7.0 
21.7 ±4.7 
High phenol diet 
4.19 ±0.76 
1.52 ±0.37 
2.26 ± 0.59 
0.90 ± 0.32 
20.7 ± 7.7 
21.8 ±5.1 
Differences between high and 
low phenol diet 
(95% CI) 
-0.06 (-0.15, 0.04) 
-0.01 (-0.06, 0.04) 
-0.04 (-0.12, 0.05) 
-0.02 (-0.08, 0.04) 
0.3 (-1.0,1.6) 
0.1 (-1.0,1.2) 
Values are means ± SD. Participants (15 men and 31 women) consumed both diets in random order for 3 wk each. 
a
 To convert to mg/dL, multiply by 38.67. 
" To convert to mg/dL, multiply by 88.54. 
DISCUSSION 
Our data show that consumption of 18 mg/d of phenols from olive oil for 3 wk does not affect in 
vitro susceptibility of LDL to oxidation or other markers of oxidation in fasting blood of healthy 
volunteers. 
Our results are in line with two other human studies that addressed the effect of minor 
components in olive oil on the susceptibility of LDL to oxidation in fasting blood (Nicolaiew et al, 
1998; Bonanome et al, 2000). In these studies, extra virgin olive oil versus high oleic acid 
sunflower oil or refined olive oil also did not affect the in vitro susceptibility of LDL to oxidation in 
fasting plasma samples. Other human studies on the effect of olive oil on LDL oxidation 
addressed the effects of oleic acid rather than olive oil phenols per se (Reaven et al, 1991; 
Bonanome et al, 1992; Tsimikas et al, 1999). In vitro, the olive oil phenols hydroxytyrosol and 
oleuropein strongly inhibited LDL oxidation (Visioli et al, 1995; Visioli & Galli, 1994). Also, 
tyrosol, oleuropein, and extracts of minor components from extra virgin olive oil decreased the 
oxidation of LDL as assessed by oxysterol formation (Berra era/, 1995; Caruso era/, 1999). We 
realise that LDL oxidation ex vivo is different from LDL oxidation in vitro. Phenols or antioxidants 
might get lost during isolation of LDL from plasma by centrifugation, a process that is absent 
when doing experiments in vitro. However, in rabbits and rats, non-tocopherol antioxidants from 
olive oil showed a favourable effect on the susceptibility of LDL to oxidation ( Scaccini et al, 
1992; Wiseman etal, 1996; Coni et al, 2000). This suggests that during isolation phenols might 
stay in or attached to lipoprotein particles where they might affect the resistance of LDL to 
oxidation. Thus, results of animal and in vitro studies suggest a protective effect of phenols from 
olive oil on LDL oxidation, but such an effect was not observed in fasting blood samples of 
humans in the present and other studies (Nicolaiew era/, 1998; Bonanome etal, 2000). 
One explanation might be that our study did not address postprandial effects. If phenol 
clearance is fast, phenol concentrations might be elevated in the first hours after a meal and 
during that time protect LDL from oxidation, but not after 12 h of fasting as in our study. Visioli et 
al actually found that the phenols tyrosol and hydroxytyrosol were mostly excreted within 24 h 
after intake of 50 mL extra virgin olive oil, which indicates that clearance of phenols from 
plasma is fast (Visioli etal, 2000). Furthermore, Bonanome et al found a significant postprandial 
effect 2 h after intake of 100 g of extra virgin olive oil on plasma antioxidant capacity, but they 
did not include a control group (Bonanome et al, 2000). Nicolaiew et al, on the other hand, did 
not find a significant effect on the lag time or maximum rate of LDL oxidation of extra virgin olive 
oil 6 h after intake (Nicolaiew et al, 1998). The proper study of postprandial effects requires 
more insight into the kinetics of phenol transport and metabolism in man and more studies are 
needed on this aspect. 
We also did not find an effect of phenols from extra virgin olive oil on the susceptibility of 
HDL to oxidation. Like modified LDL, oxidatively modified HDL is suggested to increase 
intracellular cholesterol accumulation (Nagano et al, 1991; Gesquiere et al, 1997; Bonnefont-
Rousselot et al, 1995). The physiological role of HDL oxidation is still unclear, but in our study 
18 mg/d of phenols for 3 wk did not influence the susceptibility of HDL to oxidation in fasting 
plasma samples. 
Furthermore, we did not find an effect of olive oil phenols on other markers of lipid and 
protein oxidation (lipid hydroperoxides, malondialdehyde, protein carbonyls, and FRAP). The 
average plasma values of the oxidation markers in our study were in line with those found in 
other studies. Lag time of LDL oxidation was about 110 min, which is relatively high (Esterbauer 
& Jiirgens, 1993). This can be explained by methodological differences and the high dose of 
oleic acid that increases the resistance of LDL to oxidative modification (Bonanome et al, 1992; 
Reaven et al, 1991; Tsimikas et al, 1999). Mean plasma lipid hydroperoxide and 
malondialdehyde concentrations and FRAP were similar to values found by others (Wong et al, 
1987; Benzie & Strain, 1996). Protein carbonyls were slightly higher in our subjects than in 
healthy subjects in the study by Buss et al, but much lower than in 23 critically ill subjects in the 
same study (Buss et al, 1997). Thus, plasma values of the markers of oxidation were within 
previously reported ranges. 
The phenol oleuropein-aglycone and some of its derivatives (Figure 3.1) from extra virgin 
olive oil are lipid-soluble, while oleuropein, tyrosol and hydroxytyrosol are water-soluble 
(unpublished data, Unilever Research Vlaardingen). We therefore hypothesised that the lipid-
soluble aglycones, which are the main phenols in olive oil, may accumulate in LDL and HDL 
particles and provide better protection of LDL against oxidation than other, more water-soluble, 
dietary compounds like phenols from tea and wine, for example. The amount of phenols 
needed to protect LDL and HDL from oxidation is unknown. Also, data about the amounts of 
other antioxidants needed to protect LDL from oxidation are scarce. Vitamin E is the most 
important lipid-soluble antioxidant in the body (Princen et al, 1995; Jialal et al, 1995). In one 
dose-response study Princen et al suggested that intake of 25 mg/d of vitamin E for 2 wk was 
sufficient to reduce the susceptibility of LDL to oxidation (Princen et al, 1995). In another dose-
response study, Jialal et al investigated the effects of vitamin E intake in doses of 60, 200, 400, 
800, 1200 mg/d. They found that at least 400 mg/d of vitamin E was needed to reduce the 
susceptibility of LDL to oxidation (Jialal et al, 1995). Thus, the minimum dose of vitamin E 
needed to reduce the susceptibility of LDL to oxidation is as yet unclear. However, if 25 mg/d of 
vitamin E is the minimum effective amount and if olive oil phenols and vitamin E would be 
equally effective, then the amount of 18 mg/d in our study might have been too low to detect an 
effect on LDL oxidisability. Moreover, vitamin E might partition better into LDL particles and thus 
be more effective in reducing the susceptibility of LDL to oxidation than phenols from olive oil. 
This implies that even more dietary phenols would be needed to detect an effect. Thus, the 
amount of 18 mg/d of olive oil phenols in our study, a very high intake in terms of practical 
realistic diets, might have been too low to affect LDL oxidisability. 
More is known about the in vitro than about the in vivo antioxidant activity of olive oil 
phenols. In vitro dose-response studies by Visioli and co-workers demonstrated that pre-
incubation of LDL with 10 umol/L oleuropein or 10 umol/L hydroxytyrosol inhibited the decrease 
of vitamin E in LDL during copper-mediated oxidation and delayed the formation of conjugated 
diene formation, lipid peroxides, and thiobarbituric acid-reacting substances (Visioli et al, 1995; 
Visioli & Galli, 1994). These studies showed that the protection of vitamin E from oxidation was 
correlated with the concentration of oleuropein or hydroxytyrosol, and that a concentration of 1 
umol/L provided much less protection than a concentration of 10 umol/L (Visioli ef al, 1995; 
Visioli & Galli, 1994). Visioli et al suggested that olive oil phenols retard the oxidation of the 
natural vitamin E pool in LDL and in this way indirectly protect LDL from oxidation. We do not 
know the plasma concentration of the various phenols that were reached in our study, but it is 
unlikely that it reached 1 umol/L after a whole-body dose of 18 mg/d (about 50 umol) for 3 wk. 
Thus, on the basis of in vitro data the concentration of phenols in LDL was probably too low to 
produce detectable effects on LDL oxidisability. 
It remains possible that amounts of olive oil phenols higher than the 18 mg/d fed in our 
study can affect LDL oxidisability. However, we supplied the maximum dose that is achievable 
with practical every-day diets. Olives were specially selected to obtain a large difference in 
phenol concentration between the experimental oils, and the subjects consumed large amounts 
of olive oil (69 g/d). The average daily intake of phenols from olive oil is not exactly known, but 
estimations from the Mediterranean diet indicate that 10-20 mg/d of total phenols may be 
supplied by olive oil (Visioli et al, 1995). According to our data, this is probably not enough to 
affect markers of antioxidant status in fasting plasma samples. 
It is conceivable that the background diet of our subjects contained too high an amount of 
antioxidants to allow additional antioxidant effects of the phenols of extra virgin olive oil. Our 
subjects consumed a background diet low in vitamin E, which was confirmed by the low plasma 
vitamin E concentrations. Furthermore, subjects were not allowed to take vitamin supplements. 
However, it is possible that tissue stores of vitamin C and vitamin E, for example, after the run-
in period were still considerable, and it may require depletion periods to show an effect. Thus, 
olive oil phenols might theoretically still affect oxidisability of fasting LDL in subjects who are 
depleted in dietary antioxidants. 
The oxidative modification hypothesis of atherosclerosis is an attractive one, but it is still not 
proven that dietary antioxidants prevent coronary heart disease (Zock & Katan, 1998). Only a 
few studies have reported the relation between markers of oxidation and coronary heart 
disease, and the results of these studies are inconsistent (van de Vijver et al, 1998; de Rijke et 
al, 1995; Cominacini et al, 1993; Croft era/, 1992). Thus, none of the oxidation markers have 
yet been validated as risk factors for atherosclerosis, although it may be that markers more 
representative of in vivo changes, like oxidised LDL antibodies, may be more sensitive to 
changes in LDL antioxidant content. Much work remains to be done here. In addition, 
randomised clinical trials with hard endpoints are needed to prove that dietary antioxidants, 
such as the phenols from olive oils, may offer protection against coronary heart disease. 
The serum concentrations of total and LDL cholesterol did not differ between the 2 diets. It 
has been suggested that minor components, such as phenols, may be responsible for a 
cholesterol-lowering effect (Matsumoto etal, 1998). We therefore studied the effects of olive oil 
phenols on serum cholesterol concentrations. Our results are in line with those of Nicolai'ew et 
al, who found that a diet with extra virgin olive oil and a diet with oleic-acid-rich sunflower oil 
produced the same cholesterol concentrations (Nicolai'ew et al, 1998). Thus, the cholesterol-
lowering effect of olive oil is probably not due to its phenolic compounds. 
We also measured the liver enzymes alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST). Phenols from extra virgin olive oil are responsible for the bitter taste of 
extra virgin olive oil. This bitter taste might be a warning from nature for possible adverse or 
toxic effects. We therefore measured ALT and AST as indicators of such effects. In our study 
the serum concentrations of ALT and AST did not differ between the 2 diets. This suggests that 
phenols from olive oil have no adverse affects on liver integrity. 
In conclusion, we did not find an effect of a high intake of phenol-rich olive oil on the 
susceptibility of LDL and HDL to oxidation and other markers of oxidation in fasting plasma. 
The natural concentration of phenols in olive oil might be too low or their clearance from plasma 
too fast to produce an effect on markers of oxidation in the post-absorptive phase. 
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ABSTRACT 
A high intake of olive oil has been proposed as an explanation for the low incidence of coronary 
heart disease in Mediterranean countries, but it is unclear whether olive oil offers specific 
benefits beyond a low content of saturated fat. Some types of extra virgin olive oil are rich in 
non-polar phenols, which might be taken up by plasma LDL particles and protect these from 
becoming atherogenic by oxidative modification. In a pilot study we found that consumption of 
47 g fortified olive oil containing 31 mg phenols significantly increased the lag time of LDL 
oxidation from 112 ± 5 min before to 130 ± 7 min 2 h after the meal. However, this study was 
not controlled, and in the current study we therefore investigated whether olive oil phenols 
increase the lag time of LDL oxidation in postprandial samples when compared with a control 
group. 
Twelve healthy men and women consumed 4 different olive oil supplements with a meal on 
4 separate occasions: one similar to the supplement in the pilot study (positive control); one 
containing mainly non-polar olive oil phenols; one containing mainly polar olive oil phenols; and 
one without phenols (placebo). Lag time significantly increased 2 h after the meals with the 
positive control (8 ± 2 min), the polar phenols (8 ± 2 min), and the placebo (8 ± 2 min), but not 
after the non-polar phenols (-0.4 ± 3 min). Increases were not statistically different between 
supplements. 
These results indicate that the lag time of LDL oxidation is increased after consumption of a 
meal. This increase is probably due to non-specific meal or time effects and not to phenols from 
olives or olive oil. Furthermore, these findings stress the need for adequate controlled studies to 
avoid misinterpretations of the data. 
INTRODUCTION 
The Mediterranean diet, with olive oil as the major fat source, has been shown in 
epidemiological studies to be associated with a reduced incidence of coronary heart disease 
(Keys et al, 1986). The replacement of dietary saturated fatty acids with monounsaturated oleic 
acid from olive oil decreases plasma LDL concentrations, which presumably contributes to the 
low incidence of coronary heart diseases (Katan et al, 1995). It has also been suggested that a 
high-monounsaturated fat diet lowers the risk of coronary heart disease by producing oleic acid-
enriched LDL particles, which are more resistant to oxidative modification (Reaven et al, 1991; 
Bonanome et al, 1992; Mata et al, 1997). Oleic acid, however, may not be the only component 
of olive oil protecting LDL from oxidation. Some types of extra virgin olive oil contain phenols 
with antioxidative properties. These phenols are aglycones formed in olives by removal of 
glucose from the parent compound oleuropein or ligstroside, and they are less polar. End 
products of hydrolysis of ligstroside- and oleuropein-aglycones are tyrosol and hydroxytyrosol 
which are polar (Figure 4.1). 
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Figure 4.1 Structures of phenols present in olives and olive oil, their degradation into aglycones during 
ripening, and hydrolysis of aglycones into tyrosol and hydroxytyrosol. 
Oxidation of LDL may be an important risk factor for atherosclerosis, the underlying cause of 
coronary heart disease, and olive oil phenols may be particularly effective in preventing 
oxidation of LDL. Due to their relatively lipophilic nature the olive oil phenols might directly 
dissolve into LDL particles where they can protect LDL from oxidation. Results of animal 
(Wiseman et al, 1996; Scaccini et al, 1992; Coni era/, 2000) and in vitro studies (Visioli et al, 
1995; Visioli & Galli, 1994; Salami etal, 1995; Caruso etal, 1999) do suggest a protective effect 
of phenols from olive oil on LDL oxidation. Some human studies suggest that such an effect 
may also apply to the practical in vivo situation. Visioli and co-workers found that administration 
of phenol-rich oils resulted in a dose-dependent decrease in urinary excretion of 
F2-isoprostanes, which indicates less overall oxidation of arachidonic acid (Visioli et al, 2000). 
Results of other human studies, on the other hand, are inconsistent (Nicolaiew et al, 1998; 
Ramirez-Tortosa et al, 1999; Bonanome era/, 2000; Vissers era/, 2001). In a previous human 
study (Vissers et al, 2001) we did not find an effect on LDL oxidisability in fasting blood after 
subjects had consumed extra virgin olive oil that was naturally high in phenols (21 mg/d) for 
3 wk. From that study we concluded that a dose of 21 mg/d of phenols was not high enough to 
affect markers of oxidation, or that we missed an effect because we measured blood samples 
taken at least 12 h after the last meal. Because the metabolism of olive oil phenols might be 
fast, we investigated effects on LDL oxidation in plasma taken shortly after intake of olive oil 
phenols in a pilot study. In this pilot study 10 healthy men and women consumed in one meal 
47 g of olive oil fortified with a phenol-rich extract from olives containing 31 mg phenols. The 
mean lag time of LDL oxidation increased from 112 ± 5 min before to 130 ± 7 min 2 h after the 
meal (95% CI of change, 5.3 to 30.8 min) (Figure 4.2). However, this study did not include a 
concurrent control group, and the observed decrease in LDL oxidisability may have been due to 
non-specific meal or time effects. Therefore we performed a controlled intervention study on 
whether olive oil phenols affect LDL oxidisability directly after intake. 
before after 
Figure 4.2 Individual lag times of LDL oxidation in samples taken before and 2 h after intake of the phenol-
rich supplement in the pilot study (n = 10). In this pilot study subjects started with a 7-d run-in period in which 
they were not allowed to consume olives, olive oil, or olive oil products. On day 8 they consumed 47 g fortified 
olive oil containing 31 mg phenols with breakfast at our department. The subjects consumed their breakfast 
within half an hour and did not eat or drink anything else except water until 3 h after supplement intake. 
METHODS 
Subjects 
The study protocol was approved by the Medical Ethical Committee of Wageningen University. 
The protocol was fully explained to the participants before they gave their written informed 
consent. 
Twelve healthy subjects (8 females, 4 males) were recruited, with a mean age of 22 years 
(range 20-28 years), and with a mean body mass index of 21.8 kg/m2 (range 18.3-27.1 kg/m2). 
Subjects had no history of gastrointestinal, liver or kidney disease, did not use any drugs 
known to affect concentrations of serum lipids, and were not pregnant, lactating, or on a 
prescribed diet. Subjects were all healthy as judged by normal blood count, the absence of 
glucose and protein in urine, and a medical questionnaire, which was reviewed by an 
independent physician. Subjects had a serum concentration of total cholesterol <7.0 mmol/L, 
and fasting triglycerides <2.3 mmol/L. 
Design and Treatment 
Each subject consumed a single dose of 4 different supplements, in random order (cross-over). 
The study consisted of a 4-wk treatment period, during which subjects were not allowed to 
consume olives, olive oil, olive oil products, and products extremely rich in vitamin E, like 
peanut butter and nuts. At the end of each week, on day 8, 15, 22, and 29, we provided the 
subjects with a supplement between 8:00 and 9:30 h at our department. The supplement was 
consumed together with a standard breakfast, containing bread, tomato, cucumber, tuna, ham, 
cheese, milk or buttermilk, and tea or coffee with or without sugar and evaporated milk. 
Products were low in vitamin E to prevent any effect of vitamin E on LDL oxidation. The 
breakfast were not protein-free, but protein content was kept as low as possible to minimise the 
possible binding of phenols to proteins in the intestines. To this end, we instructed the subjects 
not to consume more than 1 slice of ham or cheese and not to drink more than 150 mL milk or 
buttermilk. The breakfasts contained 3.0 ± 0.8 MJ as energy, and 26 ± 7 g protein. The 
breakfast with the positive control contained 4.2 ± 0.8 MJ as energy because of the higher dose 
of olive oil in this supplement. The subjects consumed breakfast within half an hour. Each 
subject consumed exactly the same amount of breakfast on each of the 4 occasions. The only 
exception was that subjects were allowed to consume some more cucumber or salad with one 
of the supplements (positive control), in order to facilitate the intake of the higher amount of 
olive oil in this supplement than in the other 3 supplements. Tea, coffee or other foods and 
drinks were not allowed until the last blood sample had been taken. Blood samples were taken 
before, and Vz h and 2 h after the experimental breakfast. All subjects kept daily records of 
illness and deviations from the protocol. 
Supplements 
The positive control supplement was similar to the supplement consumed in the pilot study 
in which we found a postprandial effect on the lag time. The supplement consisted of 65 g 
mayonnaise prepared with 47 g olive oil, water, egg yolk powder, vinegar, pizza herbs, 
mustard, salt and pepper. This extra virgin olive oil was fortified with a phenol-rich olive fraction. 
The total phenol concentration in the fortified oil was 674 mg/kg. Thus, the supplement 
contained 31.1 mg of phenols (Table 4.1). 
The supplement with non-polar phenols consisted of 37 g mayonnaise prepared with 
14.5 g phenol-enriched olive oil, sour cream and small amounts of water, egg yolk powder, 
vinegar, mustard, honey, pizza herbs, salt and pepper. The phenols were extracted from extra 
virgin olive oil by food-grade ethanol, which was evaporated in a later stage. The total phenol 
concentration of the olive oil used in this supplement was 6876 mg/kg, thus the supplement 
provided 100 mg of olive oil phenols (Table 4.1). 
The supplement with polar phenols was not a mayonnaise because the olive oil extract 
was watery and not suitable to prepare a mayonnaise. The supplement was extracted from 
extra virgin olive oil by reversed osmosis. Subjects drank 8.7 g of this supplement containing a 
total phenol concentration of 11470 mg/kg. Thus, the supplement provided 100 mg of phenols 
(Table 4.1). Subjects also consumed 37 g mayonnaise prepared with 14.5 g olive oil without 
phenols to equalise fat intake between breakfasts. The mayonnaise was similar to the placebo 
supplement. 
The placebo supplement also consisted of 37 g mayonnaise prepared with 14.5 g olive 
oil without phenols and vitamin E, sour cream and small amounts of water, egg yolk powder, 
vinegar, mustard, honey, pizza herbs, salt and pepper. The olive oil without phenols and 
vitamin E was prepared by stripping it several times. 
The phenol concentration of the fortified oil was measured with an HPLC method based on 
the method of Montedoro et al (1993). With this HPLC method hydroxytyrosol and tyrosol and 
10 derivatives of the oleuropein- and ligstroside-aglycones were separated, and the peaks of 
the aglycones were identified using HPLC-MS-MS (Table 4.1, Figure 4.3). The 12 major peaks 
in the HPLC chromatogram were quantified using the area/ug at X=280 nm of the individual 
compounds hydroxytyrosol, tyrosol and oleuropein or of mixtures of aglycones. The aglycone 
reference mixture was obtained by enzymatic hydrolysis of oleuropein by p-glucosidase. The 
various derivatives differ mainly in their ring structure, which can either be open or closed in two 
different forms (van Boom et al, in preparation). Because some peaks could not be identified, 
the concentrations of phenols in the experimental oils might be an underestimation of the total 
amount of phenolic substances from olive oil. Thus intake of phenols might have been even 
higher. 
Table 4.1 The amount of the various phenols and vitamin E present in the supplements, analysed by 
HPLC. The placebo did not contain any phenols or vitamin E. 
Phenol intake 
Peak number and type of phenola 
Hydroxytyrosol (1) 
Tyrosol (2) 
Oleuropein-aglycone(peaks3,4, 5,7, 8, 9,10)a b 
Ligstroside-aglycone (peaks 6,11,12)a " 
Total phenols 
Positive control 
(mg/47 g oil) 
3.7 
1.2 
19.0 
7.2 
31.1 
Non-polar 
(mg/14.5goil) 
1.4 
16.9 
19.0 
62.8 
100.1 
Polar 
(mg/8.7 g extract) 
36.2 
22.9 
34.1 
6.9 
100.1 
Alpha-tocopherol 10.0 0.1 0.0 
a
 10 derivatives of the aglycones were separated and the peaks identified (van Boom etal, in preparation). 
The various derivatives differ mainly in their ring structure, which can be either open or closed in two different 
forms. 
6
 The numbering of the various phenols in this table refer to the numbering of the peaks in Figure 4.3. 
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Figure 4.3 Chromatogram of various identified phenols in the non-polar (A) and the polar (B) supplement. 
The numbering of the peaks refer to the numbering of the various phenols in Table 4.1: 1 = hydroxytyrosol; 
2 = tyrosol; 3, 4, 5, 7, 8, 9,10 = oleuropein-aglycones; 6,11,12 = ligstroside-aglycones. 
Blood sampling 
Venous blood samples for determination of LDL oxidisability were taken using vacuum tubes 
containing EDTA. Blood was sampled before and Vz and 2 h after breakfast. Plasma was 
prepared within 30 min by centrifugation at 4°C for 10 min at 2,500 g, and 10 uL of a 600 g/L 
sucrose solution was added per mL plasma (Kleinveld et al, 1992). Samples were stored at 
-80°C until analysis less than 3 months later. 
LDL isolation and LDL oxidation 
Plasma lipoproteins were isolated by density gradient ultracentrifugation in an SW 41 Ti rotor 
(Beckman Instruments, Palo Alto, USA) for 24 h at 10°C (Redgrave et al, 1975). LDL was 
isolated in a density range of 1.019-1.063 g/mL Density gradients solutions contained 
0.1 mmol/L Na2EDTA to inhibit metal ion catalysed LDL oxidation during the isolation 
procedure. 
The susceptibility of LDL to copper-mediated oxidation was determined in duplicate by 
monitoring the formation of conjugated dienes, as described by Princen et al (1992). 
Determinations before, and 1/z h and 2 h after supplement intake were done per 2 supplements 
of one subject in one single run. The duplicates of these determinations were done in another 
run. 
Statistical analyses 
The duplicate values obtained from each subject were averaged before data analysis. 
LDL-oxidisability before, and V2 and 2 h after intake of the supplement were compared 
using Student's paired t-tests. To compare differences in LDL oxidisability between the various 
supplements we applied ANOVA using the General Linear Models (GLM) of the Statistical 
Analyses System (SAS Institute Inc. 1989). Before statistical analysis, the lag time and 
maximum rate of each individual subject before supplement intake were subtracted from the lag 
time and maximum rate at Vz h or 2 h after intake. Then, these differences were compared 
among the various supplements. The positive control, the supplement also used in the pilot 
study, was statistically compared with the placebo supplement without phenols. The 
supplements containing polar or non-polar phenols were statistically compared with each other 
and with the placebo supplement only. The Tukey method was used to adjust for multiple 
comparisons and to calculate the 95% confidence limits of the differences between the 
supplements. Data are presented as mean ± SE. 
RESULTS 
One subject did not consume the breakfast containing the non-polar phenol-supplement 
because of personal reasons not related to the study. 
The mean lag time increased significantly both at V2 h and 2 h after the meals with the 
positive control (10 ± 4 min at V2 h and 8 ± 2 min at 2 h), the polar phenols (4 ± 1 min at V2 h 
and 8 ± 2 min at 2 h), and the placebo (7 ± 3 min at V2 h and 8 ± 2 min at 2 h), but not after the 
non-polar phenols (4 ± 2 min at V2 h and -0.4 + 3 min at 2 h) (Table 4.2). The maximum rate of 
diene formation was not affected by any of the 4 supplements (Table 4.3). 
The increase in lag time and maximum rate did not differ significantly between the positive 
control supplement and the placebo supplement, neither at Vz h nor at 2 h after intake. Also, the 
increases did not significantly differ between the supplement with polar or non-polar phenols 
and the placebo supplement (Table 4.4). 
Table 4.2 The lag time of LDL oxidation (min) before intake and Vz h and 2 h after intake of the 4 
experimental supplements and differences in lag time Vz h and 2 h after compared to before intake of the 
supplements (n= 12). 
Supplement 
Placebo 
Polar phenols 
Non-polar phenols 
Positive control6 
Lag time of LDL oxidation 
Before 
supplement 
intake 
(t = 0) 
76 ±2 
74 ±2 
79±3a 
74 ±3 
Vz h after 
supplement 
intake 
(t = %) 
82±4 a 
78 ±2 
83±3a 
83 ±4 
2 h after 
supplement 
intake 
(t = 2) 
84 ±3 
82 ±3 
79±4a 
82 ±4 
Differences in lag time 
compared 
t = M> 
(95% CI) 
7(0.4,14.2) 
4(1.7,6.8) 
4 (-0.3, 8.3) 
10(1.8,17.5) 
tot=0 
t = 2 
(95% CI) 
8.0 (3.5, 11.9) 
8.0(2.9,13.3) 
-0.4 (-6.9, 6.1) 
8.0(3.2,12.4) 
Values are means ± SE. All subjects (4 men, 8 women) were included in the analyses. Each subject 
consumed each supplement in random order. 
a
 n = 11: there was not enough plasma of one subject to do the analyses (placebo supplement, t = V2); and 
one subject was not able to consume the non-polar phenol-supplement. 
6
 Positive control was the same supplement as used in the pilot study in which we found an increased lag 
time of 18 min. 
Table 4.3 The maximum rate of LDL oxidation (nmol conjugated dienes/min/mg LDL protein) before 
intake and V2 h and 2 h after intake of the 4 experimental supplements and differences in maximum rate Vz h 
and 2 h after compared to before intake of the supplements (n = 12). 
Supplement 
Maximum rate of LDL oxidation 
Before Vz h after 2 h after 
supplement supplement supplement 
intake intake intake 
(1 = 0) (t = %) (t = 2) 
Differences in maximum rate 
compared to t=0 
t = M> 
(95% CI) 
t = 2 
(95% CI) 
Placebo 23.4 ± 0.7 
Polar phenols 22.5 ± 0.7 
Non-polar phenols 21.4 ± 0.7a 
Positive control 22.9 ±0.6 
22.4±0.9a 21.9 ±0.8 
21.5 ± 0.8 21.4 ± 0.4 
21.0±0.6a 21.8±0.9a 
22.4 ± 0.7 22.6 ± 0.7 
-0.9 (-2.0, 0.16) 
-1.0 (-2.5, 0.42) 
-0.4 (-1.4, 0.6) 
-0.5 (-1.8, 0.9) 
-1.6 (-2.9,-0.2) 
-1.1 (-2.3,0.16) 
0.4 (-0.5, 1.4) 
-0.3 (-1.4, 0.9) 
Values are means ± SE. All subjects (4 men, 8 women) were included in the analyses. Each subject 
consumed each supplement in random order. 
a
 n = 11: there was not enough plasma of one subject to do the analyses (placebo supplement, t = Vz); and 
one subject was not able to consume the non-polar phenol-supplement. 
b
 Positive control was the same supplement as used in the pilot study in which we found an increased lag 
time of 18 min. 
Table 4.4 The difference in lag time and maximum rate of LDL oxidation between the supplements with 
non-polar phenols, polar phenols, and the placebo supplement and between the positive control and the 
placebo supplement: Vfe h and 2 h after compared to before intake of the supplements (n = 12). 
Supplement Difference in lag time 
compared to t=0 
(min) 
t = 1/2 (95% CI) t = 2 (95% CI) 
Difference in maximum rate 
compared to t=0 
(nmol conjugated dienes/ 
min/mg LDL protein) 
t = 1/2 (95% CI) t = 2 (95% CI) 
Polar phenols vs. placebo 
Non-polar phenols vs. placebo 
Polar vs. non-polar phenols 
-3.0 (-10.8, 4.8) 0.4 (-7.5, 8.4) 
-3.3 (-11.3, 4.7) -8.0 (-16.2, 0.1) 
0.3 (-7.5, 8.1) 8.4(0.3,16.6) 
-0.1 (-2.1,2.0) 0.5 (-1.6, 2.5) 
0.5 (-1.5, 2.6) 2.0 (-0.1, 4.1) 
-0.6 (-2.7,1.4) -1.5 (-3.6, 0.6) 
Positive control3 vs. placebo 2.3 (-8.8,13.5) 0.2 (-3.8, 4.1) 0.5 (-1.3, 2.2) 1.3(0.0,2.5) 
Values are means ± SE. All subjects (4 men, 8 women) were included in the analyses. Each subject 
consumed each supplement in random order. 
a
 Positive control was the same supplement as used in the pilot study in which we found an increased lag 
time of 18 min. 
DISCUSSION 
Our study shows that consumption of a high dose of phenols from olives and extra virgin olive 
oil does not affect LDL oxidisability in postprandial blood samples. We found that the increase 
in lag time after intake of a meal with phenol-rich olive oil was not different from the increase 
after intake of a meal with placebo olive oil. Thus, the decrease in LDL oxidisability that we 
observed in the pilot study was not due to phenolic substances but probably to non-specific 
effects of the meal or to changes in LDL oxidisability over the day. 
Adequate control groups 
Our findings stress the need for adequate control groups to avoid misinterpretations of the data. 
In the pilot study we found that the phenol-rich breakfast decreased LDL oxidisability, which 
would have suggested a positive effect of the phenols on LDL oxidisability. However, if 
compared with a control group, the effect turned out to be a non-specific meal or time effect 
rather than an effect of the phenols. The importance of a control group should thus not be 
underestimated, and the results of studies should be interpreted very carefully when no control 
group is included. Thus, for a conclusive effect of dietary components on antioxidative markers, 
including a control group is essential. 
Olive oil phenols and LDL oxidation 
Our findings are similar to those from the studies of Nicolaiew et al (1998) and Bonanome et al 
(2000) in which extra virgin olive oil also did not affect the lag time of the ex vivo susceptibility of 
LDL to oxidation as compared to the control group, both in fasting and in postprandial plasma 
samples. In contrast to what we found, those studies did not show an increase in lag time after 
eating a meal. A reason for that might be that blood samples were taken 6 h after the oral fat 
load in the study of Nicolaiew et al instead of the 2 h in our study (Nicolaiew et al, 1998). 
However, Bonanome era/measured LDL oxidisability 30,60,120,240 and 360 min after intake 
of 100 mL olive oil, and did not find an effect on lag time on all these time points (Bonanome et 
al, 2000). 
Bonanome et al did find an increase of total plasma antioxidant capacity, another marker 
than lag time, in postprandial plasma samples 2 h after intake of a single dose of 100 mL extra 
virgin olive oil (Bonanome et al, 2000). However, they did not include a control group and this 
effect might therefore, like in our study, also be a non-specific meal or time effect. 
Other human studies addressed long-term effects of phenols from olive oil in fasting blood 
and not immediate effects in postprandial blood (Nicolaiew et al, 1998; Ramirez-Tortosa et al, 
1999; Bonanome et al, 2000; Vissers ef al, 2001). Ramirez-Tortosa et al (1999) showed a 
decreased LDL oxidisability after 3 months of consumption of extra virgin olive oil compared to 
refined olive oil. However, LDL oxidation was assessed as the amount of thiobarbituric acid-
reactive substances (TBARS) formed after incubation for 24 h with various concentrations of 
copper ions instead of assessing LDL oxidation as the lag time as in the current study. The 
value of TBARS as a measure of in vivo oxidation is questionable (Meagher & FitzGerald, 
2000), but Ramirez-Tortosa et al also found that extra virgin olive oil reduced uptake by 
macrophages of oxidised LDL in fasting blood compared to refined olive oil. Other human 
studies did not find an effect on LDL oxidisability in fasting blood (Nicolaiew et al, 1998; 
Bonanome et al, 2000; Vissers ef al, 2001). Taken together, results from human studies are 
thus inconsistent. 
Increased lag time in postprandial samples 
Few data are available on the diurnal variation of the lag time. Studies of LDL oxidation have 
mainly focussed on the fasting state. In the postprandial state triglyceride concentrations in the 
LDL fraction increase (Cohn et al, 1988; Lechleitner et al, 1994), which is thought to increase 
the susceptibility of LDL to oxidation and thus, in contrast to what we found, decrease the lag 
time (Regnstrom etal, 1992). But the type of fatty acids in the supplement might also affect LDL 
oxidisability. Olive oil is rich in oleic acid, which reduces LDL oxidisability (Reaven etal, 1991). 
VLDL or chilomicrons might exchange lipid molecules with other lipoproteins (Zilversmit 1995), 
like LDL, and thereby decrease the LDL oxidisability in postprandial plasma. Unfortunately we 
did not measure the fatty acids composition of the LDL fractions. However, other studies did not 
show an effect of boluses of up to 100 g olive oil on the lag time of LDL oxidation in 
postprandial samples ( Nicolaiew etal, 1998; Nielsen etal, 2000; Bonanome etal, 2000). Thus, 
an acute effect of an oleic acid bolus on LDL composition and subsequent LDL oxidisability is 
not likely. Furthermore, fat intake was similar among all supplement groups and could thus not 
have affected the results of the phenols on LDL oxidisability. 
We did not measure vitamin E concentrations in plasma. However, we think it is not likely 
that vitamin E could have confounded the results. The amount of vitamin E that subjects 
consumed from the supplement was at maximum 10 mg in the positive control supplement. 
One dose-response study suggested that a daily ingestion for 2 wk of at least 25 mg vitamin E 
was needed to reduce LDL susceptibility (Princen et al, 1995). Another study even suggests 
that much higher daily doses are needed (Jialal et al, 1995). Furthermore, Dimitrov et al 
demonstrated in a kinetic study that a single dose of as much as 440, 880, and 1320 mg 
vitamin E hardly elevated plasma vitamin E concentrations 2 h after intake, and that a peak is 
reached as late as 12-24 h after ingestion (Dimitrov et al, 1991). Thus, we think it is unlikely that 
the single dose of at most 10 mg of vitamin E materially influenced plasma vitamin E 
concentrations and LDL oxidisability. Furthermore, the amount of vitamin E in the background 
diet was 2.3 ± 1.0 mg, which is probably too low to affect LDL oxidisability 2 h after intake. 
The pizza herbs mainly consisted of oregano, which is known to have antioxidant 
properties in vitro (Tsimidou et al, 1995). However, subjects consumed only 0.37 g of the herbs, 
and each supplement contained exactly the same amount and type of the herbs, which thus 
could not have affected the differences in effects on LDL oxidisability between the supplements. 
Thus, our results indicate that phenols from extra virgin olive oil do not affect LDL 
oxidisability, but a non-specific time or meal effect might be responsible for the decreased LDL 
oxidisability after the meal. Future research should more precisely determine the 24-h time 
course of LDL oxidisability, including effects of meals. 
Dose of phenols 
The plasma concentration of phenols needed to protect LDL from oxidation in vivo is unknown. 
In vitro dose-response studies by Visioli and co-workers demonstrated that pre-incubation of 
LDL with 10 umol/L oleuropein or 10 umol/L hydroxytyrosol protected vitamin E from oxidation, 
but that a concentration of 1 umol/L provided much less protection (Visioli et al, 1995; Visioli & 
Galli, 1994). We do not know the plasma concentration of the various phenols that were 
reached in our studies, but a single dose of 100 mg (about 275 umol) does probably not result 
in a plasma concentration higher than 1 umol/L (Hollman et al, 1997). Thus, it is likely that the 
plasma concentrations in our studies were too low to produce an effect on the ex vivo oxidation 
of LDL. Furthermore, estimations of the average daily intake of phenols from olive oil in the 
Mediterranean diet indicate that 10-20 mg/d of total phenols may be supplied by olive oil (Visioli 
et al, 1995), which is at least 5 times less than the amount given by us in a single dose. 
Therefore the phenol content of olive oil may be too low to produce a measurable effect on LDL 
oxidisability in vivo. 
Pharmacokinetics of phenols from olive oil 
In the pilot study we measured the LDL oxidisability 2 h after intake of the meals (Bonanome et 
al, 2000). We found an intriguing increase in lag time and we therefore repeated measurement 
at this time point in the current study. In this study we also measured the effect at Vz h after 
intake because Hollman and co-workers found a plasma peak concentration of quercetin 
(Hollman ef al, 1997), a compound that is comparable with the olive oil aglycones, Vi h after 
intake of a quercetin-rich breakfast. However, we can not be sure that olive oil phenols were 
present in plasma or LDL Vfe h or 2 h after intake. Thus, more insight into the time course of 
plasma phenol concentrations after intake is required to conclude whether olive oil phenols can 
add a positive health effect in humans. Future research should focus more on the kinetics and 
metabolism of phenols and other potential antioxidants in humans. 
Conclusion 
We did not find an effect of a large single dose of olive oil phenols on plasma LDL oxidisability. 
More insight into the kinetics of phenol transport and metabolism in humans is required to study 
the potential health effects of olive oil phenols in humans. 
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A B S T R A C T 
It has been suggested that phenols present in olive oil contribute to the health effects of the 
Mediterranean life-style. Olive oil antioxidants, and in particular the orfno-dihydroxy phenol 
hydroxytyrosol, increase the resistance of low density lipoproteins (LDL) against oxidation in 
vitro. Human dietary intervention studies have failed to demonstrate a consistent effect of olive 
oil consumption on LDL resistance to oxidation when determined ex vivo. 
To close this gap, a method has been used that mimics the exposure of LDL to olive oil 
phenols in its natural environment, i.e. in plasma. Plasma was incubated with individual olive oil 
phenols and with olive oil extracts rich in ortno-dihydroxy phenols, oleuropein-aglycone and 
hydroxytyrosol, and/or mono-hydroxy phenols, ligstroside-aglycone and tyrosol. LDL was 
subsequently isolated and challenged for its resistance against copper-mediated oxidation. 
The results show that olive oil phenols increase LDL resistance. As predicted from their 
structural features, the orfno-dihydroxy phenols (hydroxytyrosol and oleuropein-aglycone) are 
more efficient than their mono-hydroxy counterparts (tyrosol and ligstroside-aglycone) in 
protecting against lipid peroxidation. However, the concentration of antioxidants required to 
inhibit LDL oxidation when added to whole plasma was substantially higher compared to 
previously published data where antioxidants had been added directly to isolated LDL. 
Furthermore, the hydrophilic oleuropein-glycoside only marginally increased LDL resistance, 
whereas its lipophilic aglycone counterpart is a more potent antioxidant in this model system. 
In conclusion, this in vitro study has shown that extra virgin olive oil phenols can provide 
protection to LDL in plasma. The explanation that in vitro studies show protective effects in 
contrast to the lack effect in the majority of human studies may be due to the fact that the dose 
of the phenols and thus their plasma concentration in humans was too low to reduce ex vivo 
LDL oxidisability. Further studies on the bioavailability, metabolism and other mechanisms of 
action of olive oil phenols are needed for a better understanding of the potential health benefits 
that extra virgin olive oil may provide. 
INTRODUCTION 
In Mediterranean countries, where olive oil is the major source of fat, rates of coronary heart 
disease are relatively low compared with more Northern European societies (Keys etal, 1986). 
In addition to the favourable effects of the monounsaturated fatty acids on blood cholesterol 
concentrations (Katan etal, 1995) and on LDL oxidisability (Reaven etal, 1991), animal and in 
vitro studies suggest that the high concentration of phenolic antioxidants in extra virgin olive oil 
also may contribute to the healthy nature of this diet ( Scaccini etal, 1992; Visioli & Galli, 1994; 
Visioli et al, 1995; Salami et al, 1995; Wiseman et al, 1996; Visioli et al, 1998; Caruso et al, 
1999; Coni et al, 2000). The most abundant phenols in extra virgin olive oil are the less polar 
oleuropein- and ligstroside-aglycones. They are formed in olives by enzymatic removal of 
glucose from the parent compound oleuropein-glycoside. Hydroxytyrosol and tyrosol are end 
products produced from the hydrolysis of oleuropein- and ligstroside-aglycones, respectively, 
and they are polar compounds (Figure 5.1). 
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Figure 5.1 The main phenols present in olives and olive oil. The main phenols in olive oil are the aglycones, 
which are derived from oleuropein-glycoside by enzymatic degradation. Tyrosol and hydroxytyrosol are 
derived from ligstroside- and oleuropein-aglycones by hydrolysis. 
Oxidation of LDL is believed to increase the risk of atherogenesis, the underlying cause of 
coronary heart disease. Olive oil phenols may be particularly effective in preventing oxidation of 
LDL. Due to their relatively non-polar nature, they may directly associate with LDL particles. 
This association may lead to an increased resistance of LDL against oxidation and this could be 
one of the potential mechanisms by which extra virgin olive oil may benefit health. This 
hypothesis is supported by in vitro experiments, where it has been demonstrated that 
oleuropein-glycoside and hydroxytyrosol increase the resistance of LDL against copper-
induced oxidation (Visioli & Galli, 1994; Visioli et al, 1995). However, in the majority of human 
studies (Nicolaiew etal, 1998; Bonanome etal, 2000; Vissers etal, 2001a; Vissers etal, 2001b) 
no effect of phenols present in extra virgin olive oil on ex vivo LDL oxidisability could be found in 
fasting or postprandial plasma samples. An explanation for this apparent discrepancy may be 
that the concentrations in human plasma were too low to influence ex vivo LDL susceptibility. 
Alternatively, human plasma olive oil phenols may also associate with other plasma proteins 
than LDL. If those phenols are directly added to the isolated LDL fraction, LDL is the major 
protein source to which they can bind. Finally, phenols may dissociate from LDL during isolation 
from plasma. 
The aim of the present in vitro study was to evaluate the effect of olive oil phenols on the 
resistance of LDL to oxidation. In order to mimic the in vivo situation as closely as possible, 
plasma was incubated with olive oil phenols. LDL was subsequently isolated and the resistance 
of LDL to oxidation was evaluated by monitoring copper-induced lipid peroxidation. In addition 
to pure olive oil compounds, we also examined the effects of structurally similar compounds, 
other dietary antioxidants like vitamin E and tea catechins, and 3 olive oil extracts with different 
phenolic compositions in order to determine whether not only phenol concentration but also the 
antioxidant properties influence the resistance of LDL to oxidation. 
MATERIALS AND METHODS 
T e s t e d a n t i o x i d a n t s 
The following antioxidants or olive oil extracts were investigated for their ability to protect LDL 
against copper-induced oxidation and their antioxidant properties: tyrosol (Acros, New Jersey, 
USA); oleuropein-glycoside (Roth, Karlsruhe, Germany); DL alpha-tocopherol (Merck, 
Darmstadt, Germany); green tea extract (Lipton, New Jersey, US). Gallic acid, 3,4-di-
hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid and catechin were obtained from Sigma, 
Saint Louis, USA. Hydroxytyrosol, 2 non-polar extracts and a polar extract derived from extra-
virgin olive oil were prepared at Unilever Research Vlaardingen, the Netherlands. 
Two batches of hydroxytyrosol were prepared according to the method described by 
Baraldi et al (1983). The purity of the 2 batches was determined to be at least 93%. 
Oleuropein- and ligstroside-aglycones (Figure 5.1) and their derivatives were not available 
in the pure form. Therefore, we prepared several olive oil extracts, in which the various phenols 
were present in varying amounts (Table 5.1). 
The phenol composition was determined by HPLC according to Montedoro et al (1993). 
With this HPLC method it was possible to identify hydroxytyrosol, tyrosol and 10 derivatives of 
the oleuropein- and ligtroside-aglycones. The aglycones were identified with HPLC-MS-MS. 
The 12 major peaks in the HPLC chromatogram were quantified using the area/ug at ^=280 nm 
of the individual compounds hydroxytyrosol, tyrosol and oleuropein or of mixtures of aglycones. 
The aglycone reference mixture was obtained by enzymatic hydrolysis of oleuropein by 
p-glucuronidase. The various derivatives differ mainly in their ring structure, which can either be 
Non-polar extract 1 
Non-polar extract 2 
Polar extract 
21 
31 
31 
26 
2 
45 
14 
53 
4 
open or closed in two different forms (van Boom et al, in preparation). The total phenol 
concentration in each extract was standardised to a concentration of 1000 umol/L 
Table 5.1 The relative amount (%) of the various phenols in the tested olive oil extracts. 
Description of the extract3 Tyrosol Hydroxytyrosol Ligstroside-aglycone Oleuropein-aglycone 
39 
14 
20 
aThe phenol concentrations was determined by HPLC according to Montedoro et al (1993) and van Boom 
era/(in preparation). The total phenol concentration in each extract was standardised to a concentration of 
1000 umol/L. The polar extract was extracted from extra virgin olive oil by reversed osmosis. The non-polar 
extracts (1 and 2) were extracted from extra virgin olive oil with ethanol, which was later removed by 
evaporation. 
LDL isolation and the measurement of the resistance of LDL to 
copper-induced oxidation 
Plasma was prepared by centrifugation at room temperature for 10 min at 2,500 g, and 10 ul of 
a 600 g/L sucrose solution was added per mL plasma (Kleinveld et al, 1992). Plasma was 
stored at -80°C until use. Plasma was mixed with the compounds and extracts tested for 30 min 
at room temperature. A control plasma was treated in the same way. The olive oil extracts were 
added directly, whereas alpha-tocopherol was dissolved in ethanol, and all other antioxidants 
were dissolved in water prior to addition to plasma. The concentrations of all compounds and 
extracts tested were 1000 umol/L. For a selection of these compounds (the 2 non-polar 
extracts, the polar extract, hydroxytyrosol, tyrosol, oleuropein-glycoside, and DL alpha-
tocopherol) the minimal concentration required to increase LDL resistance to oxidation was 
determined by incubating plasma with a concentration range: 0, 50, 100, 250, 500, and 1000 
umol/L. For the green tea extract the concentrations were 0, 80, 160, 320, 640, and 
960 umol/L 
LDL was subsequently isolated by density gradient ultracentrifugation using an SW 41 Ti 
rotor (Beckman Instruments, Palo Alto, USA), 36,000 gfor 24 h at 10°C (Redgrave et al, 1975). 
Density gradient solutions contained 0.1 mmol/L Na2EDTA to prevent metal ion catalysed LDL 
oxidation during the isolation procedure. The LDL-fraction was isolated in a density range of 
1.019-1.063 g/mL 
The protein concentration of the LDL fraction was determined as approximately 500 ug/mL 
(Lowry et al, 1951). This fraction was initially diluted to a concentration of 200 ug/mL with 
gradient solution (density was 1.019 g/mL) and was further diluted with PBS to a concentration 
of 50 ug per mL in a thermostat controlled cuvette at a temperature of 30°C. The oxidation of 
LDL was initiated by the addition of 10 uL of 5 mmol/L CuCI2 in a total volume of 1 mL. This 
method was essentially the same as described by Princen et al (1992). The formation of 
conjugated dienes was monitored spectrophotometrically at a wavelength of 234 nm at 2 min 
intervals for a period of 400 min or until oxidation was complete, using a UV-Vis 
spectrophotometer equipped with a thermostat controlled multicuvette holder (Cary 50 
Spectrophotometer, Varian Inc., Mulgrave, Victoria, Australia). The oxidation profile of each 
LDL sample was plotted against time. The lag time and the maximum rate of oxidation were 
determined as described by Esterbauer era/(1992). Each condition was tested in duplicate. 
Determination of alpha-tocopherol levels in LDL 
A small aliquot of the LDL fraction that had been incubated with DL-alpha-tocopherol, was 
stored at -80eC until analysis of its concentration in alpha-tocopherol. Butylated Hydroxy 
Toluene (BHT) was added to prevent oxidation. Alpha-tocopherol in LDL was determined by 
HPLC on a 5-um column (Lichrospher RP-18; Merck, Darmstadt, Germany). Alpha-tocopheryl 
acetate (Merck) was used as an internal standard. The mobile phase consisted of methanol: 
isopropanokwater (50:50:8), by vol) and the flow rate was 0.6 mL/min. Alpha-tocopherol was 
detected by UV-Vis spectrometry at 292 nm, and alpha-tocopheryl acetate at 284 nm. 
Statistical analyses 
The duplicate values were averaged before data analysis. We applied the Least Square Means 
of the General Linear Models (GLM) of the Statistical Analyses System (SAS Institute Inc. 
1989) to analyse whether the various tested phenols significantly affected the absolute values 
of the lag time and maximum rate of LDL oxidation compared to control-treated plasma (one-
tailed, P<0.05). Control-treated plasma was included in each experiment as either a monoplo or 
duplo and the observed lag time and maximum rate were adjusted for run as an independent 
variable. The Dunnett multiple comparison test was used to adjust for multiple comparisons. 
For the concentration-dependent oxidisability of LDL we compared each concentration with 
the control-treated plasma by using ANOVA, with dose and run as independent variables. 
RESULTS 
Effect of olive oil phenols, extracts and other dietary antioxidants on 
LDL oxidisability 
The effects of pre-incubation of plasma with antioxidants at a concentration of 1000 umol/L on 
the lag time of copper-induced LDL oxidation are presented in Figure 5.2. 
Hydroxytyrosol, 3,4-dihydroxyphenylacetic acid and catechin all increased the lag time of 
the LDL oxidation process compared to LDL derived from control treated plasma, indicating that 
an ortho-dihydroxy structure on the phenol ring is important in determining antioxidant function. 
The mono-hydroxy phenols (tyrosol and 4-hydroxyphenyl acetic acid) were, on the other hand, 
ineffective in affording protection. This was also the case for alpha-tocopherol, whereas gallic 
acid slightly increased the lag time. Green tea extract was most efficient in delaying the lag time 
compared to all other ingredients examined in this study. All 3 olive oil extracts, normalised to a 
concentration of 1000 umol of phenols per litre, were shown to increase LDL resistance to in 
vitro oxidation. 
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Figure 5.2 Effect of all compounds and extracts on the lag time of copper-mediated LDL oxidation. Plasma 
was incubated with the compounds at a concentration of 1000 umol/L LDL was isolated by means of density 
gradient ultracentrifugation and submitted to oxidation by the addition of cupric ions. The formation of 
conjugated dienes was monitored spectrophotometrically and the lag time of the oxidation process was 
determined as described in detail in Materials and Methods. The results presented are the mean lag time ± SD 
of 2 independent determinations. Compounds indicated with # are present in olives or olive oil. * = Significant 
increase in lag time compared to the control samples. 
The effect of all compounds or extracts tested on the maximum rate of oxidation during the 
propagation phase at a concentration of 1000 umol/L were also determined. Green tea extract 
and 3,4 dihydroxyphenyl acetic acid slightly, albeit significantly, reduced the oxidation rate 
compared to control plasma (18.6 nmol conjugated dienes/min/mg LDL protein for the green 
tea extract (P=0.004) and 19.3 nmol conjugated dienes/min/mg LDL protein for 3,4-dihydroxy 
phenylacetic acid (P=0.02) versus 22.5 nmol conjugated dienes/min/mg LDL protein for the 
control plasma). All other components did not significantly alter the oxidation rate (data not 
shown). 
For some of the compounds investigated, the minimum concentration required to increase 
LDL resistance to oxidation was determined by incubating plasma with concentrations ranging 
from 0 -1000 umol/L The results are shown in Figure 5.3. 
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Figure 5.3 Effect of antioxidant concentration on the lag time of copper-induced LDL oxidation. Plasma was 
incubated with the antioxidants in concentrations varying between 0 and 1000 umol/L. LDL was isolated and 
its resistance to oxidation was determined as described in Materials and Methods. The results presented are 
the mean of 2 independent determinations of the lag time. * = Significant increase in lag time compared to 
control samples. 
For most olive oil components a minimum concentration of 100 umol/L was required to 
significantly increase the lag time, and at this concentration the increases in lag time were 
comparable for these components. However, when higher concentrations were used, the 
increase in lag time varied considerably between the ingredients. Green tea extract, 
hydroxytyrosol, non-polar extract 1 and the polar extract all progressively increased the lag time 
with increasing concentrations. In contrast increasing doses of non-polar extract 2 and 
oleuropein-glycoside only moderately influenced the lag time. 
The maximum rates of LDL oxidation during the propagation phase were not studied for the 
various concentrations of the compounds and extracts tested as for the lag time, because pre-
incubation of plasma with those compounds at a concentration of 1000 umol/L had no major 
effect on the maximum rate of LDL oxidation. 
Effect of incubation of plasma with alpha-tocopherol on its levels in 
LDL 
Due to its lipophilicity, vitamin E is incorporated in lipoproteins such as LDL. The effect of 
incubating plasma with alpha-tocopherol on its partitioning in LDL was evaluated. The results in 
Figure 5.4 show that alpha-tocopherol was incorporated dose-dependently in LDL. Despite the 
nearly five-fold increase in vitamin E content of the LDL particles following an incubation of 
plasma with 1000 umol/L alpha-tocopherol, only a marginal increased protection of LDL against 
oxidation was observed (Figures 2 and 3). 
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Figure 5.4 Vitamin E content in LDL isolated from plasma that was incubated with vitamin E concentrations 
ranging from 0 to 1000 umol/L. LDL was isolated by means of density centrifugation and the vitamin E content 
in LDL was determined by HPLC as described in Materials and Methods. Vitamin E concentrations are 
expressed in nmoles per mg LDL protein. 
D I S C U S S I O N 
The results of the present study show that LDL isolated from plasma that has been incubated 
with the ortno-dihydroxy phenol hydroxytyrosol and with extracts rich in hydroxytyrosol, have an 
increased resistance of LDL to copper-induced oxidation. However, the mono-hydroxy 
counterparts, tyrosol and tyrosol-rich olive oil extracts appeared to have little effect on the 
susceptibility of LDL to oxidation. 
We compared the effects of the various phenols to determine whether structural features 
influence antioxidant activity. The importance of the ortno-dihydroxy feature in antioxidant 
function is confirmed in this study, since hydroxytyrosol, 3,4-dihydroxy-phenylacetic acid and 
catechin all efficiently increased the lag time of the LDL oxidation process. From the literature it 
is known that mono-hydroxy polyphenols have weak antioxidant properties (Rice-Evans et al, 
1996), which was also the case for tyrosol and 4-hydroxyphenylacetic acid in the present study. 
In addition to pure individual phenols, olive oil extracts and green tea extract were also tested. 
The polar and non-polar olive oil extracts as well as green tea extract all contained phenols, 
including ortfto-dihydroxy phenols. Indeed all extracts increased LDL resistance. A positive 
relationship between the concentrations of hydroxytyrosol and oleuropein-aglycone in the 
extract and the lag time could be observed: non-polar extract 1 and the polar extract both with a 
relatively high content of oleuropein-aglycone and hydroxytyrosol were more effective in 
protecting LDL from oxidation than non-polar extract 2 with a relatively low oleuropein-aglycone 
and hydroxytyrosol content (Table 5.1, Figure 5.2). 
Only green tea extract and 3,4 dihydroxyphenyl acetic acid slightly reduced the oxidation 
rate of the propagation phase of the LDL oxidation process, whereas all other antioxidants or 
antioxidant-rich extracts did not influence this oxidation rate. This indicates that, similar to the 
loss of antioxidants endogenously present in LDL, the majority of supplementary antioxidants is 
destroyed during the lag phase and that, after complete consumption of the antioxidants 
present in LDL, other constituents such as lipids become prone to copper-mediated oxidation 
(Esterbauer era/, 1992). It should be noted that we would expect the maximum rate of oxidation 
to be affected when the lipid composition in the LDL particle had changed, which is not the case 
in this in vitro system. 
Of all antioxidants evaluated, alpha-tocopherol was the most lipophilic. Alpha-tocopherol 
levels in isolated LDL increased approximately five-fold after incubation of plasma with 1000 
umol/L of this antioxidant, but only marginally increased LDL resistance. In contrast, human 
studies have reported vitamin E (DL alpha-tocopherol) supplementation protects LDL from 
oxidation (Princen et al, 1995; Jialal et al, 1995). The concentrations of vitamin E in isolated 
LDL in the current in vitro study were similar to the concentrations of vitamin E in isolated LDL 
in a human study by Princen et al (1995) (5.3-23.7 nmol/mg LDL protein and 13.2-29.6 
nmol/mg LDL protein, respectively). However, the amounts added to plasma in the current in 
vitro study were much higher (0-1000 umol/L) compared to the plasma concentrations of the 
subjects in the human study of Princen et al (23.6-61.2 umol/L) who consumed vitamin E 
supplements for minimally 2 wk. This indicates that under these in vitro conditions, the plasma 
alpha-tocopherol concentration needs to be much higher to end up with similar concentrations 
in LDL after isolation compared to the in vivo situation. A likely explanation for this difference 
may be that after ingestion vitamin E is incorporated in LDL through the alpha-tocopherol 
transfer protein (Stacker & Azzi, 2000), which is not present in an in vitro situation. In addition, 
the location of vitamin E within the LDL particle after incubation may differ from vitamin E that is 
incorporated via the metabolic route. This might influence its effectiveness in protecting lipids in 
LDL particles against oxidation. Comparison with other in vitro studies also reveals several 
discrepancies. Some studies showed no or limited protecting effects of vitamin E (Vinson er al, 
1995), whereas another in vitro study (Esterbauer et al, 1989) showed a protective effect of 
vitamin E. Differences in experimental conditions, such as incubation time or higher vitamin E 
concentrations in LDL, make it difficult to compare these in vitro studies. 
The amounts of antioxidants required to inhibit LDL oxidation when added to whole plasma 
were substantially higher compared to experiments where antioxidants are directly added to 
isolated LDL (Visioli & Galli, 1994; Visioli et al, 1995). An approximately 100 fold higher 
concentration of antioxidants needs to be added to plasma in order to achieve a similar 
inhibitory effect compared to the condition where antioxidants are directly added to isolated 
LDL. When phenols are directly incubated with isolated LDL they can directly trap radicals 
generated in the system. Furthermore, they have no other alternative than to associate with 
LDL, and this leads to a substantially higher accumulation of phenols in LDL compared to the 
plasma incubation method. In plasma, olive oil phenols might bind to a number of other proteins 
present. In fact, the majority of the polyphenol quercetin indeed binds to plasma proteins of 
which serum albumin is the major binding site (Boulton ef al, 1998). Phenols are less lipophilic 
than tocopherol and carotenoids, therefore integration within the core of the LDL particle is 
unlikely. Also, a loss of phenols during the isolation procedure might lead to reduced 
concentration in the final experimental conditions (Carbonneau ef al, 1997). Fito ef al (2000) 
compared the effect on LDL oxidisability of plasma that was spiked with antioxidants before 
analyses with that of isolated LDL that was incubated with phenols directly. They showed that 
plasma needed to be spiked with substantially higher amounts of olive oil phenols in order to 
achieve an increase in LDL resistance to oxidation. Our observations are in line with those 
observed by Fito and co-workers. They found that 160 mg caffeic acid equivalents per L of 
plasma, which equals to about 900 umol of olive oil phenols per L of plasma, extended the lag 
time by about 110%, which is comparable to the increases in lag time observed in the current 
study. 
The ability of olive oil phenols to associate with LDL may be an important factor 
determining LDL resistance, which is suggested by the different effects of oleuropein-glycoside 
and its aglycone. Like its aglycone, oleuropein-glycoside is equipped with a hydroxytyrosol 
moiety but is considerably more hydrophilic due to its glycosylation and is, therefore, expected 
to show less association with LDL. Indeed oleuropein-glycoside only slightly increased the LDL 
resistance whereas the oleuropein-aglycone rich extract resulted in a considerable protection of 
LDL against oxidation. 
Feeding trials in rabbits and rats demonstrated that phenolic antioxidants from olive oil 
showed a favourable effect on the susceptibility of LDL to oxidation (Scaccini ef al, 1992; 
Wiseman ef al, 1996; Coni ef al, 2000;). During these feeding trials, the animals were fed with 
considerable amounts of olive oil for a prolonged period. In the study reported by Wiseman ef al 
(1996), rabbits were fed for a 6-wk period with an experimental diet rich in extra virgin olive oil. 
This probably leads to much higher plasma levels of olive oil phenols leading to the 
accumulation of sufficient amounts of phenols in LDL that provide protection in the ex vivo 
determination of LDL resistance. 
In contrast most human intervention studies (Nicolaiew ef al, 1998; Bonanome etal, 2000; 
Vissers etal, 2001a; Vissers etal, 2001b), have failed to demonstrate a protective effect of olive 
oil consumption on ex vivo LDL oxidisability in either fasting and postprandial plasma samples. 
Only the study of Ramirez-Tortosa ef al (1999) showed a decrease in LDL oxidisability after 3 
months of consumption of extra virgin olive oil compared to refined olive oil. However, the 
method for measurement of LDL oxidation described in this study was completely different and 
cannot be compared with our own study and the other published studies. One possible 
explanation for the lack of effect in the majority of the human studies is that the dose of the 
phenols was too low to reduce LDL oxidisability. We do not know the plasma concentrations of 
the various phenols that were reached in these human studies but, based on results of a study 
with quercetin, a dose of maximally 100 mg (about 275 umol) did probably not result in a 
plasma concentration higher than 1 umol/L (Hollman et al, 1997). Daily intake of olive oil 
phenols in the Mediterranean is estimated to be 10-20 mg (Visioli et al, 1995), which implies 
that the level of phenols in olive oil is too low to produce meaningful effects on LDL oxidisability 
within the normal range of consumption. Thus, it is likely that the plasma concentrations in 
humans were too low to produce an effect on the ex vivo oxidation of LDL. 
Data concerning intestinal absorption of phenols from olive oil is scarce. Furthermore, it is 
not known whether sufficient phenols accumulate in LDL particles to provide protection from 
oxidation. Until now, only Bonanome et al (2000) recovered hydroxytyrosol and tyrosol in LDL, 
albeit, with a high variability among subjects. Phenols are probably present in the conjugated or 
metabolised form in plasma or LDL. Recently, it has been shown that tyrosol and 
hydroxytyrosol were mainly excreted in urine in the conjugated form (Visioli et al, 2000a) and 
also that the metabolite Omethylated hydroxytyrosol was excreted in high amounts after 
phenol-rich olive oil had been consumed (Visioli et al, 2000b). Conjugation, such as 
glucuronidation and sulfation, renders phenols more hydrophilic and this might reduce their 
antioxidant capacity (Morand et al, 1998; Manach et al, 1998). The antioxidant capacity of the 
metabolite Omethylated hydroxytyrosol is not known, but for quercetin it has been 
demonstrated that the magnitude of prolonging the lag phase for 3'-0-methylquercetin is about 
half of that of its aglycone (Manach et al, 1998). Future research should therefore focus more 
on the kinetics and metabolism of phenols in humans. 
In conclusion, the present in vitro study shows that olive oil phenols and olive oil extracts 
rich in phenols increase the resistance of LDL against peroxidation. The orffto-dihydroxyphenol 
and oleuropein-aglycone are more efficient than their mono-hydroxy counterparts in protecting 
LDL. The ability of phenols to partition in LDL is also expected to be a relevant factor for the 
antioxidant efficacy. Glycosylated phenols, such as oleuropein-glycoside, are very hydrophilic 
and only marginally increase LDL resistance, whereas a mixture rich in the aglycone 
counterparts display more antioxidant activity in this model system. The explanation that in vitro 
studies show protective effects whereas the majority of human studies do not, may be due to 
the fact that the dose of the phenols and thus their plasma concentration in humans was too 
low to reduce LDL oxidisability. This implies that the level of phenols in olive oil is too low to 
produce meaningful effects on ex vivo LDL oxidisability within the normal range of olive oil 
consumption. However, more in vivo studies are needed to confirm these protective effects. In 
addition, it is plausible that olive oil antioxidants may play a role in other mechanisms of actions 
related to coronary heart disease. Thus, we need to increase our knowledge on the 
bioavailability, metabolism and other mechanisms of action of olive oil phenols for a better 
understanding of the potential health benefits that extra virgin olive oil may provide. 
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ABSTRACT 
Animal and in vitro studies suggest that olive oil phenols are effective antioxidants. The most 
abundant phenols in extra virgin olive oil are the non-polar oleuropein- and ligstroside-
aglycones which can be hydrolysed into the polar hydroxytyrosol and tyrosol. 
Aim of this study was to get more insight into the absorption and metabolism of olive oil 
phenols in humans. We therefore measured their absorption and urinary excretion in 8 healthy 
ileostomy subjects. To assess the influence of colonic bacteria in the metabolism of those 
phenols we also determined urinary excretion in 12 subjects with a colon. Subjects consumed 
single doses of 3 different supplements containing 100 mg of olive oil phenols on separate days 
in random order. Ileostomy subjects consumed a supplement with mainly non-polar phenols, 
one with mainly polar phenols, and one with the parent compound oleuropein-glycoside. 
Subjects with a colon consumed a supplement with mainly non-polar phenols, one with mainly 
polar phenols, and one without phenols (placebo). Ileostomy effluent and urine were collected 
for 24 h after supplement intake. 
Tyrosol and hydroxytyrosol concentrations were low (<4 mol% of intake) in the ileostomy 
effluent, and no aglycones could be detected. We estimated that the apparent absorption of 
phenols was at least 55-66 mol% of the ingested dose. 
Absorption was confirmed by the excretion of tyrosol and hydroxytyrosol with urine. In 
ileostomy subjects 12 mol% and in subjects with a colon 6 mol% of the phenols from the non-
polar supplement was recovered in urine as tyrosol or hydroxytyrosol. In both subject groups 5 
to 6 mol% of the phenols was recovered from the polar supplement. When ileostomy subjects 
were given oleuropein-glycoside 16 mol% was recovered in 24-h urine, mainly in the form of 
hydroxytyrosol. 
We conclude that humans absorb a large part of ingested olive oil phenols. Furthermore, 
oleuropein-glycoside and oleuropein- and ligstroside-aglycones are probably hydrolysed into 
hydroxytyrosol and tyrosol and further metabolised after absorption. 
INTRODUCTION 
Olive oil is the principle fat source of the traditional Mediterranean diet, a diet that has been 
associated with a low incidence of coronary heart disease (Keys ef al, 1986). Oleic acid, the 
main fatty acid in olive oil, has favourable effects on blood cholesterol concentration, when 
compared to saturated fat (Katan et al, 1995), and on LDL oxidisability (Reaven ef al, 1991). 
However, extra virgin olive oil also contains phenolic compounds with antioxidant activity, which 
are potentially beneficial against LDL oxidation (Wiseman ef al, 1996; Scaccini ef al, 1992; 
Visioli ef al, 1995; Salami ef al, 1995; Caruso ef al, 1999). The most abundant phenols in extra 
virgin olive oil are the non-polar oleuropein- and ligstroside-aglycones and their derivatives. 
They are formed in olives by enzymatic removal of glucose from the polar parent compound 
oleuropein-glycoside. End products of hydrolysis of oleuropein- and ligstroside-aglycones in 
olive oil are the polar compounds hydroxytyrosol and tyrosol, respectively (Figure 6.1). 
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Figure 6.1 Structures of phenols present in olives and olive oil, their degradation into aglycones during 
ripening, and hydrolysis of aglycones into tyrosol and hydroxytyrosol. 
A Mediterranean diet rich in olive oil supplies about 10-20 mg of phenols per day (Visioli ef al, 
1995). However, it is unknown to what extent olive oil phenols are absorbed. An in vitro study in 
Caco-2 cells showed that hydroxytyrosol is transported via passive diffusion in a dose 
dependant manner (Manna ef al, 2000). A human study also showed that tyrosol and 
hydroxytyrosol are excreted in urine (Visioli ef al, 2000a). These results suggest that these 
simple olive oil phenols are absorbed in the intestine after ingestion, but it is unclear to what 
extent tyrosol and hydroxytyrosol are absorbed in humans. Furthermore, data on the absorption 
of oleuropein- and ligstroside-glycosides and -aglycone are scarce. Using an isolated perfused 
rat intestine, Edgecombe ef al (2000) found that oleuropeine-glycoside was poorly absorbed. 
However, no information is available on the extent of absorption of oleuropein- and ligstroside-
glycosides and -aglycones in humans. 
In the present study we estimated the apparent absorption of the various phenols from 
extra virgin olive oil and that of oleuropein-glycoside, the parent compound of the phenols 
present in olive leafs and olives (Soler-Rivas et al, 2000). A major problem in studying the 
absorption of phenols in humans is their degradation by micro-organisms in the colon, which 
results in an overestimation of the absorbed amount when faecal excretion is measured. We 
therefore determined the absorption in healthy ileostomy subjects with a complete small 
intestine. To get more insight into the metabolism we also determined urinary excretion of the 
phenols. However, the ileostomy model does not take into account the influence of colonic 
bacteria in the metabolism of those phenols. We therefore also determined the urinary 
excretion of tyrosol and hydroxytyrosol in volunteers with a colon. 
SUBJECTS AND METHODS 
Subjects 
The study protocol was approved by the Medical Ethical Committee of the Division of Human 
Nutrition and Epidemiology of Wageningen University. We fully explained the protocol to the 
participants before they gave their written informed consent. 
Ileostomy subjects. We recruited ileostomy subjects from a group of volunteers who 
successfully participated in previous studies at our division (Olthof et al, 2001; De Roos et al, 
1998; Hollman et al, 1995). Ileostomy subjects have had their colon completely removed and 
the terminal ileum brought out onto the anterior abdominal wall as a fistula. Exclusion criteria 
were resection of more than 50 cm of the terminal ileum; signs of diseases related to the 
gastrointestinal tract; an ileostomy that did not function properly; use of drugs that influenced 
gastrointestinal transit; present illness; and pregnancy or lactation. Four men and 4 women, 
with a mean age of 57 y (range 37-75 y) and a mean body mass index of 25.2 kg/m2 (range 
22.1-28.8 kg/m2), were eligible and willing to participate. All subjects had had a total colectomy 
for ulcerative colitis or polyposis coli 8-31 y ago. 
Subjects with a colon. Subjects with a colon were volunteers who also participated in a 
larger study on the effect of phenols on LDL oxidation in which urine was collected (Vissers et 
al, 2001). The 12 healthy subjects (8 females, 4 males) had a mean age of 22 y (range 
20-28 y), a mean body mass index of 21.8 kg/m2 (range 18.3-27.1 kg/m2), serum cholesterol 
concentrations <7.0 mmol/L, and fasting triglycerides <2.3 mmol/L Subjects had no history of 
gastrointestinal, liver or kidney disease, did not use any drugs known to affect concentrations of 
serum lipids, and were not pregnant, lactating, or on a prescribed diet. 
Both subject groups with an ileostoma and with a colon were healthy as judged by normal 
blood count, the absence of glucose and protein in urine, and a medical questionnaire, which 
was reviewed by an independent physician. 
Study designs 
Design, duration, and setting of the studies in subjects with and without a colon were essentially 
similar. Each subject consumed a single dose of 3 different supplements, on separate days in 
random order (cross-over). Both studies consisted of a 3-wk treatment period, during which 
subjects were not allowed to consume olives or olive oil. At the end of each week, on days 8, 
15, and 22, subjects consumed one of the provided supplements together with a standard 
breakfast. All subjects kept daily records of illness and deviations from the protocol. 
Ileostomy subjects. We delivered the supplement and the breakfast at the subjects' home 
on the day before each supplement intake (days 7, 14, and 21). Breakfast consisted of bread, 
cheese, ham, strawberry jam, honey, milk, buttermilk, tea or coffee, plus the supplement. Each 
subject consumed exactly the same amount of breakfast on each of the 3 occasions. Tea, 
coffee or other foods and drinks were not allowed until lunch. 
Subjects with a colon. The study design for subjects with a colon was the same as that 
for ileostomy subjects, except that the supplements were incorporated into a mayonnaise and 
that breakfast also contained cucumber, tomato, and tuna. Furthermore, subjects with a colon 
consumed the supplements at our department instead of at home. Tea, coffee or other foods 
and drinks were not allowed until 2 h after supplement intake. 
Subjects with a colon consumed a fourth supplement containing 31 mg of mainly non-polar 
aglycones (Vissers etal, 2001), but because of its low dose of phenols compared with the other 
supplements we do not present the urine excretion data. 
Supplements 
Subjects consumed single doses of 3 different supplements containing 100 mg of olive oil 
phenols. Ileostomy subjects consumed a supplement with mainly non-polar phenols, one with 
mainly polar phenols, and one with the parent compound oleuropein-glycoside. Subjects with a 
colon consumed a supplement with mainly non-polar phenols, one with mainly polar phenols, 
and one without phenols (placebo). There were minor batch differences in phenol concentration 
between supplements for ileostomy subjects and those for subjects with a colon (Table 6.1). 
Non-polar supplement. The supplement with non-polar phenols was extracted from extra 
virgin olive oil with food-grade ethanol, which was evaporated at a later stage. This produced a 
dark green oil-like fluid rich in non-polar phenols. Ileostomy subjects drank 17.2 g of this 
supplement. Subjects with a colon consumed 37 g mayonnaise prepared with 14.5 g of the 
supplement (Table 6.1). 
Polar supplement. The supplement with polar phenols was extracted from extra virgin 
olive oil by reversed osmosis. This produced a clear watery fluid rich in polar phenols. Ileostomy 
subjects drank 10.3 g of this supplement. Subjects with a colon drank 8.7 g of this supplement 
(Table 6.1) plus 37 g mayonnaise prepared with 14.5 g olive oil without phenols to equalise fat 
intake between breakfasts. 
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Oleuropein-glycoside. The supplement containing oleuropein-glycoside was 
commercially available in capsules (Solgar Laboratories, Leonia N.J., USA). Ileostomy subjects 
swallowed 4 capsules, which was 1.9 g (Table 6.1). 
Placebo supplement. Subjects with a colon consumed a placebo supplement that 
consisted of 37 g mayonnaise prepared with 14.5 g olive oil without phenols. 
Analyses of phenols. We measured the phenol concentration of the supplements with an 
HPLC method based on the method of Montedoro et al (1993). With this HPLC method 
hydroxytyrosol and tyrosol and 10 derivatives of the oleuropein- and ligstroside-aglycones were 
separated, of which the peaks were identified with HPLC-MS-MS (Table 6.1, Figure 6.2). The 
12 major peaks in the HPLC chromatogram were quantified using the area/ug at X = 280 nm of 
the individual compounds (hydroxytyrosol, tyrosol and oleuropein) or mixtures (aglycones). The 
aglycone reference mixture was obtained by enzymatic hydrolysis of oleuropein by 
p-glucosidase. The various derivatives differ mainly in their ring structure, which can either be 
open or closed in two different forms (van Boom et al, in preparation). 
-J»« 
1; 
1411 
B 
Figure 6.2 Chromatogram of various identified phenols in the non-polar (A) and the polar (B) supplement. 
The numbering of the peaks refer to the numbering of the various phenols in Table 6.1: 1 = hydroxytyrosol; 
2 = tyrosol; 3,4, 5,7, 8,9,10 = oleuropein-aglycones; 6,11,12 = ligstroside-aglycones. 
Collection of ileostomy effluent and urine 
On days 8,15, and 22 subjects collected a sample of ileostomy effluent and/or urine just before 
intake of the supplement and breakfast. After intake of the supplement they collected all 
ileostomy effluent and/or urine for 24 h. Ileostomy subjects changed the ileostomy bag every 
2 h during the daytime. They immediately stored collected ileostomy effluent in a polystyrene 
box containing dry ice (-80°C) to minimise degradation of the contents by residual bacterial 
flora. During the night subjects changed the ileostomy bags 1 to 3 times. 
Subjects collected all urine during 24 h in plastic bottles of 0.5 L containing 0.13 g thymol 
(#8167, Merck, Amsterdam, The Netherlands) as a preservative and stored the bottles with 
urine on dry ice immediately after voiding. We checked the completeness of urine collection by 
assessment of recovery of 250 umol lithium chloride in urine (Sanchez-Castillo et al, 1987a; 
Sanchez-Castillo et al, 1987b). Therefore, subjects drank a solution of 250 umol lithium chloride 
in 10 mL of tap water daily, starting 7 d before the first urine collection. Urinary recovery of 
lithium was 98 ± 15%, which indicated good compliance in collecting urine. 
Sample preparation 
The filled ileostomy bags were frozen with liquid nitrogen, the plastic bags were removed, and 
the frozen contents were lyophilised, ground to pass through a 0.5 mm sieve, and stored at 
-20°C until analysis. All urine samples were thawed in a water bath of approximately 40°C, 
pooled by subjects, homogenised, and stored at -80°C until analysis. Ileostomy and urine 
samples collected before breakfast (pre-supplement sample) and the final collection 24 h after 
intake of the supplement were prepared separately. 
Stability of phenols in gastrointestinal fluids 
We evaluated the stability of the phenols in gastric juice and duodenal fluid in vitro in order to 
assess possible losses of phenols during gastrointestinal transit. Gastric juice and duodenal 
fluid were obtained from 2 fasted healthy volunteers with a colon by means of a probe and 
stored at -20°C. We incubated 1 mg of tyrosol (Fluka, Buchs, Switzerland), hydroxytyrosol 
(prepared by Unilever Research Vlaardingen), and oleuropein-glycoside (Roth, Karlsruhe, 
Germany) in 1 mL human gastric juice plus 10 mL water at 37°C for 0.5 and 2 h (Roxburgh et 
al, 1992; Jebbink et al, 1992). We also incubated 3 mg of tyrosol, hydroxytyrosol, and 
oleuropein-glycoside in 3 mL human duodenal fluid plus 9 mL water at 37°C for 1 and 4 h, 
corresponding to the average and maximal transit time in the small intestine, respectively 
(Malagelada et al, 1984). All measurements were done in triplicate. 
We studied the stability of tyrosol, hydroxytyrosol, and oleuropein-glycoside in ileostomy 
effluent in a separate experiment. Two ileostomy subjects did not consume olives, olive oil, and 
olive oil products for 4 d. On day 4 they connected an ileostomy bag to their ileostoma 
containing 30 mg tyrosol mixed into 3 g strawberry jam. They collected ileostomy effluent into 
this bag for 2 h during which they regularly kneaded the content to mix the strawberry jam with 
the ileostomy fluid. They then repeated the process with a bag containing 30 mg hydroxytyrosol 
mixed into 3 g strawberry jam and with a bag containing 30 mg oleuropein-glycoside mixed into 
3 g strawberry jam. The contents of each ileostomy bag were then stored and analysed as 
described below. 
We could not study the in vitro stability of the various aglycones, because these were not 
available in the pure form. 
Analytical methods 
Tyrosol and hydroxytyrosol in ileostomy effluent. 
We extracted 0.25-1.0 g of lyophilised effluent with 50 mL dimethylformamide (DMF), dispersed 
the suspension with a Polytron mixer (model PT10/35, Kinematica AG, Lucerne, Switzerland) at 
medium speed for 1 min, and equilibrated it for 30 min. The suspension was shaken after 15 
and 30 min, and then centrifuged at 3000 rpm (1580 x g) for 10 min. We silylated 0.25 mL of 
the supernatant with 0.25 mL of A/,0-£>/s(trimethylsilyl)-trifluoroacetamide with 1% 
trimethylchlorosilane, heated the extract at 70°C for 45 min, and splitlessly injected 1 ul of the 
effluent extract on a GC-MS apparatus (GC model 5890, MSD 5971, Hewlett-Packard GmbH, 
Waldbronn, Germany) that was equipped with a 25 m x 0.25 mm CP-SIL5-CB low bleed MS 
column (Chrompak Intemation B.V., Middelburg, The Netherlands). We used helium as carrier 
gas at a flow rate of 20 cm/sec. We used the same oven conditions, temperatures of injection 
port, transfer line and detector as described by Bai et al (1998), except that the final oven 
temperature of the program was extended to 27 min. We applied selected ion monitoring for 
quantification of phenols and recorded target ions at 179.1 m/z for tyrosol and at 267.1 m/z for 
hydroxytyrosol. Peaks were identified based on retention times and qualifier ions that were 
recorded at 282.2 m/z for tyrosol and at 370.1 m/z for hydroxytyrosol. We obtained calibration 
curves by 6 injections of different concentrations of 2 standards before and after the samples, 
and we performed calculations by the external standard method. We carried out all 
determinations in duplicate. The detection limits were 10.1 nmol for tyrosol and 7.1 nmol for 
hydroxytyrosol per g lyophilised ileostomy effluent. Addition of 38.5 ug tyrosol and 37.0 ug 
hydroxytyrosol per g ileostomy effluent yielded a recovery of 114.4 ± 12.8% for tyrosol and 
115.6 + 9.2% for hydroxytyrosol. 
Oleuropein-glycoside and ligstroside-aglycone derivative in ileostomy effluent. 
We dissolved 0.5 g of lyophilised ileostomy effluent in 9.5 mL water/methanol (40:60, v/v) and 
extracted it at 75°C under nitrogen for 1 h. We sonicated the suspension for 5 min, shook it with 
2 mL hexane, and centrifuged it for 10 min (4500 x g, 7°C). Hexane was removed and the 
water-phase was filtered through a 0.45 urn filter. We injected 25 ul of the water-phase onto an 
HPLC with an Inertsil ODS-3 (GL Sciences Inc, Tokyo) column (4.6 x 250 mm, 5 urn particle 
size) using a gradient of 2% acetic acid in water and methanol as mobile phase, at a flow rate 
of 1 mL/min. We measured the phenolic compounds at 280 nm with a Waters 996 diode-array 
detector (Waters, Milford, MA) semi-quantitatively, using the peak height/mg supplement for 
quantification. 
We quantified oleuropein-glycoside in the ileostomy effluent after subjects had ingested the 
oleuropein-glycoside supplement. Furthermore, we quantified only one ligstroside-aglycone 
derivative in the ileostomy effluent after subjects had ingested the non-polar supplement 
(Figure 6.2A, #6). In order to determine the detection limit we added various doses of the 
supplements as consumed by subjects to blank ileostomy effluent without olive oil phenols. We 
estimated from these measurements that the detection limit in ileostomy effluent of the 
oleuropein-glycoside and the ligstroside-aglycone derivative corresponded with about 25% of 
their amount ingested. This corresponded with 48 umol/24 h for the oleuropein-glycoside and 
45 umol/24 h for the ligstroside-aglycone derivative. The detection limits of other aglycones and 
derivatives in the ileostomy effluent was higher than 100% of their amount ingested. We 
therefore could not quantify those other aglycones and derivatives in ileostomy effluent after 
subjects had consumed the non-polar and polar supplements. Two additional larger peaks in 
the non-polar supplement could not be identified (Figure 6.2A) and were therefore not taken 
into account. We measured every ileostomy sample with and without the addition of the non-
polar supplement, the polar supplement, or the oleuropein-glycoside supplement in order to 
compare the time of the peaks found in the effluent with those present in the supplement. 
Addition of 110 mg non-polar supplement per gram lyophilised ileostomy effluent yielded a 
recovery of 58 ± 9%. Addition of 15 mg oleuropein-glycoside supplement per g lyophilised 
ileostomy effluent yielded a recovery of 86 ± 21%. We present the estimated apparent 
absorption with and without correction for these analytical losses. 
Tyrosol and hydroxytyrosol in urine 
We added 3 mg of p-glucuronidase dissolved in 200 ul phosphate buffer pH 5 (Sigma, 
St. Louis, MO, USA) to 1 mL of urine, and incubated the mixture at 37°C for 24 h. Subsequently 
we added 1 ug/mL of a-naphthol as internal standard and extracted the urine twice with ethyl 
acetate. The organic phase was evaporated to dryness under nitrogen. We dissolved the 
residue in a mixture of dimethylformamide and A/,0-b/s(trimethylsilyl)-trifluoroacetamide with 
1% trimethylchlorosilane and heated it for 45 min at 70°C. We performed GC-MS analysis and 
quantification of the phenols in the same way as for the ileostomy samples. The target and 
qualifier ions for a-naphthol were recorded at 216.0 m/z and 200.95 m/z, respectively. We 
carried out all determinations in duplicate. The detection limit, i.e. the concentration producing a 
peak height 3 times the standard deviation of the baseline noise, was 0.04 umol/L for tyrosol 
and 0.05 umol/L for hydroxytyrosol. Addition of 0.15 ug and 1.6 pg tyrosol per mL urine yielded 
a recovery of 100 ± 6% and 99 ± 4%, respectively. Addition of 0.25 pg and 2.5 pg 
hydroxytyrosol per mL urine yielded a recovery of 103 ± 17% and 105 ± 8%, respectively. 
Oleuropein-glycoside and the ligstroside-aglycone were not analysed in urine. 
RESULTS 
Composition of the supplements 
Chromatograms of the phenol composition of the non-polar and polar supplements are 
presented in Figure 6.2A and 6.2B. The main phenol in the non-polar supplement was the 
ligstroside-aglycone derivative (#6) whereas the main phenols in the polar supplement were 
hydroxytyrosol (#1), tyrosol (#2), and an oleuropein-aglycone derivative (#3). Oleuropein-
glycoside was the only phenol present in the oleuropein-glycoside supplement (data not 
shown). 
Stability of phenols 
Olive oil phenols appeared stable in gastric juice and in duodenal fluid. Tyrosol and oleuropein-
glycoside were also reasonably stable in ileostomy effluent: Incubation of these phenols with 
ileostomy effluent for 2 h yielded a mean recovery of 76% for tyrosol 8 1 % for oleuropein-
glycoside. Mean recovery for hydroxytyrosol added to ileostomy effluent was only 51 %: 29% for 
one subject and 72% for the other (Table 6.2). 
Table 6.2 Percentage of tyrosol, hydroxytyrosol, and oleuropein-glycoside recovered after incubation with 
human gastric juice or duodenal fluid in vitro, or with ileostomy effluent ex vivo. 
Supplement 
Tyrosol 
Hydroxytyrosol 
Oleuropein-glycoside 
Gastric 
0.5 h 
113 
96 
99 
juicea 
2h 
128 
112 
98 
Duodenal fluid3 
1 h 
(%) 
99 
89 
101 
4h 
95 
79 
98 
Ileostomy 
effluent" 
2h 
76 (76-77) 
51 (29-72) 
81 (79-82) 
a
 Mean of triplicate analyses 
" Mean (range) of recoveries in ileostomy bags on the bodies of two subjects. Analytical recovery after addition to 
lyophilized effluents was 114% for tyrosol, 116% for hydroxytyrosol, and 86% for oleuropein-glycoside (see Analytical 
methods). 
Excretion of phenols in ileostomy effluent 
Excretion of tyrosol and hydroxytyrosol in ileostomy effluent was low. It was highest on the non-
polar supplement rich in aglycones, but it was always less then 4 mol% of total phenol intake 
(Table 6.3). 
The ileostomy effluent of subjects who had ingested the oleuropein-glycoside supplement 
contained a small amount of material with the retention time of oleuropein-glycoside 
(Figure 6.3). The ileostomy effluent of subjects who had consumed the non-polar supplement 
contained a minor amount of a compound with the retention time of the major component of this 
supplement, the ligstroside-aglycone derivative #6 (Figure 6.4). However, the size of both 
these peaks was less than 25% of the size of the peaks seen when one daily dose of 
oleuropein-glycoside or non-polar supplement was mixed into blank ileostomy effluent and 
analysed. Such in vitro mixing studies showed that the detection limit for oleuropein-glycoside 
and for the ligstroside-aglycone derivative #6 was about 25% of the administered daily dose per 
24-h collection of ileostomy fluid (data not shown). This means that the amount excreted in the 
ileostomy effluent was less than could be reliably identified and quantified. We therefore 
assumed that 25% of the ingested dose was the maximum amount present in the ileostomy 
effluent. Thus, maximally 48 umol oleuropein-glycoside was present in the ileostomy effluent 
after subjects had ingested the oleuropein supplement, and maximally 45 umol ligstroside-
aglycone derivative #6 was present after subjects had ingested the non-polar supplement 
(Table 6.3). 
We could not detect other aglycones and derivatives in ileostomy effluent after subjects 
had consumed the non-polar and polar supplements, but these peaks were also not detectable 
reliably if a full dose of supplement was mixed into blank ileostomy fluid. We therefore assumed 
that the excretion of these non-quantifiable aglycones in the ileostomy effluent was at most 
equal to the amount ingested (Table 6.3). 
Under these assumptions at least 55 to 66 mol% of the phenols from the non-polar 
supplement had been absorbed; 55 mol% if we corrected for the analytical loss of the phenols 
plus their degradation within the ileostomy bag, and 66 mol% if we did not. Apparent absorption 
was somewhat higher for the polar supplement and for oleuropein-glycoside (Table 6.3). 
Excretion of phenols in urine 
The low excretion of olive oil phenols into ileostomy effluent suggested that a large proportion 
was absorbed. We therefore expected to find tyrosol and hydroxytyrosol in urine, as tyrosol and 
hydroxytyrosol were major components of the polar supplement, and likely metabolites of the 
aglycones administered (Figure 6.1). Indeed, both subject groups excreted 5-6 mol% of the 
phenols from the polar supplement into urine in the form of tyrosol or hydroxytyrosol. Ileostomy 
subjects excreted 12 mol% of the phenols from the non-polar supplement into urine in the form 
of tyrosol or hydroxytyrosol. For subjects with a colon this figure was 6 mol% (Table 6.4, 
Figure 6.5). Sixteen mol% of oleuropein-glycoside administered to ileostomy subjects was 
recovered in urine, largely in the form of hydroxytyrosol (Table 6.4, Figure 6.5). Thus, 5 to 
16mol% of total phenols ingested was found back in urine in the form of tyrosol or 
hydroxytyrosol. Oleuropein- and ligstroside aglycones were not measured. Therefore, we do 
not know how much of these phenols was excreted unchanged with the urine. 
The placebo supplement did not contain olive oil phenols. Nevertheless, the urine of one 
subject contained 12.2 umol/24 h of tyrosol and 3.6 umol/24 h of hydroxytyrosol. As a 
consequence, the mean total excretion in urine after the placebo supplement was 
2.6 umol/24 h. Excluding this subject from analysis resulted in mean excretion of 
0.43 ± 0.92 umol/24 h for tyrosol and 0.97 ± 0.97 umol/24 h for hydroxytyrosol. This subject 
reported that he had not eaten olives, olive oil or olive oil products in the days before ingestion 
of the placebo supplement. One explanation might be that tyrosol and hydroxytyrosol are not 
unique to olives and olive oil. 
MB 
4? 
E o 
8 
CD 
& 
c 
CD 
E 
a 
a. 
a. 
3 
o 
c 
<B 
Q . 
s 
o 
o 
o 
>^  O ) 
( 0 
o 
CO 
o 
>. 
• 5 , 
X § 
T 3 
O 
CO 
o 
£• 
o 
<D 
^ 3 
c 
eo 
to 
CD 
A 
CO 
1 -
a> 
> o 
*-• 
CD 
3 
CD 
>. E 
o 
to 
o 
_CD 
c 
c 
g 
CD 
o X 
CD 
c 
ce 
CD 
E 
"c 
CD 
3 
t r CD 
( 0 
.a 3 
CO 
CD 
03 
c 
c 
CD 
E 
CD a. 
a . 
3 
C/3 
. 2 ^ 
S . c 
o . 2 
co t : 
. a o 
co a . 2 
i S i o 
•5 co E- p 
r
 a co o 
co JD 
CO 
c 
s S" 
£ E 
o 3 . 
.2 ~ 
_ o si 
1- 9 
C CD 
CD " O 
Q . 'co 
O O 
c co 
2 y 
3 
CD 
O 
CD 
CO 
O 
£; 
CO 
.2> 
^ U > 
CO 
CO 
CD 
c 0 
0 
5, 
as 
CO O CO 
IS! CD S 
in 00 co 
•K <K 1? 
to co in 
o • - • 
^ 
S CO CO 
CM CO CM 
V V V 
CO CO T * 
c c V 
V 
CO o> 
0 
.c 
0 
CO 
0 
CO 
2 
CO 
in 
0 0 
•<t 
T ^ 
C M 
C\i 
O 
T " 1 
CM .CO 
s 
- 0 
c 
CO 
8" 
2 
% 
0 
5^ 
O 
8 
^ 
s? 
S C\l 
0 
1 
§ 
c 
0 
CD 
£ 
CD 
(1) 
(1) 
5 
rii 
2 
>. E 
Q 
CO 
O 
CD 
CD 
£ 
c 
!c 
15 
E 
§ 
E 
£ 
1 3 
CD 
IS 
E 
•<o 
CD 
3 
1 
c 0 
1 
CD 
•a 
5 
0 
CD 
J 3 
C 
CO 
3 
O" 
0 
c 
CD 
. C 
"5 
c 
.0 
8 
CD 
a 
x: 
•co 
£ 
- 0 
CD 
E 
3 
CO 
CO 
CO 
CD 
5 
_: 
co 
l. 
c 
CD 
E CD 
Q . 
Q . 
3 
CO 
CO 
c 
0 
Z 
0 0 
. C 
CD 
E 
CD 
a . 
a . 
3 
CO 
CO 
0 
a. 
0 
CD 
• D 
'co 
O 
8. 
c 
CD 
Q . 
O 
3 
CD 
O 
CD 
CD 
• O 
3 
O 
CO 
CD 
3 
5 
Q 
+1 
c 
CO 
CD 
5 10 
£ 
CO 
Q . 
Q . 
CO 
CD 
i 
CO 
E 
GO 
CD 
CD 
3 
•Q 
O 
O 
CD 
O 
O 
.CO 
CD 
O ! 
CD 
a. 
to 
S 
0 
CD 
J I 
CO 
at 
a 
CB 
t 
o 
" D 
1 
1 
C\J 
0) 
1 
J = 
0 
1c 
(0 
9> S 
CD 
a. g 
3 
CD 
O 
8 
(0 
(0 
CD 
T3 
W 
g 
"So 
,D> 
CD 
• O 
C 
ca 3 
a-
>, c 
0 
a> 5 
u 
CZ 
CD 
CO 
<D 
Q . 
CO 
§ 
• a 
£ 
CO 
CD 
C3) 
c 
CD 
CO 
O 
T3 
CD 
^ 
60 min 
Figure 6.3 HPLC chromatogram of ileostomy effluent after subjects ingested the oleuropein-glycoside 
supplement. Ileostomy effluent was analysed with (B) and without the addition of the oleuropein-glycoside 
supplement (A). We added 50% of the amount of ingested supplement to the total amount of lyophilised 
ileostomy effluent excreted during 24 h. Line C is the chromatogram of the supplement. The arrow indicates 
oleuropein-glycoside. 
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Figure 6.4 HPLC chromatogram of ileostomy effluent after subjects ingested the non-polar supplement. 
Ileostomy effluent was analysed with (B) and without the addition of the non-polar supplement (A). We added 
50% of the amount of ingested supplement to the total amount of lyophilised ileostomy effluent excreted 
during 24 h. Line C is the chromatogram of the supplement. The arrow indicates the ligstroside-aglycone 
derivative #6. 
Table 6.4 Intake of total phenols from the 4 supplements consumed by ileostomy subjects (n = 8) and/or 
subjects with a colon (n = 12) and subsequent mean excretion of tyrosol and hydroxytyrosol in urine over 
24 h. 
Supplement 
Non-polar supplement 
ileostomy subjects 
subjects with a colon 
Polar supplement 
ileostomy subjects 
subjects with a colon 
Oleuropein-glycoside6 
Placebo supplement0 
Intake 
(umol) 
371.4 
382.0 
497.9 
526.4 
190.0 
0.0 
Urinary excretion3 
tyrosol 
33.5 ±13.9 
15.5 ±4.6 
4.1 ±3.1 
5.6 ± 8.8 
1.3 + 1.5 
1.4 ±3.5 
(umol) 
hydroxytyrosol 
10.8 ±4.5 
6.0 ±1.7 
24.7 ±10.9 
21.6 ±4.8 
28.4 ± 8.7 
1.2 ±1.2 
sum 
44.3 
21.5 
28.8 
27.2 
29.7 
2.6 
Total excretion as 
proportion of intake 
(%) 
12 
6 
6 
5 
16 
-
a
 Mean ± SD, values include the final but not the prebreakfast sample. Mean excretion in prebreakfast samples was 
<0.4 [jmol 
" Only consumed by ileostomy subjects 
c
 Only consumed by subjects with a colon 
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Figure 6.5 Intake of total phenols from the 3 various supplements consumed by ileostomy subjects (n = 8) 
and/or subjects with a colon (n = 12) and subsequent mean excretion of tyrosol, hydroxytyrosol in urine over 
24 h. I: intake; E: excretion. 
DISCUSSION 
We estimate that at least 55-66 mol% of ingested olive oil phenols is absorbed in our volunteers 
and that 5-16 mol% is re-excreted as tyrosol and hydroxytyrosol in urine. Thus, only a fraction 
of ingested olive oil phenols is recovered in urine. However, we did not analyse urinary 
excretion of the other components of the supplements, namely oleuropein-glycoside, 
oleuropein- or ligstroside-aglycones. Furthermore, phenols are probably metabolised into other 
compounds after absorption (Visioli et al, 2000b; Williamson et al, 2000; Hollman & Katan, 
1998). Therefore the figure of 5-16 mol% recovered in urine as tyrosol or hydroxytyrosol 
supports our finding that humans absorb a major part of the dietary olive oil phenols that they 
eat. 
Metabolism of phenols 
To study the absorption and metabolism of tyrosol and hydroxytyrosol we supplied subjects 
with phenol-rich supplements prepared from olive oil. A disadvantage of this mixture of phenols 
is that individual phenols might be converted into hydrolysis products or other metabolites, 
which is hard to estimate. Therefore, we would have preferred to use pure tyrosol or 
hydroxytyrosol, but there are not such substances available that are food grade. Pure 
oleuropein- and ligstroside-aglycones are not commercially available at all. We therefore could 
not study the absorption of the individual phenols. 
We estimated that >55 mol% of ingested olive oil phenols were absorbed in ileostomy 
subjects, which implies that most, if not all, phenols are absorbed in the small intestine. 
Subjects with a colon might theoretically also absorb phenols from the colon (Williamson et al, 
2000; Hollman & Katan, 1998). If this is the case then the urinary excretion of tyrosol and 
hydroxytyrosol should be increased. However, we found similar or lower levels of tyrosol and 
hydroxytyrosol in urine of subjects with a colon than subjects without a colon, which confirms 
that olive phenols are absorbed mainly in the small intestine, rather than in the colon. 
An important step in metabolism of olive oil phenols in the body might be that oleuropein-
glycoside and oleuropein- and ligstroside-aglycones are split into hydroxytyrosol or tyrosol and 
elenolic acid (Figure 6.6). This was indicated by our finding that 15 mol% of the pure 
oleuropein-glycoside supplement was excreted in urine as tyrosol and hydroxytyrosol. 
Oleuropein-glycoside and oleuropein- and ligstroside-aglycone might be split either in the 
gastrointestinal tract before they are absorbed, or in the intestinal cell, in blood, or in the liver 
after they are absorbed. Although we did not measure the stability of oleuropein- and 
ligstroside-aglycones or their derivatives in gastric or duodenal fluid, the stability of oleuropein-
glycoside in these fluids (Table 6.2) suggests that oleuropein-glycoside, oleuropein- and 
ligstroside-aglycone are mainly split after they have been absorbed. However, it is possible that 
the in vivo situation is different. 
Another important step in metabolism is conjugation to glucuronic acid because tyrosol and 
hydroxytyrosol are mainly excreted as glucuronides. Glucuronidation possibly takes place in the 
enterocytes and in liver cells (Figure 6.6) (Scheline 1978; Donovan et al, 2001; Spencer etal, 
1999). Our analysis method did not distinguish between free and conjugated phenols, but other 
studies showed that about 90% of tyrosol and hydroxytyrosol is excreted in the conjugated form 
(Visioli et al, 2000a; Miro-Casas et al, 2001a; Miro-Casas et al, 2001b). One more possible 
metabolic step of dihydroxy-phenols is O-methylation, which mainly takes place in the liver 
(Figure 6.6) (Scheline 1978). Recently it was shown that O-methylated hydroxytrosol is an 
important metabolite in urine after intake of olive oil phenols (Manna et al, 2000; Visioli et al, 
2000b; Miro-Casas et al, 2001a). Thus, absorbed olive oil phenols are probably extensively 
modified before the kidneys excrete them. 
Our assay could detect tyrosol and hydroxytyrosol only in the free form or conjugated to 
glucuronic acid, but not as O-methylated hydroxytyrosol or other metabolites. It is also possible 
that part of the ingested phenols remained undetected in urine as aglycones or oleuropein-
glycoside. Thus the urine of our subjects probably contained other olive oil phenols and their 
metabolites which we could not detect. 
Comparisons with previous studies 
A study of Visioli et al (2000a) showed that when humans ingested a single dose of 50 mL of 
phenol-rich olive oil they excreted 20-60% of the tyrosol and hydroxytyrosol in that dose into 
their urine. This is much higher than what we found. However, Visioli ef al calculated the 
recovery of tyrosol and hydroxytyrosol in urine as the percentage of tyrosol and hydroxytyrosol 
intake, but did not take into account the possible hydrolysis of oleuropein- and ligstroside-
aglycones in the body. The recovery of 20-60% found in the study of Visioli et al (2000) may 
therefore be an overestimate. Miro-Casas et al also found high recoveries: 72% of 
hydroxytyrosol and oleuropein-like substances were recovered as hydroxytyrosol and 34% of 
tyrosol and ligstroside-like substances was excreted as tyrosol in urine of 8 subjects (Miro-
Casas etal, 2001a). A reason for their high recovery might be that they hydrolysed conjugated 
hydroxytyrosol in tyrosol with HCL instead of with ^-glucuronidase as in our study. They could 
therefore not provide specific information about the type of conjugate (Miro-Casas ef al, 2001 a). 
It is possible that other types of conjugates were present in urine, or that the ingested 
aglycones were excreted as well. 
We are not aware of human studies on the absorption of oleuropein-glycoside or 
oleuropein- and ligstroside-aglycones. In a study with an isolated perfused rat intestine, 
Edgecombe et al (2000) found that oleuropeine-glycoside was poorly absorbed from an 
aqueous solution. However, the validity of this model for the human in vivo situation is unclear, 
and orally ingested oleuropein-glycoside in an oily matrix might be absorbed better 
(Edgecombe etal, 2000). 
Validity of the ileostomy model 
In our study subjects collected ileostomy effluent for 24 h. This period should have been long 
enough to collect all non-absorbed phenols in ileostomy effluent, because transit time of 
ingested food through the stomach and small intestine is approximately 8-16 h (Fallingborg 
etal, 1990; Goldberg et al, 1996). This is also supported by the amounts of phenols found in 
ileostomy effluent and urine after 24 h; these amounts were similar to those before supplement 
intake. Thus, it was probably long enough to collect ileostomy effluent for 24 h. 
It is unlikely that high amounts of tyrosol or oleuropein-glycosides were degraded in the 
ileostomy bag or during analysis in the laboratory. In vitro tests with added tyrosol and 
oleuropein-glycoside showed that these substances are fairly stable in ileostomy effluent; 
recovery over 2 h was 76-81%. Stability of hydroxytyrosol in ileostomy effluent was more 
variable, 72% for one person and 29% for the other (Table 6.2). Conceivably, the vehicle for 
hydroxytyrosol was not completely mixed with ileostomy effluent in the bag. Nevertheless, it is 
possible that hydroxytyrosol is unstable in the ileostomy bag or during sample preparation. 
Therefore we corrected the estimated absorption for these possible losses in the ileostomy bag 
or during analysis (Table 6.3). 
We also assessed possible losses of phenols during gastrointestinal transit by in vitro 
incubation of these substances in gastric juice and duodenal fluid. De Roos et al showed that 
24-32% of coffee diterpenes, which are other plant components, were lost during incubation 
with gastric juice in vitro. This decrease could not be fully explained by low pH, which indicates 
that this in vitro test might be useful to study the stability of compounds in the gastrointestinal 
tract (De Roos et al, 1998). Our in vitro tests showed that oleuropein-glycoside, tyrosol, and 
hydroxytyrosol are stable compounds and that they are hardly degraded in the gastrointestinal 
fluids. 
Mechanism of absorption 
The mechanism of absorption of olive oil phenols is unclear. Different polarity of oleuropein-
glycoside, oleuropein- and ligstroside-aglycones, and tyrosol and hydroxytyrosol probably 
results in different mechanisms of absorption. Tyrosol and hydroxytyrosol are polar compounds 
and their transport might occur via passive diffusion (Manna et al, 2000). However, it seems 
less likely that the also polar but much larger oleuropein-glycoside readily diffuses through the 
lipid bilayer of the epithelial cell membrane. This glycoside is more likely absorbed via a glucose 
transporter (Edgecombe et al, 2000), which is supported by the studies of Hollman et al (1995, 
1999), who found significant absorption of quercetin glycoside, another phenolic compound, in 
humans. Another possible mechanisms of absorption of oleuropein-glycoside is via the 
paracellular passive diffusion (Edgecombe et al, 2000). Oleuropeine- and ligstroside-aglycones 
are less polar compounds, and at present no data are available on their mechanism of 
absorption. Furthermore, even though our in vitro studies with gastric juice and duodenal fluid 
do not suggest it, it is possible that oleuropein-glycosides, oleuropein- and ligstroside-aglycones 
are hydrolysed in the gastrointestinal tract. Then tyrosol and hydroxytyrosol are absorbed 
instead of the whole molecule oleuropein-glycoside or the aglycones. Thus, the mechanism of 
absorption is not clear for oleuropein- and ligstroside-like substances. 
Biliary tract 
Urine 
Faeces 
( > = (hydroxy)tyrosol 
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Figure 6.6 Schematic presentation of the possible metabolism of olive oil phenols. Olive oil phenols are 
probably absorbed >66 mol%. They can be glucuronidated in the enterocyte as well as in the liver. 
O-methylation of hydroxytyrosol is another important metabolic step, which also takes place in the liver by 
catechol-O-methyltransferase. Probably the aglycones are hydrolysed in the body, but is it not known whether 
this takes place in the intestine before absorption or in the circulation after absorption. It is also not known 
whether the aglycones are excreted in urine. 
Conclusion 
We found that humans absorb a large part of the ingested olive oil phenols, mainly in the small 
intestine. The human body seems able to hydrolyze oleuropein- and ligstroside-aglycones into 
hydroxytyrosol and tyrosol and to metabolise these phenols extensively, probably after 
absorption from the small intestine. 
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ABSTRACT 
Objective: To review the bioavailability and antioxidant effects of phenols from extra virgin olive 
oil. 
Search Strategy: We searched the MEDLINE database for the years 1966-2001. To review 
the bioavailability of olive oil phenols, we selected in vitro, animal, and human studies that 
studied the absorption, metabolism and urinary excretion of olive oil phenols. We also 
estimated the intake of the various phenols in the Mediterranean area. 
To review the antioxidant effects of olive oil phenols, we included human and animal 
studies on the effect of olive oil phenols on markers of oxidative processes in the body. We 
excluded studies without a proper control treatment and studies in which the antioxidant effects 
of phenols could not be disentangled from those of the fatty acid composition of olive oil. 
Results: Bioavailability studies in humans show that the absorption of olive oil phenols is 
probably larger than 55-66 mol%, and that at least 5% is excreted in urine as tyrosol and 
hydroxytyrosol. 
Animal studies suggest that phenol-rich olive oil lowers oxidisability of ex vivo LDL particles 
or lowers markers in urine of oxidative processes in the body. In 5 out of 7 human studies, 
however, these effects of phenols were not found. 
There are no data on the phenol concentrations in plasma that are attainable by intake of 
olive oil. We estimate that 50 g of olive oil per day provides about 2 mg or ~13 umol of 
hydroxytyrosol-equivalents per day, and that the plasma concentration of olive oil phenols with 
antioxidant potential resulting from such an intake can be at most 0.06 umol/L. This is much 
lower than the minimum concentrations of these phenols (50-100 umol/L) required to show 
antioxidant activity in vitro. 
Conclusion: Although phenols from olive oil seem to be well absorbed, the content of olive oil 
phenols with antioxidant potential in the Mediterranean diet is probably too low to produce a 
measurable effect on LDL oxidisability or other oxidation markers in humans. The available 
evidence does not suggest that consumption of phenols in the amounts provided by dietary 
olive oil will protect LDL against oxidative modification to any important extent. 
INTRODUCTION 
Oxidation of Low Density Lipoproteins (LDL) is hypothesised to play an important role in the 
development of atherosclerosis, an underlying factor of cardiovascular diseases. LDL oxidation 
might be prevented or reduced by intake of antioxidants such as vitamin E. Other compounds 
with potential antioxidant effect are dietary phenols. Phenols are compounds with an aromatic 
ring structure with one or more hydroxyl groups. Phenols with two or more hydroxyl groups 
show antioxidant capacity in vitro, whereas phenols with one hydroxyl group have little or none 
(chapter 5; Rice-Evans et al, 1996). Extra virgin olive oil contains phenols with either one or two 
hydroxyl groups (Figure 1.3, page 16). Today olive oil is marketed as being healthier than other 
vegetable oils because of the presence of these phenols, but a pertinent question is whether 
this suggestion or claim is correct? 
This article reviews the evidences from human and animal studies on the potential of olive 
oil phenols to protect LDL against oxidation. Three important questions in this context are: 
1) Can olive oil phenols affect oxidative processes in the human body?; 2) How much of the 
phenolic compounds from olive oil are absorbed in the human body?; and 3) How are they 
subsequently metabolised? We first describe the possible effects of olive oil on coronary heart 
disease, the chemistry of the olive oil phenols, and their estimated intake. 
Olive oil and the risk of coronary heart disease 
Keys and coworkers showed that in the period between 1960 and 1975 men in Southern 
European countries such as Italy, Greece, and Yugoslavia had a much lower incidence of 
coronary heart disease than men in Northern Europe. These differences between countries 
could be largely explained by differences in the ratio of monounsaturated to saturated fatty 
acids in the diet (Keys et al, 1986). This suggested that in particular the type of dietary fat in the 
Mediterranean area, mainly olive oil, protects against coronary heart disease, because olive oil 
has a high ratio of monounsaturated to saturated fatty acids. 
Controlled dietary trials in humans have showed that replacement of dietary saturated fatty 
acids with monounsaturated oleic acid (C18:1n-9) from olive oil decreases plasma LDL 
concentrations, which presumably contributes to the low incidence of coronary heart diseases 
(Katan et al, 1995). It has also been suggested that a high-monounsaturated fat diet lowers the 
risk of coronary heart disease by producing LDL particles that are enriched in oleic acid at the 
expense of linoleic acid (C18:2n-6). Such a change in fatty acid composition renders LDL 
particles more resistant to oxidative modification (Reaven et al, 1991; Bonanome et al, 1992; 
Berry etal, 1992; Mata era/, 1997). 
Oleic acid, however, may not be the only component of olive oil protecting LDL from 
oxidation; in particular the phenols in extra virgin olive oil could be effective antioxidants. The 
oxidative modification hypothesis of atherosclerosis states that LDL particles are oxidatively 
modified and then taken up by macrophages inside the arterial wall. Dietary antioxidants might 
inhibit atherogenesis by inhibiting oxidation of LDL and accumulation of LDL in macrophages 
(Witztum & Steinberg, 1991). When olive oil is ingested, the phenols might dissolve into or 
attach to LDL particles in plasma, where they may prevent LDL from oxidation. 
Chemistry and content of phenols in olive oil 
The types of phenols in extra virgin olive oil are different from those of the olive fruit. The olives 
mainly contain the polar glycosides oleuropeine and ligstroside. Oleuropein is the ester of 
elenolic acid with 3,4'-dihydroxyphenylethanol (hydroxytyrosol), and ligstroside is the ester of 
elenolic acid with 4-hydroxyphenylethanol (tyrosol). Oleuropein and ligstroside are the parent 
compounds of the less polar oleuropein- and ligstroside-aglycones. Oleuropein- and ligstroside-
aglycones are formed by removal of the glucose moiety from the oleuropein- and ligstroside-
glycoside by p-glucosidase during ripening. Those aglycones and their various derivatives are 
the most abundant phenols in olive oil. The derivatives differ mainly in their ring structure, which 
can either be open or closed in two different forms (unpublished data, personal communication 
from Dr. S. van Boom). The polar compounds hydroxytyrosol and tyrosol are the end products 
of hydrolysis of oleuropeine- and ligstroside-aglycone or their derivatives in olives and olive oil 
(Figure 1.3 page 16). 
The concentration of phenols in olive oil varies from 50 to 800 mg/kg (Visioli & Galli, 1995), 
with a mean value for commercial olive oils of approximately 180 mg/kg (unpublished data, 
personal communications from Dr. S. van Boom). The phenol concentration in olive oil depends 
on variety, climate, area of growth, latitude, and ripeness of the olive. The phenols, and in 
particular the ortrto-diphenols, have been demonstrated to contribute considerably to the 
oxidation stability of the oil (Gutfinger 1981; Papadopoulos & Boskou, 1991; Visioli & Galli, 
1998; Rice-Evans et al, 1996). Ortfto-diphenols are the phenols with two adjacent hydroxyl 
groups to the ring structure: hydroxytyrosol and oleuropein and its derivatives (Figure 1.3, 
page 16). 
Intake of phenols from olive oil 
Intake of olive oil in the Mediterranean countries is estimated to be 30-50 g/d, based on the per 
capita disappearance of 10-20 kg of olive oil per year in Greece, Italy, and Spain (Helsing 1995; 
Boskou 2000; Food and Agricultural Organization 2000). A daily consumption of 50 g olive oil 
with a concentration of 180 mg/kg of phenols results in an estimated intake of about 9 mg of 
olive oil phenols per day. This is similar to the intake of flavonols and catechins from apples 
(about 10 mg/d), but lower than that of catechins from tea (50 mg/d) (Arts et al, 2001) or 
phenolic acids from coffee (200 mg/d) (Radtke et al, 1998). However, it is more relevant to 
express the amount of dietary antioxidants in moles rather than milligrams, because the 
antioxidant activity depends on the number of reactive OH groups. In six Greek olive oils, which 
were specifically analysed to measure the phenol content by HPLC, tyrosol and hydroxytyrosol 
was comprised on average 10 weight% (range 5-16%) and aglycones 90 weight% (range 
84-96%) (unpublished data, personal communication from Dr. S. van Boom). Based on these 
figures and assuming a phenol intake of 9 mg/d in Mediterranean countries, we can estimate 
that about 1 mg (6 umol) JS derived from hydroxytyrosol and tyrosol and about 8 mg (23 umol) 
from the aglycones. Then, total phenol intake in the Mediterranean area is about 29 umol. 
However, this does not yet represent the amount of effective olive oil phenols. Part of the 
phenols in olive oil are ligstroside-aglycones and tyrosol, which are mono-phenols (figure 1) 
with little or no antioxidant capacity (Rice-Evans et al, 1996; chapter 5). Of the 6 analysed 
Greek olive oils, the mean percentage of diphenols was 44 mol% (range 39-51 mol%). Thus, 
the intake of phenols with antioxidant capacity is about 0.44 x 29 = 13 umol, which is equivalent 
to 2 mg of hydroxytyrosol per day. Thus, if the 6 Greek oils are considered as representative for 
the Mediterranean area, then the intake in that area can be estimated to be 2mg 
hydroxytyrosol-equivalents per day. 
METHODS 
To identify studies on the health effects and metabolism of olive oil phenols we searched the 
MEDLINE database (National Library of Medicine, Bethesda, MD) for the years 1966-2001 
using the following keywords: phenol*, polyphenol*, olive oil, tyrosol, hydroxytyrosol, oleuropein, 
antioxidant, oxidation, absorption, bioavailability, and metabolism. We also searched the ISI 
Web of Science Citation Databases for articles that cited two well-known publications on this 
topic (Visioli et al, 1995; Wiseman era/, 1996). 
To address the bioavailability of olive oil phenols we reviewed animal and human studies 
on the absorption, metabolism and urinary excretion of olive oil phenols. 
We selected human and animal intervention studies that examined the effect of 
consumption of olive oil phenols on oxidation markers in plasma. We excluded studies in which 
we could not disentangle the antioxidant effects of phenols from those of the fatty acid 
composition of olive oil, studies without a control diet, and studies in which the amount of 
ingested phenols was not reported or could not be estimated. Human studies were stratified 
according to measurement of oxidation markers in fasting versus postprandial blood. 
We specifically extracted data on the lag time of LDL oxidisability and combined these in a 
random-effects model assuming heterogeneity (DerSimonian & Laird, 1986). To this end we 
extracted or estimated for each study the differences in lag time between the high and low 
phenol treatment, and the standard error of these differences. A model assuming equal 
sampling variances for each study, i.e., each study having equal weight, and a fixed-effects 
model assuming homogeneity, yielded similar results. 
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RESULTS 
We found ten publications that addressed absorption, metabolism or urinary excretion of olive 
oil phenols: four animal (Bai etal, 1998; Coni era/, 2000; Tuck etal, 2001; Visioli era/, 2001), 
and six human studies (chapter 6; Visioli et al, 2000a; Visioli et al, 2000c; Bonanome ef a/, 
2000; Miro-Casas et al, 2001a; Miro-Casas et al, 2001b). One study by our group (chapter 6) 
showed that apparent in vivo absorption of the ingested olive oil phenols was more than 55-66 
mol% in humans. Also, a study in rats showed that bioavailability of radiolabeled tyrosol and 
hydroxytyrosol was 71-99% compared to intravenously administered tyrosol and hydroxytyrosol 
(Tuck et al, 2001). Seven studies showed that of the total amount of ingested phenols at least 
5% was excreted in urine as tyrosol and hydroxytyrosol (chapter &, Visioli et al, 2000a; Visioli et 
al, 2000c; Visioli et al, 2001; Tuck et al, 2001; Miro-Casas et al, 2001a; Miro-Casas et al, 
2001b), mainly conjugated to glucuronic acid (Visioli ef al, 2000c; Miro-Casas et al, 2001a; 
Miro-Casas etal, 2001b) and in the O-methylated form (Visioli etal, 2000a). 
Ten published papers addressed the antioxidant effects of consumption of phenol-rich olive 
oil compared to consumption of phenol-poor olive oil. Seven human studies (Table 7.1) and 
three animal studies (Table 7.2) investigated the effects of olive oil phenols on oxidation 
markers in blood and urine. Five studies compared the effects between phenol-rich and phenol-
poor olive oil in fasting blood samples (Table 7.1 A) and three in postprandial blood samples 
(Table 7.1 B). 
The three animal studies showed a lower LDL oxidisability or a lower concentration of 
oxidation products in urine after consumption of phenol-rich olive oil than after consumption of 
phenol-poor olive oil (Table 7.2). In 5 out of 7 human studies, however, these effects of phenols 
were not found (Table 7.1 A and 7.1 B). The only oxidation marker that could quantitatively be 
combined across studies was the lag time of LDL oxidation (Figure 7.1). Although animal 
studies suggest a protective effect, human studies suggest that olive oil phenols reduced the 
lag time somewhat and thus increased rather than decreased LDL oxidisability. The combined 
estimate of the difference in lag time of LDL oxidisability between high and low phenol 
treatment was -3.7 ± 2.2 min (mean ± SE) (Figure 7.1). 
FASTING BLOOD SAMPLES: 
Nicolaiew et al, 1998* 
Bonanome et al, 2000 * 
Vissers et al, 2001 
POSTPRANDIAL BLOOD SAMPLES: 
Nicolaiew et al, 1998 (6 h) * 
Vissers et al, 2001 (non-polar phenols 2 h) 
Vissers et al, 2001 (polar phenols 2 h) 
COMBINED 
-F=r 
-20 -15 -10 10 15 20 
Figure 7.1 The effect of olive oil phenols on the lag time of LDL oxidisability compared to a control group of 
monounsaturated vegetable oil in humans. Bars are mean changes, and the lines are 95% CI's. We estimated 
the standard error of the difference in studies with an asterisk by adding the variances of the groups 
consuming high or low phenol oil. In the postprandial study of Nicolaiew et al (1998) we subtracted the lag 
times of t=0 from the lag times at t=6, and then calculated the difference in lag time between consumption of 
the olive oil and sunflower oil. CI's were calculated by 1.96 * SE. 
DISCUSSION 
Bioavai labi l i ty 
The first requirement for a dietary compound to be a potential in vivo antioxidant in humans is 
that it enters the blood circulation. Animal and human studies show that olive oil phenols are 
well absorbed. Absorption is confirmed by the recovery of tyrosol and hydroxytyrosol with urine 
after intake of olive oil phenols. A further requirement for protection against oxidative LDL 
modification is that the ingested compound becomes available in plasma or LDL in a form with 
antioxidant capacity, because the original antioxidant activity of an absorbed compound may 
alter upon metabolism. Thus, insight into the kinetics and metabolism of olive oil phenols is 
needed to assess their potential for increasing the antioxidant capacity of LDL or plasma in the 
human body. 
The amount and form in which the olive oil phenols are present in plasma or are excreted 
in urine may give insight into their metabolism in the human body. At present, the plasma 
phenol concentration that can be reached after consumption olive oil is not known. One study 
measured the amounts of hydroxytyrosol and tyrosol in LDL of humans, but the variability was 
too high to provide reliable estimates of concentrations in LDL (Bonanome et al, 2000). Bai et al 
(1998) found only low concentrations of plasma hydroxytyrosol concentrations in rats after oral 
administration of a high single dose of hydroxytyrosol. However, Bai et al analysed 
hydroxytyrosol without prior deconjugation, which may cause underestimation of total 
hydroxytyrosol in plasma. Likewise, Coni et al (2000) also analysed olive oil phenols without 
deconjugation in plasma of rabbits that consumed extra virgin olive oil for six weeks. Thus, 
reliable data on plasma concentration of olive oil phenols are scarce. An alternative is to look at 
olive oil phenols excreted in urine; these may provide information on the form in which phenols 
are present in plasma. The reported figure for the recovery of ingested olive oil phenols as 
tyrosol and hydroxytyrosol in urine range between 5 and 72%, most of them conjugated to 
glucuronic acid (chapter 6, Visioli et al, 2000a; Visioli ef al, 2000c; Miro-Casas et al, 2001a; 
Miro-Casas et al, 2001b). This wide range is probably due to the various approaches to 
calculate urinary excretion and to different analytical analyses. For instance, Visioli et al 
(2000c) measured the percentage recovery in urine of total ingested tyrosol and hydroxytyrosol 
without taking into account the production of additional hydroxytyrosol and tyrosol from ingested 
oleuropein- and ligstroside-aglycones in the body. Their reported recovery of 20-60% may thus 
be an overestimate. Miro-Casas et al found a recovery for hydroxytyrosol of 72% of total 
ingested hydroxytyrosol-like substances, after acidic hydrolysis instead of enzymatic hydrolysis 
in the chemical analysis. They could therefore not provide specific information about the type of 
conjugate, and it is possible that other types of conjugated metabolites were present in urine 
(Miro-Casas et al, 2001 a). We found a recovery of 5-16 mol% of total ingested phenols (chapter 
6), which is lower than reported by others. However, our finding may be an underestimate 
because we did not measure metabolites of olive oil phenols, such as O-methylated 
hydroxytyrosol (3-hydroxy-4-methoxyphenylethanol) in urine (Manna era/, 2000; Visioli et al, 
2000a). Taken together, data on urinary excretion indicate that at the very least least 5% of 
ingested olive oil phenols is recovered in urine as (glucuronidated) tyrosol and hydroxytyrosol. 
The remaining phenols are probably metabolised into other compounds, such as O-methylated 
hydroxytyrosol (Manna et al, 2000; Visioli et al, 2000a). Thus, olive oil phenols may be present 
in plasma mainly in the glucuronidated and O-methylated form. However, this suggestion needs 
to be confirmed by analyses of phenols and their metabolites in plasma. Therefore, 
development of methods to analyse these phenols in plasma is needed. 
Studies on LDL oxidisability and other markers of oxidation 
Animal studies suggest that olive oil phenols protect LDL against oxidation as indicated by 
decreased LDL oxidisability or other markers of oxidation (Table 7.2). In contrast, four human 
studies do not point to protective effects of olive oil phenols on LDL oxidisability. Our meta-
analysis (Figure 7.1) suggested that the lag time of ex vivo LDL oxidation after high phenol 
treatment was 3.7 min lower (95% CI, -8.0 to 0.6 min) than after low phenol treatment, which 
does not suggest decreased susceptibility of LDL to oxidation. 
Some other studies do suggest protective effect of olive oil phenols as indicated by markers of 
oxidation other than the lag time of LDL oxidation. Visioli et al (2000a) found that administration 
of phenol-rich oils resulted in a dose-dependent decrease in urinary excretion of 8-iso-
prostaglandin F2o, an F2-isoprostane, which indicates less overall oxidation of arachidonic acid. 
Ramirez et al (1999) showed a decreased LDL oxidation rate as measured by thiobarbituric 
acid-reactive substances and a reduced in vitro uptake of oxidised LDL by macrophages in 
fasting blood after 3 mo of consumption of extra virgin olive oil compared to refined olive oil. 
Furthermore, Bonanome et al (2000) found an increase of antioxidant capacity of postprandial 
plasma samples measured by a crocin-bleaching test 2 h after intake of 100 mL extra virgin 
olive oil. However, this study did not include a control group and the effect might therefore be 
due to a non-specific meal or time effect. Thus, results of human studies on the effects of olive 
oil phenols on various markers of oxidation are inconsistent, with most studies showing no 
effect. 
Are phenols antioxidants in vivo? 
How can we explain that animal and in vitro studies suggest antioxidant effects of olive oil 
phenols, while most human studies do not find effects? Possible explanations include the dose 
and plasma concentration of phenols, type of oxidation marker, and metabolism of the phenols 
in the body. In addition we should consider the possibility of publication bias. We speculate that 
negative outcomes of human studies may have a higher chance of being published than 
negative outcomes of animal studies, either because human studies are more expensive and 
difficult, which increases the pressure to publish for investigators, or because they are more 
likely to be accepted for publication. We found only three animal studies that specifically studied 
the antioxidant effect of consumption of phenol-rich olive oil compared to consumption of 
phenol-poor olive oil. It is conceivable that more animal studies have been carried out but 
remained unpublished because of negative results. However, we are aware that this is pure 
speculation, and it is quite possible that laboratory animals simply react differently to olive oil 
phenols than humans. 
Differences in the doses of phenols fed might also explain discrepant results between 
animal and human studies. An important question is whether the doses and thus the plasma 
concentration of antioxidant phenols in humans was high enough to affect the markers of LDL 
oxidation. Unfortunately, reliable data on plasma concentration of olive oil phenols are lacking. 
We can put a ceiling on attainable plasma concentrations as follows. Fifty g/d of olive oil 
provides 2 mg or 13 umol of hydroxytyrosol-equivalents. If these are absorbed immediately and 
completely dissolved into a blood compartment of 5 L this would result in a plasma level of 
2.6 umol/L In reality, absorption is slow and incomplete, and clearance and redistribution will 
remove phenols from plasma immediately after absorption. We make a more realistic guess at 
attainable plasma concentrations using data on other phenolic compounds. For instance, intake 
of 225 umol of quercetin-glucosides (68 mg quercetin equivalents) from onions, which are 
absorbed for about 50% (Hollman etal, 1995), produced a peak level of 0.75 umol of quercetin 
per L plasma in humans (Hollman et al, 1997). This peak rapidly fell off in the hours after 
consumption. By analogy, intake of 2 mg of hydroxytyrosol-equivalents (13 umol), which is 
absorbed for 66% (chapter 6), might produce a peak level of 0.06 umol of hydroxytyrosol-
equivalents per L of plasma. In contrast, when olive oil phenols were added directly to plasma 
in vitro, concentrations of 50-100 umol/L were required to protect LDL from oxidation (chapter 
5). This is several orders of magnitude higher than our estimate of the maximum concentration 
attainable after intake of a high dose of olive oil phenols in vivo. Other in vitro studies 
demonstrated that pre-incubation of a purified LDL fraction with 10 umol/L of olive oil phenols 
prevented oxidation (Grignaffini et al, 1994; Visioli et al, 1995; Caruso et al, 1999). However, 
phenols react avidly with many proteins, and therefore in whole plasma olive oil phenols will 
bind to other proteins like albumin, whereas in an purified LDL fraction these phenols can only 
bind to LDL. Hence, higher concentrations of olive oil phenols would be needed to protect LDL 
from oxidation in plasma than in a purified LDL fraction. Thus, it is likely that the plasma 
concentrations of olive oil phenols in the human studies were too low to affect LDL oxidisability. 
Our estimate of the in vivo plasma concentration is of course crude and subject to a number of 
errors, but it is unlikely to be several orders of magnitude too low, which is the difference 
between our estimate and the concentrations needed in vitro. 
The actual concentration of phenols within the core of the LDL particle might be higher if 
phenols are lipophilic and accumulate inside lipoproteins. The mean water/lipid partition 
coefficient of the most lipophilic phenols, i.e. the aglycones, is about 0.7 (unpublished data, 
personal communications Dr. S. Van Boom) which implies that their concentration in the lipid 
core of LDL will be 1:0.7 = 1.4 times higher than in the surrounding aqueous medium. However, 
the same partitioning occurs in vitro. Even if some phenols show a higher affinity for the inside 
of the LDL particles, the concentration in the aqueous medium evidently still needs to be about 
50 to 100 umol/L to produce inhibition of conjugated diene formation. 
The use of different markers of oxidation might also explain discrepancies in results. Olive 
oil phenols might act as plasma antioxidant in ways other than dissolved in LDL particles. Visioli 
et al (2000a) measured the urinary excretion of 8-iso-prostaglandin F2a instead of the LDL 
oxidisability. They found a negative correlation between intake of olive oil phenols and excretion 
of these markers of oxidative stress, which indicates less overall oxidation of arachidonic acid. 
The ex vivo LDL oxidisability is measured in LDL particles isolated from plasma by 
centrifugation. For this ex vivo analysis it is necessary that all phenols in or attached to LDL are 
isolated and not lost during centrifugation. Tyrosol and hydroxytyrosol are polar and will not 
easily dissolve into LDL particles, but in vivo they might loosely bind to the surface of the LDL 
particle (Vinson et al, 1995). If so, tyrosol and hydroxytyrosol might get lost during the 
centrifugation of LDL (Halliwell 2000; Carbonneau et al, 1997), and the ex vivo method would 
underestimate in vivo effects. Urinary excretion of F2-isoprostanes might be a better marker 
because those F2-isoprostanes are formed in vivo. However, F2-isoprostanes have, like other 
oxidation markers, not yet been validated as true predictor of coronary heart disease endpoints. 
It remains possible that phenols from olive oil decrease LDL oxidisability, but that the currently 
available markers are not suitable to measure such an effect. Thus, for definitive answers as to 
the health effects of olive oil phenols through their antioxidant capacity, we need markers of 
oxidative processes in the body that reliably predict disease risk. 
The antioxidant capacity of conjugated or O-methylated metabolites of hydroxytyrosol 
might be less than that of the hydroxytyrosol itself. The glucuronides might have less 
antioxidant activity than the ingested compounds, as was shown for quercetine-glucuronide 
compared to quercetin (Manach et al, 1998; Day ef al, 2000). Also, we do not know the 
antioxidant capacity of O-methylated hydroxytyrosol. However, the extra methyl group 
substitutes an original hydroxyl group, and O-methylated hydroxytyrosol is thus not an ortho-
diphenol. Consequently, it probably has less antioxidant activity than hydroxytyrosol, as was 
shown for O-methylated quercetin compared to quercetin (Manach ef al, 1998; Yamamoto et al, 
1999). To determine the true antioxidant activity of olive oil phenols in vivo, future studies 
should focus on the antioxidant activity of the metabolites actually present in plasma rather than 
on the in vitro antioxidant activity of the phenols as present in the olive oil. 
CONCLUSION 
Although the olive oil phenols are well absorbed, the amount of olive oil phenols in the diet is 
probably too low to produce a quantifiable and biological significant effect on LDL oxidisability. 
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Concluding remarks 
The studies described in this thesis investigated whether minor components from vegetable oils 
can improve health by decreasing cholesterol concentrations or oxidative modification of low 
density lipoprotein (LDL) particles. This objective was subdivided into three main questions in 
the general introduction (chapter 1). This chapter summarises the answers to these questions, 
gives the main conclusion, and gives recommendations for further research. 
MAIN QUESTIONS AND SUMMARY OF CONCLUSIONS 
7. What is the effect of various plant sterols from rice bran oil and triterpene alcohols from 
sheanut oil on serum cholesterol concentrations in humans? 
Plant sterols from rice bran oil lower serum total and LDL cholesterol concentrations. This 
effect is probably due to p-sitosterol and not to the 4,4'-dimethylsterols. Triterpene alcohols 
from sheanut oil do not affect cholesterol concentrations (chapter 2). These results indicate 
that 4,4'-dimethylsterols from rice bran oil and triterpene alcohols from sheanut oil are not 
able to decrease cholesterol concentrations. 
2. Do phenols from extra virgin olive oil decrease LDL oxidisability in humans? 
We found that consumption of olive oil phenols does not decrease LDL oxidisability or 
other markers of antioxidant capacity in humans, neither in fasting plasma samples after 
3-wk consumption (chapter 3), nor in postprandial samples after a single high dose 
(chapter 4). The in vitro study (chapter 5) showed that the dose of the phenols and 
consequently their plasma concentration in humans is probably too low to reduce LDL 
oxidisability. 
3. To what extent are olive oil phenols absorbed and how are they metabolised? 
The apparent absorption in the small intestine of humans is more than 55-66 mol% of the 
ingested olive oil phenols. Absorption was confirmed by urinary excretion of free or 
glucuronidated tyrosol or hydroxytyrosol of at least 5 mol% of ingested phenols. The 
human body hydrolyses oleuropein-glycoside into hydroxytyrosol, and the remainder of 
ingested phenols is probably metabolised into forms that we could not detect in urine 
(chapter 6). The antioxidant activity of the phenol metabolites is unknown. 
CONCLUSION 
Although the olive oil phenols are well absorbed, the amount of phenols in olive oil and their 
consequent attainable plasma concentration in humans is probably too low to reduce LDL 
oxidisability. Furthermore, our studies provide no evidence that 4,4'-dimethylsterols from rice 
bran oil or triterpene alcohols from sheanut oil are able to decrease cholesterol concentrations. 
Consequently, there are no indications that the minor components from vegetable oils 
described in this thesis have important effects on serum lipoproteins. 
RECOMMENDATIONS FOR FUTURE RESEARCH 
Plant sterols 
Abundant research shows that 4-desmethylsterols in vegetable oils, such as (3-sitosterol or 
sitostanol, reduce serum LDL cholesterol concentrations. We found that chemically related 
structures such as 4,4'-dimethylsterols and triterpene alcohols have less or no effect. It is not 
clear what exactly determines the efficacy of the plant sterols. To elucidate that, more 
information is needed about the mechanism of action. It is generally assumed that plant sterols 
displace cholesterol from the micelles in the intestine (Heinemann et al, 1991; Vanhanen & 
Miettinen, 1992), which transport the cholesterol or plant sterols to the surface of the absorptive 
enterocytes. However, plant sterols themselves are not absorbed. It is not known whether they 
enter the enterocyte, temporarily stay there, and are excreted back into the intestinal lumen, or 
whether the do not enter the enterocyte at all. One approach to elucidate the exact cellular 
mechanism of action of plant sterols would be absorption studies with in vitro cell lines. It may 
learn us more about their mechanism of action, but also about their safety, the beneficial way of 
dosing, and the possible influence of other food components. 
Although the cholesterol lowering effects of certain plant sterols has been well established, 
studies with hard clinical end-points are lacking. Long-term prospective studies are needed to 
confirm that consumption of high doses of sterols can lower the risk of coronary heart disease. 
Furthermore, such studies will also give information about side effects of such high doses of 
plant sterols, such as the negative or positive relation with colon cancer (Tseng et al, 1996; 
Awad & Fink, 2000; Normen era/, 2001) or other diseases. 
Studies on ant iox idants 
To study the importance of antioxidant in health, reliable markers of oxidative damage are 
needed. The currently used markers have not been correlated to clinical end points such as the 
risk of coronary heart disease. It is thus imperative to find in vivo markers for antioxidant 
capacity that reliably predict the risk of coronary heart diseases. Experiments on whether such 
markers can be affected by dietary antioxidant components may shed light on the potential of 
diet to prevent the development of atherosclerosis. The Cu-induced LDL oxidation method has 
been most widely used to study the potential effects of dietary antioxidant on lipid peroxidation. 
This LDL oxidation method tests the susceptibility of LDL to copper induced oxidation in vitro, 
which may not be a valid indication of the in vivo situation (Heinecke 1998). Also, antioxidants 
might get lost during the prolonged procedures to isolate LDL from plasma, causing 
underestimation of the in vivo potential (Halliwell 2000). New promising markers of lipid 
peroxidation in vivo are F2-isoprostanes (Roberts & Morrow, 2000) or auto-antibodies against 
oxidised LDL (Holvoet & Collen, 1998). However, these markers still need to be validated as 
true predictors of coronary heart disease endpoints. 
To establish whether intake of antioxidants can protect against oxidation in vivo, we need not 
only validated markers but we also need to know that the antioxidant retains its antioxidant 
capacity after absorption into the plasma and after metabolism. It is thus essential to study the 
metabolism of dietary antioxidants in the human body and the antioxidant capacity of those 
metabolites to establish a potential health effect, before long-term and expensive intervention 
trials with antioxidant supplementation are carried out. 
Health effects of olive oil phenols 
Our studies suggest that olive oil phenols do not prevent oxidative modification of LDL. It can 
not be excluded that olive oil antioxidants may play a role in other mechanisms than the 
protection of oxidative modification of LDL. For instance, in vitro studies have shown that 
hydroxytyrosol might reduce platelet aggregation and exert anti-inflammatory effects (Petroni 
et al, 1994; de la Puerta et al, 2000). However, it is not clear whether olive oil phenols do also 
show these effects in an in vivo situation. The concentration of olive oil phenols might also be 
too low for such actions, and it is not known whether the metabolites of the olive oil phenols in 
the body also exert similar effects. 
Metabolism of olive oil phenols 
We estimated that the dose of olive oil phenols in the Mediterranean diet is too low to reach an 
effective concentration in plasma. However, we only studied the urinary excretion of the olive oil 
phenols in the form in which they were ingested. To study antioxidant efficacy it is crucial to 
know in which form the olive oil phenols become present in plasma. Unfortunately, actual 
plasma concentrations of olive oil phenols are unknown because there is as yet no reliable 
analytical method available. Development of such method would facilitate studies on the 
pharmocokinetics and plasma concentrations of these compounds. 
In all human studies subjects were supplied with olive oil or olive oil extracts that contain a 
mixture of various phenols. A disadvantage of using such a mixture is that conversion of 
individual phenols into their derivatives cannot be estimated. For instance, hydroxytyrosol in 
urine could derive directly from ingested hydroxytyrosol, but it might also be derived from 
hydrolysed oleuropein-aglycones. Pure phenolic substances should be produced and made 
food-grade to enable studies on the metabolism of individual phenols and their antioxidant 
potential in the human body. 
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Summary 
The studies described in this thesis investigated whether minor components from vegetable oils 
can improve health by decreasing cholesterol concentrations or oxidative modification of low-
density-lipoprotein (LDL) particles. 
High LDL or total cholesterol concentrations are established risk factors for coronary heart 
disease. Plant sterols or phytosterols are used as cholesterol-lowering agents in foods. The 
plant sterols p-sitosterol and sitostanol are known to decrease cholesterol concentrations, but it 
is not clear whether other chemically related structures have similar effects. 
Oxidation of LDL may also increase the risk of developing coronary heart disease. Dietary 
antioxidants may inhibit the oxidation of LDL or other oxidative processes in the body. Phenols 
from extra virgin olive oil are such antioxidants in vitro. However, the ability of olive oil phenols 
to inhibit LDL oxidation in vivo still requires confirmation. 
This thesis describes one study on the cholesterol lowering effect of plant sterols from rice 
bran oil and sheanut oil and four studies on the antioxidant activity and metabolism of phenols 
from extra virgin oil in humans. 
The effect of various plant sterols from rice bran oil and triterpene 
alcohols from sheanut oil on serum cholesterol concentrations in 
humans 
Plant sterols are minor constituents present in the unsaponifiable fraction of vegetable oils, 
such as corn, soybean and rapeseed oil. The most common plant sterols in the human diet are 
the 4-desmethylsterols, such as p-sitosterol. Beta-sitosterol can be converted into a saturated 
counterpart sitostanol by hydrogenation, although sitostanol rarely occurs in nature. The 
cholesterol lowering effects of (3-sitosterol and sitostanol have been well established. Sterols 
with other structures may vary in their potential to reduce plasma cholesterol concentrations. In 
chapter 2 we studied the effects of a combination of 4-desmethylsterols and 
4,4'-dimethylsterols from rice bran oil and of triterpene alcohols from sheanut oil on cholesterol 
concentrations in healthy, normolipemic volunteers. Sixty healthy volunteers each consumed 
30 g/d of 3 margarines for 3 wk. The study was a cross-over double-blind design and had the 
following treatments: one margarine with plant sterols from rice bran oil; one margarine with 
triterpene alcohols from sheanut oil; and one margarine without plant sterols. We found that 1.7 
g/d of plant sterols from rice bran oil lowered serum total cholesterol by 5% and LDL cholesterol 
by 9%. This was probably due to p-sitosterol and other 4-desmethylsterols but not to the 4,4'-
dimethylsterols. Triterpene alcohols from sheanut oil did not change cholesterol concentrations. 
These results indicate that 4,4'-dimethylsterols from rice bran oil and triterpene alcohols from 
sheanut oil are not able to decrease cholesterol concentrations. 
Antioxidant effect of phenols from extra virgin olive oil in healthy humans 
A high intake of olive oil has been proposed as an explanation for the reduced incidence of 
coronary heart disease in Mediterranean countries, but it is unclear whether olive oil offers 
specific benefits beyond a low saturated fat content. Extra virgin olive oil contains phenols with 
antioxidant activity and these phenols may protect LDL against oxidation. The most abundant 
phenols in extra virgin olive oil are the non-polar oleuropein- and ligstroside-aglycones which 
can be hydrolysed in olive oil into the polar hydroxytyrosol and tyrosol. In chapter 3 we 
investigated the effect of consumption of phenol-rich extra virgin olive oil for 3 wk on the 
susceptibility of LDL to oxidation and other markers of oxidation in fasting blood samples of 46 
healthy subjects. The subjects consumed two diets each supplying 69 g/d of extra virgin olive 
oil that was either rich or poor in phenols. The mean difference in phenol intake between the 
treatments was 18 mg/d. Vitamin E intake was low during the entire study. We found that 
consumption of phenol-rich olive oil did not decrease LDL oxidation or other markers of 
antioxidant capacity. 
It is possible that we did not find an effect of olive oil phenols on LDL oxidisability because 
our study was not able to address postprandial effects. If phenol clearance is fast, phenol 
concentrations may be elevated in the first few hours after a meal and during that time protect 
LDL from oxidation, but not after 12 hours of fasting as was the case in our study. Indeed, in a 
pilot study we found that consumption of 47 g fortified olive oil containing 31 mg phenols 
significantly increased the lag time of LDL oxidation from 112 ± 5 minutes before to 130 ± 7 
minutes 2 h after the meal. However, this pilot study was not placebo-controlled, and in chapter 
4 we therefore investigated the effects of olive oil phenols on the lag time of LDL oxidation in 
postprandial samples when compared to a placebo group. Twelve subjects consumed 4 
different olive oil supplements with a meal on 4 separate occasions: one similar to the 
supplement in the pilot study containing 31 mg of phenols (positive control); one containing 
100 mg of mainly non-polar phenols; one containing 100 mg of mainly polar phenols; and one 
without phenols (placebo). Lag time significantly increased 2 h after the meals with the positive 
control and the polar phenols, but also with the placebo. Lag time did not increase after the 
non-polar phenols, and increases did not differ between supplements. These results indicate 
that the lag time of LDL-oxidation is increased after consumption of a meal, but this increase is 
probably due to a non-specific meal or time effect and not to phenols from olives or olive oil. 
The phenol content of the experimental olive oils may have been too low to produce an 
effect on the ex vivo oxidation of LDL. We therefore estimated the minimum plasma 
concentration of olive oil phenols needed to change the LDL oxidisability. Chapter 5 describes 
an in vitro study that mimics the exposure of LDL to olive oil phenols in plasma. Plasma was 
incubated with olive oil phenols and olive oil extracts rich in ortfto-dihydroxy phenols 
(oleuropein-aglycone and hydroxytyrosol) and/or monohydroxy phenols (ligstroside-aglycone 
and tyrosol). LDL was subsequently isolated and its susceptibility to oxidation measured. The 
results show that olive oil phenols prevent the oxidative modification of LDL. Efficacy in 
protecting LDL against oxidative modification was consistent with prediction based on their 
structural antioxidant features; the ortho-dihydroxy phenols, hydroxytyrosol and oleuropein-
aglycone, were more efficient than their mono-hydroxy counterparts, tyrosol and ligstroside-
aglycones. However, the plasma concentration of olive oil phenols required to inhibit LDL 
oxidation were substantially higher than could be expected to be achieved by dietary 
consumption. 
In chapter 7 we review the antioxidant effects of olive oil phenols in animal and humans 
studies. Although animal studies suggest a protective effect, combined human studies suggest 
that olive oil phenols do not decrease LDL oxidisability. In chapter 7 we furthermore estimated 
the daily intake of olive oil phenols in the Mediterranean area. The estimated plasma 
concentration of olive oil phenols with antioxidant potential resulting from such an intake is 
much lower than the minimum concentrations of these phenols required to show antioxidant 
activity in vitro as found in chapter 5. Thus, the content of phenols in extra virgin olive oil 
phenols is probably too low to produce a quantifiable effect on LDL oxidisability in humans. 
Absorption and metabolism of olive oil phenols 
The first requirement for an in vivo action of a potential antioxidant in humans is that it can enter 
the blood circulation. In chapter 6 we studied the absorption and urinary excretion of olive oil 
phenols in 8 ileostomy subjects and 12 subjects with intact colons. The subjects consumed a 
single dose of 3 different supplements, each containing 100 mg of olive oil phenols on separate 
days. The treatment order was randomised. Ileostomy effluent and/or urine were collected for 
24 h after supplement intake. We found that the apparent absorption was more than 55-66 
mol% and the urinary excretion of tyrosol and hydroxytyrosol at least 5 mol% of total ingested 
phenols. 
A further requirement for an antioxidant to protect LDL against oxidation is that it retains its 
antioxidant activity after absorption into the plasma and after metabolism. In chapter 7 we 
reviewed results of studies on the metabolism of olive oil phenols. Olive oil phenols are 
extensively metabolised in the body by conjugation to glucuronic acid and O-methylation. 
Hydrolysis of oleuropein-glycoside and oleuropein- and ligstroside-aglycones into 
hydroxytyrosol and tyrosol might be another important step in the metabolism of the olive oil 
phenols. However, we do not know the antioxidant activity of the conjugated or O-methylated 
metabolites of olive oil phenols. Data from literature suggest that these metabolites may have 
lower antioxidant properties than their ingested parent compounds. 
Conclusion 
Although the olive oil phenols are well absorbed, the amount of phenols in olive oil and their 
consequent attainable plasma concentration in humans is probably too low to reduce LDL 
oxidisability. It is unclear whether much higher doses of olive oil phenols would be able to 
protect LDL from oxidation because these phenols are extensively modified in the human body. 
The antioxidant activity of phenol metabolites may be less than that of the parent compounds 
ingested. Thus, the data presented in this thesis do not support the hypothesis that olive oil 
phenols reduce LDL oxidation. Furthermore, our studies provide no evidence that 
4,4'-dimethylsterols from rice bran oil and triterpene alcohols from sheanut oil are able to 
decrease cholesterol concentrations. In conclusion, there are no indications that the minor 
components from vegetable oils described in this thesis have important effects on serum 
lipoproteins. 
Samenvatting 
ACHTERGROND 
Dit proefschrift beschrijft studies waarin we hebben onderzocht of plantensterolen en fenolen uit 
plantaardige olien de gezondheid kunnen bevorderen door nun effect op cholesterol in mensen. 
Hart- en vaatziekten, zoals een hartinfarct of een beroerte, zijn een van de grootste 
volksgezondheidsproblemen in welvarende landen. Een hoog cholesterolgehalte bij mensen is 
een van de risicofactoren voor het ontstaan van hart- en vaatziekten. Bepaalde stoffen in de 
voeding kunnen het cholesterolgehalte doen dalen waardoor de kans op hart- en vaatziekten 
afneemt. Plantensterolen oftewel fytosterolen zijn zulke stoffen. Zoals de naam al zegt, komen 
ze voor in plantaardige voedingsmiddelen, en met name in plantaardige olien. Van veel 
voorkomende plantensterolen, zoals p-sitosterol en sitostanol, is bekend dat ze het 
cholesterolgehalte kunnen verlagen. Het is echter nog onduidelijk of zeldzamere 
plantensterolen ook het cholesterol verlagen bij mensen. In een van de studies (hoofdstuk 2) 
hebben we daarom gekeken naar het cholesterolverlagende effect van plantensterolen uit 
rijstkiemolie en uit het vet van een tropische noot (de shea-noot). 
Niet alleen een hoog cholesterolgehalte, maar ook de vorm waarin cholesterol in het bloed 
aanwezig is kan de kans op hart- en vaatziekten verhogen. Cholesterol dat in het bloed 
circuleert is onder te verdelen in twee soorten, namelijk in het slechte 'low-density-lipoprotein' 
(LDL) cholesterol en het goede 'high-density-lipoprotein' cholesterol. Wanneer het slechte LDL 
deeltje in de geoxideerde vorm voorkomt, zou het schade kunnen aanrichten aan de vaatwand, 
waardoor ophopingen ontstaan die de toevoer van bloed kunnen belemmeren. Bepaalde 
voedingsstoffen, de zogenaamde antioxidanten, kunnen deze oxidatie van LDL mogelijk 
tegengaan en daarmee de kans op hart- en vaatziekten verkleinen. Voorbeelden van 
antioxidanten in de voeding zijn vitamine C en vitamine E. Ook fenolen uit extra vierge olijfolie 
staan in de belangstelling vanwege hun mogelijke antioxidant activiteit. Het is reeds lang 
bekend dat olijfolie en andere plantaardige olien door hun hoge gehalte aan onverzadigde 
vetzuren het cholesterolgehalte verlagen in vergelijking met harde vetten die veel verzadigd 
vetzuur bevatten. Hiernaast zou de aanwezigheid van fenolen met een antioxidant-werking 
extra vierge olijfolie mogelijk nog beter maken dan andere olien die geen fenolen bevatten. Of 
olijfolie-fenolen ook daadwerkelijk de oxidatie van LDL deeltjes in het menselijk lichaam kunnen 
remmen, hebben wij in hoofdstuk 3 t/m 6 onderzocht. 
PLANTENSTEROLEN 
Het cholesterol verlagende effect van zeldzame plantensterolen uit 
r i js tk iemol ie en uit het vet van een t rop ische noot 
Om dit te onderzoeken hebben we aan 60 mensen 3 verschillende margarines te eten 
gegeven, van elke margarine 30 gram per dag gedurende 3 weken. Een margarine bevatte de 
plantensterolen uit rijstkiemolie, een margarine bevatte de plantensterolen uit het vet van de 
tropische shea-noot, en een margarine zonder plantensterolen die als controle diende. 
De plantensterolen uit rijstkiemolie bestonden voor 1 gram uit p-sitosterol en voor 1 gram 
uit minder bekende plantensterolen waarvan we het effect op het cholesterolgehalte wilden 
onderzoeken. In deze studie vonden wij dat de plantensterolen uit rijstkiemolie het 
cholesterolgehalte met 5% deed dalen ten opzichte van de controle margarine. Echter, uit 
eerder onderzoek bleek dat dit effect even groot was als dat wat je van 1 gram p-sitosterol zou 
verwachten. Daarom kan het effect van de plantensterolen uit rijstkiemolie waarschijnlijk geheel 
worden toegeschreven aan p-sitosterol en zijn de minder bekende plantensterolen uit 
rijstkiemolie dus niet werkzaam. De plantensterolen uit het vet van de tropische shea-noot 
bleken ook geen effect op het cholesterolgehalte te hebben. 
Dit betekent dus dat de zeldzame plantensterolen die wij hebben onderzocht niet of minder 
effectief het cholesterolgehalte verlagen dan p-sitosterol. Voor toepassing in 
cholesterolverlagende margarine, waarvan er inmiddels enkele op de markt verkrijgbaar zijn, 
zijn de minder bekende plantensterolen uit rijstkiemolie en de shea-noot dus niet geschikt. 
FENOLEN UIT EXTRA VIERGE OLIJFOLIE 
Het ant ioxidant effect van fenolen uit extra vierge o l i j fo l ie bi j 
gezonde mensen 
Om te onderzoeken of de consumptie van een fenolrijke olijfolie de oxidatie van LDL kon 
tegengaan hebben we 46 mensen twee verschillende voedingen gegeven: 3 weken een 
voeding met 69 gram fenolrijke olijfolie per dag en drie weken een voeding met 69 gram 
fenolarme olijfolie per dag. Aan het einde van de 3 weken namen we bij alle deelnemers bloed 
af en isoleerden hieruit het LDL cholesterol. Vervolgens testten we de oxideerbaarheid van LDL 
door het in reageerbuizen bloot te stellen aan pro-oxidanten en te meten hoe lang het in deze 
test duurt voordat LDL geoxideerd wordt. Zo konden we nagaan of de fenolen uit olijfolie in de 
voeding ook effectieve antioxidanten in het LDL deeltje zijn. We vonden dat de oxidatie van 
LDL niet langer duurde bij mensen die de fenolrijke olie hadden gegeten dan bij diegenen die 
de fenolarme olijfolie hadden gegeten. Met andere woorden, olijfolie-fenolen hadden geen 
beschermend effect op de oxideerbaarheid van LDL. 
In een volgende proef aten 12 mensen 3 keer een supplement van geconcentreerde 
olijfolie met verschillende soorten fenolen en 1 keer een supplement zonder fenolen (controle-
supplement). Deze 4 verschillende supplementen werden op verschillende dagen samen met 
het ontbijt gegeten. Bij ieder supplement namen we 3 keer bloed af; 1 keer voor het ontbijt, 1 
keer een half uur na en 1 keer twee uur na het ontbijt. Ook in deze studie vonden we dat de 
oxidatie van LDL niet langer duurde na het eten van olijfolie-fenolen in vergelijking met het 
supplement zonder fenolen. En dus liet ook deze studie geen beschermend effect zien van 
olijfolie-fenolen op de oxideerbaarheid van LDL. 
Absorptie en metabolisme van fenolen uit olijfolie 
Omdat we geen effect van de olijfolie-fenolen op de oxidatie van LDL vonden, wilden we weten 
of de mate en de vorm waarin olijfolie-fenolen in het bloed komen wel voldoende is om daar 
antioxidant activiteit te hebben. Een voorwaarde voor stoffen om in het bloed terecht te kunnen 
komen is dat ze eerst door de darmen worden opgenomen. Dit konden we onderzoeken bij 
mensen met een stoma. Een stoma is een kunstmatige uitgang voor de ontlasting aan het 
einde van de dunne darm die bij mensen wordt aangelegd als hun dikke darm om medische 
redenen moet worden verwijderd. Bij mensen met een stoma worden voedingsstoffen die niet 
door de dunne darm zijn opgenomen direct via de stoma uitgescheiden en opgevangen in een 
stomazakje. Als we precies weten hoeveel olijfolie-fenolen de mensen hebben gegeten en 
meten hoeveel er in de stoma-zak is uitgescheiden, kunnen we schatten hoeveel er door de 
dunne darmen is opgenomen. 
Als olijfolie-fenolen eenmaal zijn opgenomen in het bloed kunnen ze middels 
stofwisselingsprocessen worden omgezet in andere componenten, die mogelijk een andere 
antioxidant activiteit hebben dan de oorspronkelijke stoffen. Daarom is het dus belangrijk om te 
weten in welke mate en in welke vorm de fenolen in het bloed voorkomen. Helaas is het nog 
niet mogelijk om de hoeveelheden aan olijfolie-fenolen en verschillende omzettingsproducten in 
het bloed te bepalen. Er wordt daarom vaak gekeken naar de uitscheiding van zulke stoffen in 
de urine, waarin deze stoffen gemakkelijker kunnen worden bepaald. De uitgescheiden olijfolie-
fenolen in de urine geven een indicatie over de hoeveelheid en de vorm waarin deze stoffen in 
het bloed voorkomen. 
In hoofdstuk 6 hebben we bij 8 mensen met een stoma de opname van olijfolie-fenolen in 
de dunne darm gemeten. Tevens hebben we bij 20 mensen de uitscheiding van fenolachtige 
stoffen in urine onderzocht. De deelnemers aan de proef kregen op 3 verschillende dagen 's 
ochtends bij het ontbijt 3 verschillende supplementen met olijfolie-fenolen. Ieder supplement 
bevatte olijfolie, maar ze verschilden in de soorten olijfolie-fenolen. Gedurende 24 uur na 
inname van een supplement verzamelden de deelnemers stomavloeistof en/of urine. In de 
stomavloeistof vonden we minder dan 45% van de ingenomen olijfolie-fenolen terug. Dit 
betekent dat kennelijk meer dan 55% van de fenolen in de dunne darm wordt opgenomen. In 
de urine vonden we ongeveer 5% van de ingenomen olijfolie-fenolen terug. Deze resultaten 
betekenen dat de olijfolie-fenolen waarschijnlijk goed uit de dunne darm worden opgenomen. 
Omdat we maar 5% van de fenolen in de urine terugvinden, worden ze waarschijnlijk in het 
lichaam voor een groot deel omgezet in stoffen die we niet in de urine hebben gemeten. 
Wat zeggen deze resultaten over de olijfolie-fenolen nu? 
Onze resultaten wijzen erop dat olijfolie-fenolen goed door de darmen worden opgenomen, 
maar dat ze kennelijk niet de oxidatie van LDL remmen. Hier zijn twee mogelijke verklaringen 
voor: 1) de hoeveelheid fenolen in olijfolie is te laag om er voldoende van in het bloed te krijgen 
om oxidatie van LDL te kunnen remmen; of 2) ze worden in het bloed omgezet in andere 
stoffen met minder of geen antioxidant activiteit. 
We konden niet meten hoeveel en in welke vorm fenolen in het bloed voorkomen. We 
konden wel schatten welke concentratie van fenolen in het bloed minimaal nodig is voor een 
effect op de oxidatie van LDL. In hoofdstuk 5 hebben we dat gedaan met behulp van een in 
vitro (reageerbuis) studie. Dat wil zeggen dat we in reageerbuisjes olijfolie-fenolen aan bloed 
hebben toegevoegd om te meten bij welke concentratie de LDL oxidatie werd bei'nvloed. De 
resultaten laten zien dat olijfolie-fenolen wel degelijk de LDL oxidatie kunnen remmen, maar dat 
de minimale hoeveelheid die nodig is veel groter is dan wat in bloed met het eten van olijfolie-
fenolen kan worden bewerkstelligd. In hoofdstuk 7hebben we de dagelijks inname van olijfolie-
fenolen in het Middellandse Zeegebied geschat en op basis daarvan een berekening gemaakt 
hoe hoog de concentratie van olijfolie-fenolen in het bloed zou kunnen zijn. En ook dan blijkt dat 
de concentratie waarschijnlijk te laag is om een effect op de LDL oxidatie te kunnen 
bewerkstelligen. 
Wij concluderen dan ook dat er op dit moment geen bewijs is dat olijfolie-fenolen de LDL 
oxidatie in mensen kunnen tegengaan. 
Dankwoord 
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Bedankt Martijn, ik heb met veel plezier met je samengewerkt!! 
Niet minder belangrijk was de hulp van co-promotor Peter Zock. Peter, wat ben ik blij dat je 
me in december 1996 belde om te informeren of ik interesse had in een project met 
plantensterolen. Nou en of! Ik vond het geweldig om met jou samen te mogen werken, jouw 
wetenschappelijke kennis is onuitputtelijk. Je deur stond altijd open en dat heb ik zeer 
gewaardeerd! Sinds kort ben je ook de wetenschap van het vaderschap ingeslagen, en ik wens 
je dan ook het allerbeste als wetenschapper en vader! 
Zowel het plantensterolen- als het olijfolieproject was in samenwerking met het Unilever 
Health Institute. Rianne Leenen en Annet Roodenburg, Sheila Wiseman, Karel van Putte, en 
Gert Meijer, bedankt voor de fijne samenwerking, voor het meedenken over de studie-opzetten 
en het bediscussieren van de resultaten, en natuurlijk voor de leuke, maar nuttige, tripjes naar 
Mediterrane oorden! En Eric Schuurbiers, ja ook jij wordt genoemd in het dankwoord! Jij hebt 
me de kneepjes van het LDL-oxidatie-vak bijgebracht in Vlaardingen! Dat was zeker heel 
leerzaam, maar we hebben ook erg veel lol gehad. Bedankt daarvoor! Ook alle andere 
Vlaardingers die hebben meegewerkt aan analyses en/of de productie van de margarines en 
verschillende olijfolie-supplementen: bedankt! Annet en Rianne, onze 4 maanden durende 'trio-
baan' was echt bijzonder en bovenal een heuse 'win-win' situatie! Bedankt voor jullie inleving 
en altijd motiverende woorden. Hopelijk komen we elkaar in de toekomst nog vaak tegen! 
Niet alleen in Vlaardingen werden analyses uitgevoerd, ook in Wageningen waren 
verschillende mensen actief! Peter van de Bovenkamp, Truus Kosmeyer, Dini Venema en 
Peter Hollman, bedankt voor jullie enorme inzet! Het waren geen eenvoudige analyses en ik 
ben erg blij dat het allemaal toch gelukt is! En eh... een voedingsdeskundige is nog geen 
chemicus; fijn dat jullie er altijd waren voor uitleg over analyses en de interpretatie van de 
gegevens! 
Ruud Hermus, Paul Smits, Hans Princen en Wim Jongen, bedankt voor jullie bijdrage in de 
begeleidingscommissie van het olijfolie-project. Tijdens de bijeenkomsten werd het project in 
een breder perspectief geplaatst en dat maakte de discussies voor mij zeer leerzaam. 
Prof. Kafatos, in December 1997 we visited Heraklion to talk about the study design of the 
double-study conducted in Wageningen and Heraklion. It was a good and useful meeting, and 
we learned the facts about olive oil by visiting several olive oil mills. But we also had the 
opportunity to enjoy the food like the people from Crete do! Thanks for your hospitality and your 
helpfulness whenever it was needed. 
En waar zouden we zijn zonder de diStisten! Els, Saskia, en Dieneke, er werden heel wat 
olijfolie-producten gefabriceerd en geproefd. Die olijfolie-koekjes moeten nog een keer de markt 
op! Bedankt voor alle hulp, gezelligheid, en voor het succesvol slagen van de proeven! 
Marleen, Arienne, Wilma, Brenda, Lisette en Caroline: Margarines uitdelen, koken, vroeg 
opstaan, rondsjezen in de auto, en het verwerken van biologisch materiaal, het hoorde er 
allemaal bij tijdens jullie afstudeervak. Bedankt voor jullie inzet en enthousiasme. Ik vond het 
leuk om met jullie samen te werken! 
Joke, Anita, en Jan, het bloedprikken liep altijd gesmeerd, al was dat soms wel een kwestie 
van plannen! Fijn dat er zoveel mogelijk was, en dat het allemaal goed is gelukt! 
Het leuke van voedingsonderzoek is de directe relatie met de mens. Om 
voedingsonderzoek te doen heb je ook mensen nodig. In totaal hebben 76 enthousiaste 
deelnemers aan de voedingsproeven meegedaan. De bezoekjes thuis en de maaltijden op de 
vakgroep waren altijd gezellig. En sommigen van jullie haalden zelfs het Actienieuws van 
SBS6! Maar ik vroeg nogal wat van jullie: het viel niet altijd mee om de enorme hoeveelheden 
margarine en die vele liters olijfolie of olijfolie-extracten naar binnen te werken!! Daarvoor kreeg 
ik vele liters bloed, urine of stomavloeistof terug, waaruit alle data in dit proefschrift afkomstig 
zijn. Het mag dus duidelijk zijn dat jullie moeite niet voor niks was, bedankt! 
Een van de hoogtepunten tijdens mijn AlO-periode was de organisatie van de buitenlandse 
studiereis naar Zuid-Afrika. Alida, Andre, Edine, Machteld, Margreet en Martijn, ik vond het 
geweldig om dit met jullie te ondememen en ik denk dat we van harte kunnen zeggen: het is 
geslaagd! Martijn van der Gaag, altijd met een lach en een goed humeur! Het is nog steeds niet 
te bevatten dat je er niet meer bent... Ik denk nog vaak aan je. 
Natuurlijk wil ik ook alle medewerkers van de Afdeling Humane Voeding en Epidemiologie 
bedanken voor hun bijdrage aan dit proefschrift op welke manier dan ook! En 'leuke collega's 
maken licht werk' (of hoe zeg je dat?!?). Margreet, Machteld, Edine, Liesbeth, Natasja, Juul, 
Nicole, Ingeborg, Saskia, Els, Annelies, Anouk, Floor, Mariska, Alida, Tiny, Jane, Frouwkje, 
Baukje, Rianne, Nynke, Marijke en alle andere collega's: bedankt voor alle gezellige uurtjes 
tijdens of buiten het werk! En Machteld, het was bijzonder om die laatste intensieve periode van 
ons AlO-schap samen met jou door te brengen. Bedankt voor je geweldige gastvrijheid, het 
was bere-gezellig!! 
Dear Jane, thanks for reading some parts of this thesis!! I appreciate that you had the time 
to read it carefully while you were so busy yourself! See you in Rotterdam! 
Werk is belangrijk, maar zeker zo belangrijk zijn mensen om je vrije tijd mee door te 
brengen. Bedankt lieve vrienden van Wageningen, Limburg, de afdeling, en de studie, voor alle 
leuke kletspraat, uitjes en gezelligheid! 
Marjan en Margreet, ik heb het getroffen met zulke paranimfen! Lieve Marjan, xie-xie wei le 
te-bie de you-yi!! Wat hebben we een lol gehad met het maken van de foto's voor de kaft!! En 
dat was nog maar een van die 'als vanouds' dagjes die we samen al hebben meegemaakt. Ik 
hoop dat er nog vele gaan komen, maar daar twijfel ik eigenlijk niet aan!! Lieve Margreet, steun 
en toeverlaat van '218'. Ik denk met veel plezier terug aan de lol die we hadden en aan al onze 
gesprekken, die niet alleen maar over fenolen en wortel-2 gingen!! Ik zeg '218' nu dan wel 
vaarwel, maar onze vriendschap zetten we gewoon voort, waar dan ook! 
En zo tussen de bedrijven door, waren er de weekendjes in Groningen. Jaap, Tineke, 
Saskia en Laurens, bedankt voor de gezelligheid! 
Lieve Papa en Mama, toen ik klein was riep ik: "Dat kan 6s Maudje wall", als het ging om 
het zingen van kinderliedjes. Maar '6s Maudje' had dit proefschrift nooit voor elkaar gekregen 
zonder jullie motivatie, steun en vertrouwen in mij! Ik ben er trots op dat ik dit proefschrift aan 
jullie op kan dragen. Rob en Willeke, het is altijd feest als we met z'n alien zijn! Hopelijk kunnen 
we dat nog lang zo voortzetten! En Oma Geurts en Oma Vissers, wat vind ik het bijzonder dat 
jullie bij deze gelegenheid aanwezig kunnen zijn!! 
And last but not least (... that's right!), wil ik jou bedanken, Wilfred! Jouw groningse 
nuchterheid kwam deze limburgse vaak goed van pas!! Een dikke knuffel voor het vertrouwen 
dat je altijd in me hebt gehad!! En nu kom ik echt naar het westen... 
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